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The related genes lin28a and lin28b code for conserved RNA-binding proteins, which 
contain two key RNA-binding motifs that determine their functions. Previously, our 
laboratory identified lin28a as a putative downstream target of FGF signalling in the early 
Xenopus embryo. This was found to occur at gastrulation stage, during which key signalling 
pathways such as the FGF pathway are active in specifying germ layer development. 
lin28 is a heterochronic gene in C. elegans and controls the timing of developmental 
events. In vertebrates, the lin28a gene shows pluripotent-specific expression, and has 
come to particular interest as one of four factors used to successfully re-program 
differentiated somatic cells into induced pluripotent stem cells. Both lin28a and lin28b 
have a high prevalence of ectopic expression in cancer. A well characterised target of both 
lin28a and lin28b is the microRNA let-7, inhibiting biogenesis to the mature microRNA 
form. The lin28 proteins have also been shown to potentiate translation of numerous 
mRNA targets. 
The aim of this project was to identify if lin28 has an important developmental role in 
vertebrates. Work in the Xenopus tropicalis embryo found that both lin28a and lin28b 
were targets of FGF signalling at gastrulation, and were required for correct germ layer 
patterning at this stage. In order to explore conservation in humans, mesenchymal stem 
cells were used to model the effects of FGF signalling upon the mesodermal germ layer, 
and whether lin28 played a role in this. Additional pluripotent cell models were 
investigated for their suitability in which to study lin28 function. Analysis of lin28 targets in 
Xenopus revealed that the miR-17-92 cluster family of miRNA may be positively regulated 
by the lin28 proteins, with a direct interaction possible with a member of these: pre-mir-
363. These miRNAs may have further important developmental roles in response to this 
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Chapter 1.  Introduction 
1.1 Fibroblast growth factor (FGF) signalling 
1.1.1 FGF signalling factors 
Fibroblast growth factors (FGFs) are a large family of polypeptide growth factors which are 
crucial signalling molecules that regulate many cellular functions, including cell 
proliferation, growth and differentiation. In humans and mice, the FGF family consists of 
22 known FGFs (Ornitz and Itoh, 2001); Xenopus tropicalis has been discovered to express 
orthologues to 20 of these, lacking clear orthologues to FGF-17 and FGF-18 (Lea et al., 
2009).  
FGF ligands share a conserved internal core, but also contain unique domains which result 
in differing functional roles, along with having different temporal and spatial expression 
patterns. For example, human FGF-4 is found only in embryonic tissue, whereas FGF-2 is 
expressed throughout embryonic and adult development (Ornitz and Itoh, 2001). The FGFs 
can be grouped into subfamilies, based on their different structures and expression (Itoh 
and Ornitz, 2004) (Table 1.1). Many FGF subfamilies contain N-terminal signal peptides and 
are secreted, whereas some are able to be secreted without secretion signal peptides 
(FGF-9 subfamily). FGF-22 contains a secretion signal like other members of its subfamily, 
but remains adhered to the cell surface rather than being secreted. FGF-1 and FGF-2 also 
lack a signal peptide, but can be released from cells following damage. Most FGF ligands 
are typically found in the extracellular matrix and function by binding to extracellular 
domains of transmembrane FGF receptors (FGFRs), but this is not the case for some FGFs; 
the FGF-19 subfamily members show very weak activity in activating the FGFRs, and are 
suggested to act in an endocrine fashion (Zhang et al., 2006). Additionally, the FGF-11 
subfamily ligands are not secreted, and may act intracellularly although no pathway for 
this is currently understood (Ornitz and Itoh, 2001). 
  Introduction 
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Table 1.1 FGF subfamily classifications for humans 
FGF subfamily FGF ligands Characteristics 
FGF-1  FGF-1, FGF-2 Not secreted, but are released from 
cells 
FGF-4 FGF-4, FGF-5, FGF-6 Secreted 
FGF-7 FGF-3, FGF-7, FGF-10, FGF-22 Secreted except for FGF-22 
FGF-8 FGF-8, FGF-17, FGF-18 Secreted 
FGF-9 FGF-9, FGF-16, FGF-20 Secreted, though no N-terminal 
sequences 
FGF-19 FGF-19, FGF-21, FGF-23 Secreted, but only weakly activate 
FGFRs 
FGF-11 FGF-11, FGF-12, FGF-13, FGF-14 
Do not signal through FGFRs, remain 
intracellular 
Information on FGFs collected from Itoh and Ornitz (2004), Zhang et al. (2006) and Ornitz and 
Itoh (2001). 
The FGFR family in humans contains four closely related members, FGFR1-4 (Johnson and 
Williams, 1993), transmembrane receptors which contain intracellular tyrosine kinase 
domains, and extracellular receptor domains which contain three immunoglobulin (Ig)-like 
domains. The Ig-like domains are subject to alternative splicing and modulate specificity 
for FGFs, with splice variants showing preferences for the binding of particular ligands 
(reviewed in Bottcher and Niehrs, 2005; Zhang et al., 2006). The binding of FGF ligand 
causes receptor dimerisation, with the formation of both homodimers and heterodimers 
of the FGFRs 1-4 depending on the ligand and cell type. This results in cross-
phosphorylation of the intracellular domains and activation of downstream signalling 
cascades through the phospho-tyrosine residues. The FGF-FGFR interaction is stabilised by 
the binding of heparin or heparan sulphate proteoglycans (HSPGs), which bind 
preferentially to the dimerised FGF-FGFR complex (Ornitz and Itoh, 2001) (Figure 1.1). 
1.1.2 FGF signalling pathways 
Much of the downstream activity of FGF signalling is activated by proteins containing a Src 
homology 2 (SH2) domain, which recognises phospho-tyrosine residues (Pawson et al., 
1993). Proteins containing these domains can be both adaptor proteins, which transduce 
signals to downstream pathways, and catalytic proteins capable of carrying out activities 
once activated via the domain. There are three major pathways activated by FGFRs, which 
are described below (Figure 1.1) (reviewed in Bottcher and Niehrs, 2005). 
One of the main downstream signalling pathways activated by FGF is the mitogen-
activated protein kinase (MAPK) pathway. The FGFR substrate 2 (FRS2) protein is 
associated with FGFRs and contains phosphorylation sites which are targeted by the 
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activated FGFRs (Kouhara et al., 1997). Once phosphorylated, FRS2 binds the adaptor 
protein Grb2, which further recruits and forms a complex with son of sevenless (SOS), a 
nucleotide exchange factor (Hadari et al., 2001). In this complex, SOS then acts on a GTP 
binding protein, Ras, which interacts with Raf (Dent et al., 1992). Raf is a serine/threonine 
kinase protein that stimulates the MAPK cascade, phosphorylating MEK which then 
phosphorylates MAPK/ERK (Gomez and Cohen, 1991). MAPK/ERK then phosphorylates 
transcription factors, including ETS proteins and c-myc, which relocate to the nucleus and 
activate gene transcription (Wasylyk et al., 1998). The MAPK pathway is commonly 
activated by other growth factor pathways too, including epidermal growth factor and 
nerve growth factor. 
A second pathway activated by FGF signalling is the phospholipase Cγ (PLCγ) and calcium 
release pathway. PLCγ is an enzyme activated following recruitment to the phosphorylated 
FGFRs (Mohammadi et al., 1991). Once activated, it hydrolyses phosphatidylinositol 4,5-
bisphosphate to inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 is soluble 
and stimulates the release of intracellular calcium from sites such as the endoplasmic 
reticulum. DAG activates protein kinase C (PKC), promoting its translocation to the 
membrane; PKC is additionally activated by calcium and can perform a variety of roles in 
the cell. 
The third major pathway activated downstream of FGF signalling acts via 
phosphoinositide-3 kinase (PI3K), which is activated via the FGFRs or Grb2 (Hadari et al., 
2001). A main component of this pathway which is activated is Akt/protein kinase B, a 
serine/threonine kinase (Carballada et al., 2001). 




Figure 1.1 FGF signalling pathways within the cell 
Intracellular signalling pathways following the activation of FGFRs by ligand binding.  The 
FGF:FGFR:heparin/HSPGs complex activates receptor phosphorylation. FRS2 is phosphorylated 
and activates the adaptor Grb2. This associates with SOS which activates Ras. Ras activates Raf 
which sets off the chain of phosphorylation to MEK and MAPK, which activates transcription 
factors (Tfs). Alternatively, PLCγ binds FGFRs and hydrolyses phosphatidylinositol 4,5-
bisphosphate to DAG, which activates PKC, and IP3, causing the release of calcium. FRS2/Grb2 
also activate PI3K, which activates Akt.  
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1.1.3 FGF signalling in patterning the mesoderm 
FGF signalling is involved in patterning the vertebrate embryo (Bottcher and Niehrs, 2005), 
in particular the induction of mesoderm differentiation, which has been well studied in 
Xenopus (Isaacs, 1997). Mesoderm is one of the primary germ layers along with ectoderm 
and endoderm, and is the precursor for differentiation into mesenchymal cell types, which 
includes muscle, bone and haematopoietic cells.  
Mesoderm formation in embryos is initiated by signals from the vegetal pole. There are 
two signals, a dorsal signal and a ventral signal, which induce the marginal zone to form 
dorsal and ventral mesoderm respectively. Explants of cells taken from the animal cap, the 
top cells of the animal hemisphere, are not capable of developing into mesoderm without 
the vegetal pole to provide signals, or the signals provided exogenously. Another dorsal 
signalling centre is established in the marginal zone, known as the Spemann organiser. This 
releases signals to pattern the dorso-ventral axis of the mesoderm and to induce neural 
specification in the ectoderm (Figure 1.2). As FGF treatment could induce the development 
of mesoderm in animal cap cells (Slack et al., 1987), it  was suggested that this was one of 
the vegetal signals. The FGF pathway was found to be required for both the formation and 
maintenance of the mesoderm  (Cornell and Kimelman, 1994), and an inhibition of FGF 
signalling through the use of a mutant receptor lacking the tyrosine kinase domain which 
inhibited downstream signalling resulted in the development of much of the mesoderm 
being lost (Amaya et al., 1991). However, this inhibition was seen to result in disturbed 
lateral and ventral mesoderm, rather than a complete loss, indicating it is not the primary 
inducer of mesoderm. FGF was later discovered to be acting as a competence factor, 
enabling cells to respond to activin (Cornell et al., 1995), and is expressed within the 
marginal cells and developing mesoderm, rather than the vegetal cells (Isaacs, 1997; Isaacs 
et al., 1994). 




Figure 1.2 Early developmental signals in Xenopus development 
A model of signals for germ layer induction. Dorsal and ventral signals from the endoderm 
induce dorsal and ventral mesoderm development from the marginal zone. Spemann's 
organiser signals are then released; these are further signals to the marginal zone to dorsalise 
mesoderm, and neural inductive signalling to the ectoderm.  
FGF signalling is required not just to induce mesoderm, but also to maintain and pattern it. 
An early pan-mesodermal marker, brachyury, is a target of FGF signalling (Amaya et al., 
1993), and brachyury is  in turn able to activate expression of FGF, to create an 
autocatalytic loop (Isaacs et al., 1994). This regulation of brachyury is both an early 
mesoderm-specification event, and also occurs throughout gastrulation to maintain 
mesoderm. FGF signalling acts to pattern the dorso-ventral axis in the mesoderm, with 
high FGF levels driving dorsal structures (Furthauer et al., 1997; Isaacs et al., 1994). 
This work has also been confirmed in other species. Active FGF signalling is needed for the 
proper migration of cells through the primitive streak of both mouse and chick (Chuai et 
al., 2006; Ciruna et al., 1997), with expression of brachyury, or T as it is also known, found 
in the developing mesoderm (Herrmann and Kispert, 1994; Schulte-Merker et al., 1994), 
and regulated by FGF signalling (Ciruna and Rossant, 2001). 
1.1.4 FGF in patterning neural tissue 
FGF is also involved as a signalling factor originating from the organiser which induces 
neural development. Ectoderm will only develop neural fates in the absence of bone 
morphogenetic protein (BMP) signalling, and key neural inducers expressed by the 
organiser include the BMP antagonists noggin and chordin (Piccolo et al., 1996; 
Zimmerman et al., 1996). FGF signalling can antagonise BMP signalling (Streit and Stern, 
1999), through phosphorylation of Smad-1, a downstream effector of BMP, by the MAPK 
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pathway (Pera et al., 2003), and noggin and chordin have additionally been identified as 
targets of FGF (Branney et al., 2009). However, the inhibition of BMP signalling alone is not 
sufficient for neural induction; results in the chick embryo indicated that active FGF 
signalling was needed along with BMP inhibition to drive neural fates (Streit et al., 2000). 
1.1.5 Identification of FGF targets during gastrulation 
Early specification of the mesoderm occurs during gastrulation, and it is just prior to this 
stage of development that FGF signalling is first active, signalling through the MAPK 
pathway (Branney et al., 2009; Christen and Slack, 1999; Lea et al., 2009). At this time of 
tissue induction, signals are required to drive differentiation in the correct manner, and it 
is known than FGF signalling has an effect on subsequent expression of numerous genes to 
alter cell fate. A number of gene targets for FGF signalling at this time have been long 
known, but previous work in our group was carried out to identify more targets. Branney 
and colleagues (2009) inhibited FGF signalling in Xenopus embryos through the use of 
dominant negative receptors lacking the tyrosine kinase domains, which therefore could 
not activate intracellular pathways. Embryos were studied during the important signalling 
stage of gastrulation, with comparisons between the resultant transcriptomes of control 
and FGF-inhibited embryos; the study highlighted multiple genes which have been 
previously validated as FGF targets, but also newly identified other downstream targets. 
Some validation was carried out, confirming genes such as ephrin receptor A4 and a 
Xenopus homologue to DUSP5, a target in other systems, as positively regulated FGF 
genes. There were 67 genes found to be significantly down-regulated upon FGF inhibition, 
and 16 genes were increased in expression, indicating there are more positively regulated 
targets of FGF than negatively ones regulated at this time. One gene of potential interest 
was lin28a, which showed a 2.7 fold repression, suggestive of being a positively regulated 
FGF target; lin28a is a pluripotency marker expressed in stem cells (Richards et al., 2004), 
and this gene is discussed further in 1.2. 
1.1.6 FGF and embryonic stem cells 
One function of FGF that has yet to be fully understood is its role in embryonic stem (ES) 
cell culture. For human ES cells, FGF has been shown to be required in culture conditions 
to maintain the cells in a pluripotent, undifferentiated and proliferative state, with 
inhibition of this pathway resulting in cell differentiation (Amit et al., 2000; Dvorak et al., 
2005; Levenstein et al., 2006; Vallier et al., 2005; Xu et al., 2005). This role in ES cells 
appears despite FGF signalling being previously identified as primarily a differentiation 
factor. The role in which FGF is acting in ES cells principally remains unknown; the 
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experimentation using inhibition of FGF signalling results largely in differentiation of the 
cells (Eiselleova et al., 2009; Vallier et al., 2005) and it is therefore difficult to distinguish 
between direct effects downstream of FGF signalling and wider indirect effects caused by 
subsequent differentiation. Active FGF signalling was found to be required for maintained 
expression of pluripotent genes such as Oct-4 and Nanog, and enhancement of cell 
survival and adhesion, all contributing to sustained growth and pluripotency (Eiselleova et 
al., 2009; Greber et al., 2010). ES cells are commonly grown on mouse embryonic 
fibroblasts (MEFs) as a feeder layer, and increases in FGF dosage can negate the need for 
this. One theory for how this promotes pluripotency is that active FGF signalling blocks 
BMP signalling, which would otherwise be driving differentiation, by synergising with the 
BMP antagonist noggin (Xu et al., 2005). It has further been shown that maintaining 
pluripotency with FGF culture only occurs when there is Activin or Nodal signalling also 
active (Vallier et al., 2005), transforming growth factor β (TGFβ) ligands that affect 
different pathways to BMP, although the downstream effectors of these pathways are also 
largely unknown in promoting pluripotency. 
This requirement for FGF in culturing human ES cells is in stark contrast to mouse ES cells, 
which do not require FGF supplementation for their continued growth, but instead grow in 
the presence of leukaemia inhibitory factor (LIF) and BMP (Ying et al., 2003). The culture 
conditions for human ES cells more accurately match those required for murine stem cells 
collected from the more restricted epiblast (epiSCs), later in embryonic development, 
which require FGF to maintain undifferentiated growth (Alberio et al., 2010; Brons et al., 
2007; Tesar et al., 2007). It is believed that these epiSCs represent a more primed state of  
differentiation compared to the more naïve ES cells, with restrictions on their 
differentiation potentials (Nichols and Smith, 2009). Differences in responses to FGF 
signalling is believed to be a key factor in these differentiation states, with naïve cells 
showing less of a propensity to differentiate following inhibition of FGF signalling, although 
it is not fully understood why (Hanna et al., 2010). Work has also shown that while both 
human ES cells and murine epiSCs require exogenous FGF for growth, the downstream 
effects of this treatment do differ, with this signalling required for Nanog expression in the 
ES cells thus being linked to pluripotency maintenance, but not in epiSCs (Greber et al., 
2010). 
There is low-level autocrine or paracrine FGF signalling in human ES cells (Eiselleova et al., 
2009) but there is a different innate self-renewal programme in mouse ES cells, which 
causes them to respond differently to exogenous FGF. It is suggested that mouse ES cells 
produce higher levels of FGF, and require culturing with LIF and BMP to repress the 
resultant ERK signalling (Ying et al., 2008). FGF signalling and ERK activation have been 
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shown to promote differentiation in mouse ES cells (reviewed in Villegas et al., 2010), into 
lineages including trophectoderm (Schenke-Layland et al., 2007), mesoderm (Willems and 
Leyns, 2008), neural (Kunath et al., 2007) and endoderm (Funa et al., 2008). This all 
indicates that further understanding of the nature of ES cells is required. Much of the 
downstream effects of FGF in inducing differentiation appear to function via the ERK 
pathway (Kunath et al., 2007; Stavridis et al., 2007; Yoshida-Koide et al., 2004). 
Due to the multiple FGF ligands found in species, particular effects may be attributed to 
specific ligands. FGF-4 is an important embryonic FGF ligand, expressed within the inner 
cell mass (ICM) of the embryo (Niswander and Martin, 1992), as well as in ES and 
embryonal carcinoma (EC) cells. Expression of FGF-4 is driven by the pluripotency factors 
Sox2 and Oct-4 (Yuan et al., 1995). In vivo, FGF-4 was shown to be required for 
proliferation of the ICM in the mouse embryo, from which ES cells are derived (Feldman et 
al., 1995); however, FGF-4 null ES cells are able to self-replicate and differentiate (Wilder 
et al., 1997), indicating that the function of FGF may differ depending upon cell state. FGF-
4 in murine ES cells was shown to be required for driving neural and mesodermal lineage 
differentiation (Kunath et al., 2007), and also to be involved in specifying trophectoderm 
(Schenke-Layland et al., 2007).  
1.1.7 FGF and other stem cells 
The culture of other multipotent stem cells does not show a requirement for FGF 
supplementation; however supplementing media with FGF-2 has been shown to boost 
culture in some cases. 
Multipotent mesenchymal stromal/stem cells (MSCs) showed an increased rate of 
proliferation following exposure to exogenous FGF-2, inhibiting cellular senescence; they 
also showed the ability to be cultured for longer periods of time and maintained an 
elongated morphology with FGF treatment (Coutu et al., 2011; Martin et al., 1997; 
Solchaga et al., 2005; Tsutsumi et al., 2001). Exposure to FGF-2 also increased the potency 
of the MSCs; cells showed enhanced osteogenic potential when expanded in FGF-2 before 
being treated to differentiate, producing higher levels of mineral deposits and expressing 
increased levels of bone markers (Martin et al., 1997; Pri-Chen et al., 1998; Tsutsumi et al., 
2001). Chondrogenesis differentiation was also elevated with FGF-2 treatment (Solchaga 
et al., 2005; Tsutsumi et al., 2001), but adiopogenic differentiation was not improved. 
These effects of both promoting undifferentiated growth and increasing osteogenic 
differentiation are believed to reflect differing roles for FGF signalling based upon the 
maturity of the cell (Lai et al., 2011). FGF-2 treatment in MSCs activates both the MAPK 
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and PI3K pathways, which are involved in the promotion of proliferation and prevention of 
senescence (Choi et al., 2008; Coutu et al., 2011). Research using the overexpression of 
FGFR2 in MSCs found phosphorylation of ERK and activation of PKC signalling, both of 
which were demonstrated to be involved in promoting osteogenesis (Miraoui et al., 2009). 
MSCs treated with FGF-4 have also been found to exhibit increased proliferation rates 
(Choi et al., 2008; Farre et al., 2007). 
Haematopoietic stem cells (HSCs) are another type of multipotent stem cell derived from 
the bone marrow, and display a limited potential in cell culture, with population renewal 
potential lost rapidly. It was found that culturing these cells with the addition of FGF-2 or 
FGF-1 increased the number of cells with stem cell activity, thus supporting HSC growth 
(Gabbianelli et al., 1990; Yeoh et al., 2006). However, alternative work indicated that FGF 
was not working directly on the haematopoietic progenitors, and must be having the 
effect by an indirect method (Berardi et al., 1995). Indeed, the HSCs that showed boosted 
growth with FGF treatment by Yeoh and colleagues (2006) were not purified HSCs, with 
the growth of purified HSCs not being supported by FGF treatment. More recent work has 
indicated that it is MSCs present in the bone marrow that are responsible for supporting 
HSC growth in a response to FGF treatment, with MSCs also being expanded in population 
size (Itkin et al., 2012). 
Clonal growth was also induced in neural stem cells, isolated from the adult mouse brain 
and capable of forming astrocytes, oligodendrocytes and neurons, following FGF-2 
treatment; the cells formed proliferating spheres from individual precursor cells (Gritti et 
al., 1996). In addition, FGF-2 was found to promote proliferation of neural precursors, 
particularly cells restricted to the neuronal fate, in which it also increased differentiation 
(Ray et al., 1993; Reynolds and Weiss, 1992; Richards et al., 1992). Both the MAPK and 
PI3K pathways were again found to contribute to the increased proliferation of these 
neural progenitor cells (Jin et al., 2005; Learish et al., 2000). 
1.2 lin28 
1.2.1 The lin28 genes 
The discovery of lin-28 identified it as a heterochronic gene in Caenorhabditis elegans, 
where mutations causing a loss of function resulted in precocious development (Ambros 
and Horvitz, 1984). lin-28 was identified as a cytoplasmic protein containing both a cold-
shock domain (CSD) and zinc finger motifs, two known RNA-binding domains (Ambros and 
Horvitz, 1984; Moss et al., 1997) (Figure 1.3).  
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In humans and many other vertebrates, there are two related lin28 genes: lin28a and 
lin28b, which code for the only proteins known to contain both these CSD and zinc finger 
motif RNA-binding domains.  Sequence identity conservation in humans between these 
two proteins is 52.3%, and is highest within the RNA-binding domains and lower in the 
disordered N- and C-termini. lin28b is a much larger protein than lin28a; this difference is 
mainly contributed to by a long C-terminus region (Figure 1.3, Figure 1.4A). Splice variants 
for both genes exist for a small number of species, and one of these is Xenopus where 
there are two isoforms of lin28a, these share 94.9% identity and differ only by a few amino 
acids at the N-terminus (Figure 1.3, Figure 1.4B). As for C. elegans, Drosophila 
melanogaster only contains one copy of the lin-28 gene, and consequently only a solo lin-
28 protein. Homology between species for both lin28a and lin28b proteins is apparent 
within the RNA-binding domains, with less sequence conservation within the C- and N-
termini (Figure 1.4C, D); this has directed much of the research focus on these proteins to 
concentrate on functions of the conserved RNA-binding domains, thought to impart the 
biological activity of these proteins. The lin28 proteins show high homology between 
mammalian species, with 96.7% conservation found between the human and mouse 
lin28a protein. Sequence similarity percentages for the lin28a and lin28b proteins are 
given below for a selection of species that do not contain splice variants for either gene, 
with the exception of X. tropicalis (Table 1.2, Table 1.3). 
 
Figure 1.3 Structure of lin28 proteins 
Pictorial representation of lin28 protein structures in X. tropicalis, indicating locations of the 
RNA-binding domains CSD and zinc-finger motifs. 
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Figure 1.4 Alignments of lin28 protein sequences 
Alignments of lin28 protein sequences, arranged in Clustal.  A) Human lin28a and lin28b 
proteins, B) Xenopus lin28a1 and lin28a2, grey sequence shows non-conserved region, C) X. 
tropicalis lin28a1, human lin28a, and C. elegans lin-28, D) X. tropicalis and human lin28b.  
vvvv
 = 
cold shock domain, ^^^^ = zinc finger motifs. Underlying graph shows level of conservation 
between sequences (A, C, D). 
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Table 1.2 Percentage conservation between lin28a proteins 































































































Human 19.1 34.3 61.2 64.6 64.9 79.4 93.8 96.7 
M. musculus  26.5 34.8 61.2 64.6 64 80.4 95.7  
B. taurus  26.5 35.2 62.9 66.3 65.2 82.4   
G. gallus  27.6 37.1 64.9 68.3 66.5    
D. rerio  27.1 33.7 62 61.5     
X. tropicalis a1 27.3 36.4 94.9      
X. tropicalis a2 26.5 36.4       
D. melanogaster lin-28  28.2        
Percentage of sequence conservation between lin28a proteins from varying species, with the 
exceptions of C. elegans and D. melanogaster, which only have one lin-28 protein. Species 
selected for comparison all had confirmed protein sequences and, with the exception of 
X. tropicalis, were without multiple isoforms. Percentage conservation calculated using Vector 
NTI (Invitrogen). 
  




Table 1.3 Percentage conservation between lin28b proteins 

















































Human  25.5 32.1 78.7 82.5 76.7 78.1 
M. musculus  22.6 29.2 65 69 67.6  
B. taurus  24.3 29.5 66.7 69.5   
G. gallus  26.6 29.2 83.8    
X. tropicalis  25.1 30.3     
D. melanogaster lin-28 28.2      
Percentage of sequence conservation between lin28b proteins from varying species, with the 
exceptions of C. elegans and D. melanogaster, which only have one lin-28 protein. Species 
selected for comparison all had confirmed sequences and were without multiple isoforms. 
Percentage conservation calculated using Vector NTI (Invitrogen). 
1.2.2 lin28 structure 
Both of the characterised domains of lin28 proteins are RNA-binding domains. The CSD of 
the lin28 proteins is homologous to regions in bacterial cold shock proteins and eukaryotic 
Y-box proteins, and contains the RNA-binding motifs RNP-1 and RNP-2 (Ermolenko and 
Makhatadze, 2002; Moss et al., 1997). CSDs commonly fold into five-stranded β barrels; 
the CSD in lin28a and lin28b contain key differences to vertebrate Y-box proteins, with 
differences in areas of β strands that are known to contribute to binding capabilities 
(Ermolenko and Makhatadze, 2002; Moss and Tang, 2003). The zinc finger motifs contain 
the characteristic CCHC cysteine and histidine motifs and have been found to show 
homology to retroviral nucleocapsid proteins which package viral genomic RNA, 
particularly the HIV-1 nucleocapsid NCp7  (Desjardins et al., 2011; Moss et al., 1997). The 
zinc fingers are flanked by basic amino acids, with a lysine/arginine-rich domain similar to 
NCp7, and these basic amino acids influence the binding of RNA (De Rocquigny et al., 
1993; Desjardins et al., 2011). A flexible linker is present between the RNA-binding 
domains and lacks defined structure; this may allow the protein to bend around RNA 
targets to bind multiple target sites within one RNA sequence, with the linker allowing 
varying differences in the distances between the sites (Nam et al., 2011). This linker region 
is believed to contain a nucleolar localisation signal for lin28b (Piskounova et al., 2011). 
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There has not yet been any structural analysis of the N- and C-termini of the lin28 
proteins; however, with potential functions being mediated by these domains (Jin et al., 
2011), it is clear that further characterisation of them is needed to be certain of the 
function of the proteins. With the extension seen in the C-terminus of lin28b compared to 
lin28a, it is likely that this does impart some different physiological functions upon the 
proteins. One of these differences is the inclusion in this region of a nuclear localisation 
signal (Piskounova et al., 2011), but it is likely that there are further key differences in 
these domains that may control functions. 
The Sliz group were the first to crystallise part of the lin28a protein, a truncated form of 
the protein lacking the N- and C-termini (Nam et al., 2011). This was a landmark 
development as difficulties had previously been reported with purification due to 
aggregations using the full length protein (Balzer and Moss, 2007; Desjardins et al., 2011); 
the crystallisation was only possible when the protein was bound to target RNA, which 
allowed an in-depth analysis of the way in which the protein interacted with the RNA, and 
this is discussed further in 1.3.7.  
1.2.3 lin28 and pluripotency 
lin28a was found to be expressed in pluripotent cells and downregulated upon 
differentiation (Darr and Benvenisty, 2009; Moss and Tang, 2003; Polesskaya et al., 2007; 
Richards et al., 2004), although expression in mice was found to persist in the adult in 
particular tissues including cardiac cells, gut epithelial cells, and some kidney structures, all 
rapidly regenerating cell types (Yang and Moss, 2003).  
The lin28a gene emerged to wider interest when it was used as one of four factors, along 
with Oct-4, Sox2 and Nanog to successfully re-program somatic cells into cells resembling 
ES cells, known as induced pluripotent stem (iPS) cells (Yu et al., 2007); however, another 
group found that cells could be re-programmed with an alternative set of four genes, with 
the substitution of Klf4 and c-myc in place of lin28 and Nanog, although they did not 
examine lin28 as a candidate gene (Takahashi et al., 2007; Takahashi and Yamanaka, 
2006). Nanog and lin28 were both shown to improve the efficiency of re-programming (Yu 
et al., 2007), with Oct-4 and Sox2 the critical components for re-programming, having 
been selected for use by both the Yamanaka and Thomson groups. Oct4 and Sox2 are both 
transcription factors that target numerous pluripotency genes, with expression of both 
required to maintain pluripotency (Masui et al., 2007), and Nanog expression is required 
for stem cells to have true 'ground-state pluripotency' (Silva et al., 2009). It is not fully 
understood what lin28a contributes to promoting re-programming, and why its omission is 
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not detrimental to the process, but numerous targets of lin28a have been identified that 
are involved in the maintenance of pluripotency and may be key for re-programming. 
1.2.4 lin28 expression in the cell 
The expression of lin28a in the cell is most commonly reported in the cytoplasm (Moss et 
al., 1997; Piskounova et al., 2011; Qiu et al., 2010; Sakurai et al., 2012), however in some 
cell types it has also been reported in the nucleus or nucleolus (Balzer and Moss, 2007; 
Polesskaya et al., 2007). Expression of lin28a in the cytoplasm has been found in localised 
foci (Balzer and Moss, 2007), which is discussed more in relation to its function in section 
1.2.5. Levels of nuclear lin28a were increased when RNA-binding domains were mutated, 
leading to the suggestion that lin28a is present in the nucleus to associate with mRNA, 
which it then shuttles to the cytoplasm (Balzer and Moss, 2007). Expression of lin28b was 
first reported in hepatocarcinoma cells predominantly in the cytoplasm, although in a very 
small proportion of cells there was also nuclear expression (Guo et al., 2006). Nuclear 
expression was again seen in a different carcinoma cell line, where expression was further 
detected in the nucleolus; the group identified both nuclear and nucleolar localisation 
sequences within the protein (Piskounova et al., 2011).   
1.2.5 Functions of lin28  
In C. elegans, lin-28 translation is repressed by lin-4, the first microRNA (miRNA) to be 
discovered, and let-7, another miRNA (Moss et al., 1997; Reinhart et al., 2000). It 
continues to be repressed in mammalian cells by the family of let-7 miRNAs, and the lin-4 
homolog miR-125 (Moss and Tang, 2003; Wang et al., 2012). These target the 3' 
untranslated region (UTR), and prevent protein synthesis. 
The lin28 proteins interact with both mRNA and miRNA in the cell. One target of lin28, 
which has been highly characterised, is the miRNA let-7; this will be discussed further in 
sections 1.3.6 and 1.3.7. This regulation results in a negative feedback loop. lin28 proteins 
additionally target multiple mRNAs and positively regulate translation of these. 
Within the cytoplasm lin28a associates in mRNA and protein complexes with other 
proteins including poly(A) binding protein and the initiation factor eIF3β, and with actively 
translating polysomes; the association with components of these complexes is generally 
dependent on the presence of mRNA, with the exception of eIF3β, which was seen to 
remain bound to lin28 in the absence of mRNA, although the importance of this 
interaction is not yet understood (Balzer and Moss, 2007; Polesskaya et al., 2007). It has 
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been found that with these interactions with the polysomes, lin28a promotes the 
association of target mRNAs, thus aiding their translation (Jin et al., 2011; Polesskaya et al., 
2007). However, the mere association of mRNA with polysomes via lin28 interaction is not 
sufficient to improve translation, and the recruitment of RNA helicase A (RHA), a 
ubiquitously expressed RNA helicase that is involved in translation, is proposed as a 
mechanism for this; lin28 binds to both the C- and N-termini of RHA and recruits it to 
polysomes with target mRNA, which then functions to increase translation (Jin et al., 
2011), and a loss of RHA diminishes the ability of lin28s to promote translation (Qiu et al., 
2010). Interestingly, the unstructured C-terminus of lin28 is important for this interaction 
with RHA, allowing concurrent interaction with target mRNA via the RNA-binding domains 
(Jin et al., 2011).  
Identification of mRNA targets of lin28 are helping to identify what role lin28 is playing 
during pluripotency. One target which shows enhanced translation with lin28 is Oct-4, a 
key pluripotency marker (Qiu et al., 2010), with further regulation being exhibited over cell 
cycle and proliferation genes; inhibition of lin28a expression in stem cells prevented cells 
from entering mitosis, with a stimulated growth rate following lin28 overexpression (Xu 
and Huang, 2009; Xu et al., 2009). Immunoprecipitation experiments carried out by the 
Huang group have generated a large list of potential mRNA targets for lin28, many of 
which have functions in metabolism and ribosomal function, which can affect the rate of 
cell cycle (Peng et al., 2011). Particular targets have been confirmed as including Histone 
H2A, cyclins A and B, and cdk4 (Xu and Huang, 2009; Xu et al., 2009). The cyclins and cdk 
genes are important genes in controlling the rapid cell cycle in ES cells, which is important 
in the process of self-renewal (reviewed in White and Dalton, 2005). This effect upon the 
cell cycle has also been seen in cancer cells, where a loss of lin28 reduced proliferation and 
the number of cells entering S-phase; there was also a loss in expression of CDC25a, which 
is involved in S-phase transition (Pan et al., 2011). 
Although primarily a pluripotency marker, lin28a expression and regulation of particular 
mRNA targets is important during the differentiation of particular tissue types. Insulin-like 
growth factor-2 (IGF-2) is a target of lin28, with translation enhanced by lin28 during 
skeletal muscle development (Polesskaya et al., 2007). lin28 also promotes neurogenesis, 
at the expense of glial development; this process was found to be let-7 independent, and 
although IGF-2 was showing regulation by lin28 at this time, this was not confirmed as the 
primary target that was mediating the neuron-inducing effects (Balzer et al., 2010). lin28 is 
further required for development of primordial germ cells, through the regulation of let-7 
(West et al., 2009), and expression has been found of lin28b, but not lin28a, in foetal HSCs, 
with an overexpression of lin28a in adult HSCs generating increased B-cells and T-cells 
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similar to those developing from foetal HSCs, indicative of a role in lymphopoiesis (Yuan et 
al., 2012). 
Early work by the Huang group could not find a common consensus for lin28 binding in all 
of their identified mRNA targets, and as such they proposed that lin28 recognises RNA 
structural features more than a specific sequence (Peng et al., 2011). This has further been 
identified to be partially true, with lin28 recognising an 'A' bulge flanked by GC pairs 
forming part of a stem structure; this was not a purely structural recognition, however, as 
mutations of the 'A' to a 'U' did not alter the structure of the RNA, but did reduce binding 
affinity to lin28 (Lei et al., 2012). Work has suggested that it is the zinc finger motifs in 
lin28 that are predominantly responsible for binding to the mRNA and promoting 
translation, with mutations in these regions causing a reduction in association with both 
mRNA and polysomes (Balzer and Moss, 2007; Lei et al., 2012). This is different to the 
manner in which it recognises and binds miRNA, which is discussed more extensively in 
section 1.3.7. 
Separate cytoplasmic expression of lin28 has been found in foci, which were characterised 
as P-bodies (Balzer and Moss, 2007); these are RNA granules in which mRNA can be 
degraded and decapped, repressed by miRNAs, or merely stored pre-translation. 
Expression in P-bodies does not co-localise with poly(A) binding protein or polysomes, 
indicating multiple functions for the protein, although it is not yet clear what role lin28 has 
in the P-bodies. 
1.2.6 The involvement of lin28 in cancer 
The role of lin28 in maintaining undifferentiated cells is reflected in the observation of 
increased levels of lin28a and lin28b in many cancers arising from different cell types, 
including lung, colon, prostate, breast, germ cell and cervical cancer (Cao et al., 2011; King 
et al., 2011; Nadiminty et al., 2012; Pan et al., 2011; Sakurai et al., 2012; Viswanathan et 
al., 2009; West et al., 2009), with these findings being shown in both primary tumours and 
transformed cell lines. Piskonuova and colleagues (2011) found that in transformed cell 
lines derived from tumours, lin28a or lin28b was expressed in most of the cell lines 
studied, but never together, leading them to conclude the expression of these was likely to 
be mutually exclusive in cancer cells. There have also been further reported cases of 
cancer cells expressing just one of the lin28 genes (Pan et al., 2011); however, other work 
suggests that the two genes may be expressed together in some forms of cancer (Sakurai 
et al., 2012; Viswanathan et al., 2009), and it may simply be that there is a level of 
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redundancy in the genes, with both having the same effect upon cancer, and thus ectopic 
expression of either lin28a or lin28b is sufficient.  
Correspondingly, a reduction in levels of let-7 has been found in cancer and, with the lin28 
expression data, the oncogenic activities of lin28a and lin28b have largely been attributed 
to their suppression of let-7 levels. There is a correlation of high lin28 levels with low let-7 
levels in many cancers studied, with downstream effects being rapid proliferation, 
increased migration and increased invasiveness of cells (Nadiminty et al., 2012; Pan et al., 
2011; Viswanathan et al., 2009). As this function is attributable to both lin28a and lin28b, 
this may explain why expression of these are commonly mutually exclusive in cancer.  This 
increase in lin28 and decrease in let-7 promotes the transformation of cancer cells, and 
their return to a more undifferentiated state (Viswanathan et al., 2009). Additionally, lin28 
has been found in ovarian cancer cells in conjunction with Oct4, and this co-expression 
was found to mark the more stem cell-like cells in the cancerous population (Peng et al., 
2010). There are instances, however, in which there is not a concomitant reduction in let-7 
levels where lin28 is overexpressed (Sakurai et al., 2012), and instead lin28 may be 
influencing other targets. Work has shown that the lin28s also promote transformation by 
binding to mRNA targets as discussed above, with key targets including cell cycle genes 
(Feng et al., 2012; King et al., 2011; Li et al., 2012; Pan et al., 2011). 
Expression of lin28 has also been investigated for a marker of cancer progression. The co-
expression of Oct-4 and lin28 in ovarian cancer was seen as a marker of more advanced 
tumour classification with a poorer prognosis (Peng et al., 2010), with lin28a or lin28b 
expression alone an indicator of poor prognosis in other cancers (Feng et al., 2012; 
Hamano et al., 2012). A reduction in levels of let-7 was also linked to earlier deaths in lung 
cancer (Takamizawa et al., 2004). Further work into this may determine whether lin28 can 
be a valuable marker for classification of cancer progression and prediction of prognosis. 
1.3 miRNAs  
1.3.1 miRNAs: An important class of regulatory RNAs 
The field of non-coding RNA study is becoming increasingly important, with the discoveries 
of multiple classes of such RNAs; this includes small nuclear and nucleolar RNA (snRNA, 
snoRNA), which are involved in the processing of RNA in the cell, and regulatory RNAs such 
as piwi-interacting RNA (piRNA), long intergenic non-coding RNA (lincRNA) and miRNAs. 
Mature miRNA are ~22 nucleotide (nt) RNA sequences that provide post-transcriptional 
gene regulation in the cell, via RNA interference (RNAi). RNAi affects mRNA translation as a 
  Introduction 
32 
 
form of post-transcriptional regulation, through the formation of double-stranded RNA 
(dsRNA). As mentioned above, the first miRNA to be discovered in animals was lin-4 in C. 
elegans, which was found to regulate mRNA, including lin28, by binding complementary 
elements in the 3’ UTR (Lee et al., 1993; Wightman et al., 1993), preventing protein 
expression of targets (Olsen and Ambros, 1999). 
miRNAs have been identified in both animals and plants, suggesting they represent an 
important regulatory mechanism. Over 1000 miRNA sequences are presently known in 
humans, with this list appearing to be ever expanding (Griffiths-Jones et al., 2008). 
Conservation of these sequences is high across many species (Suh et al., 2004; Watanabe 
et al., 2005), with some identical mature miRNA sequences being found in diverse species.  
For example, there are variants of the miRNA let-7 that are highly conserved from humans 
to C. elegans, and are conserved 100% at the seed region of the mature sequence (Figure 
1.5). This demonstrates the biological importance of these short regulatory RNA 
sequences.   
 
Figure 1.5 Conservation of let-7 sequences between humans and C. elegans 
Clustal alignment of all human mature let-7 sequences and C. elegans let-7. Stars represent 
conserved residues in all sequences. Box is drawn around miRNA with 100% conservation 
between humans and C. elegans. 
1.3.2 The biogenesis of mature miRNA 
miRNAs undergo multiple processing events during their biogenesis to result in the mature 
active form, which is represented in Figure 1.6. 
miRNAs are present in the genome in various different forms. Some are present in 
clusters, where numerous miRNAs are transcribed as polycistronic RNAs and cleaved to 
separate into their individual forms, with others present as individual miRNAs and 
transcribed alone (Lee et al., 2002); these routes provide the most common forms of 
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miRNA generation. Primary miRNA (pri-miRNA) from miRNA genes with independent 
promoters is synthesised by RNA polymerase II (Cai et al., 2004; Lee et al., 2004), the same 
RNA polymerase responsible for transcribing mRNA. The same modifications are further 
imparted in post-transcriptional modification onto miRNAs as for mRNA, including polyA 
tails, and 5’ capping, although this was not found to be present in all cases of miRNA 
transcription (Lee et al., 2004). Pri-miRNA has been found of varying sizes, from around 
100 nt to over 800 nt (Lee et al., 2002), which gives strength to the idea that some are 
transcribed as clusters. This pri-miRNA is processed to the mature, active form by a series 
of cleavage steps. 
Within the nucleus, the primary miRNA is cleaved to form precursor miRNA (pre-miRNA) of 
~70 nt in length, by the RNase III protein Drosha (Lee et al., 2003) as part of a 
Microprocessor complex with the involvement of other proteins including DiGeorge 
syndrome critical region 8 (DGCR8), also known as Pasha in invertebrates (Denli et al., 
2004; Gregory et al., 2004). Neither DGCR8 nor Drosha can initiate pri-miRNA cleavage 
without the other, and the method by which they recognise and bind to RNA is still being 
uncovered. Work by Zeng and Cullen (2005) showed that to be recognised for Drosha 
cleavage, the pri-miRNA must have an extended stem beyond the pre-miRNA, and a loop 
of ≥10 nt; this makes the pri-miRNA stem around three RNA helical turns in length, and 
they further found that Drosha cleaved the RNA two helical turns from the terminal loop 
(Zeng et al., 2005). However, some of this has been contested in more recent work, which 
showed that although having an unstructured loop region was required it could be internal 
to the miRNA, and the cleavage site was not dependent upon distance from this (Han et 
al., 2006). Flanking single-stranded RNA was demonstrated to be required for Drosha 
recognition (Zeng and Cullen, 2005), and it was instead suggested to be one helical turn 
from the stem-single-stranded region that determined the cleavage site, which is bound by 
DGCR8 (Han et al., 2006). This cleavage results in a stem-loop structure with a 2 nt 3’ 
overhang, a typical result of RNase III proteins, and this cleavage also determines one end 
of the mature miRNA sequence (Wu et al., 2009). In  a number of cases, it was seen that 
Drosha was capable of alternative cleaving of pri-miRNA, which resulted in altered mature 
miRNA ends and perhaps modified functions (Wu et al., 2009), which may be a further 
method in which miRNAs can be regulated.  
The pre-miRNA is exported from the nucleus, before any further modifications, by the 
Exportin-5 (Exp5) protein, a RanGTP-dependent exportin which acts primarily to export 
miRNA and short interfering (siRNA) (Bohnsack et al., 2004; Lund et al., 2004; Yi et al., 
2003), although it can also export other non-coding RNA such as tRNA and adenovirus 
RNA. Exp5 directly binds to pre-miRNA without the requirement for adaptor proteins 
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(Lund et al., 2004). Exp5 also stabilises pre-miRNA within the nucleus and prevents 
degradation before export; a knockdown of Exp5 was discovered to prevent the presence 
of both mature and pre-miRNA in the cytoplasm, but also produced reduced levels of pre-
miRNA in the nucleus without affecting pri-miRNA levels (Yi et al., 2003; Zeng and Cullen, 
2004). Exp5 had previously been demonstrated to bind RNA for export via a mini-helix with 
a 3-8 nt 3’ overhang (Gwizdek et al., 2004), but it was shown that this interaction with pre-
miRNA is more flexible. A stem of ≥16 bp was required for the interaction, with a 3’ 
overhang ranging from 1 nt to 5 nt or even a blunt end capable of binding Exp5, and with 
any 5’ overhang inhibiting the miRNA binding (Zeng and Cullen, 2004).  
Pre-miRNA is cleaved in the cytoplasm by the RNase III protein Dicer, which results in the 
duplex of two arms of the miRNA (Bernstein et al., 2001; Hutvagner et al., 2001). Dicer 
contains a dsRNA binding domain, and RNase domains which cleave double-stranded 
miRNA, around 22 nt from its terminus (Zhang et al., 2002). It also contains a PAZ domain, 
which binds to the 3' overhang generated by Drosha (Macrae et al., 2006). Dicer uses the 
length of the 3' overhang to count along nucleotides to determine the cleavage site (Ma et 
al., 2004; Vermeulen et al., 2005). As Drosha cleavage has already determined one end of 
the mature miRNA, processing by Dicer selects the other end and determines the final 
sequence length of the miRNA. The resulting duplex of both arms of the miRNA dissociate, 
leaving single-stranded RNA (ssRNA), with the incorporation of an active mature miRNA 
into an RNA-induced silencing complex (RISC). 
There are alternative processes to generating miRNA; a small number are present within 
introns of genes, known more specifically as mirtrons, and are present in both 
invertebrates and vertebrates (Ruby et al., 2007; Sibley et al., 2011). There are further 
examples of miRNA generated from tRNA-like structures, or transcribed straight into short 
hair-pin sequences (reviewed in Curtis et al., 2012). Mirtrons are not processed by Drosha, 
but instead by splicing and debranching of the mRNA, which results in pre-miRNA-like 
structures (Ruby et al., 2007). These are then processed in the same manner as pre-
miRNA. Some of the alternative pathways, such as tRNA-like structures, can be processed 
independently of Drosha and the spliceosome to pre-miRNA-like structures, or straight to 
mature miRNA sequences (reviewed in Curtis et al., 2012). A reduced dependence on 
Exp5/Dicer has been reported for some mirtrons, but an alternative pathway for these has 
not yet been determined (Sibley et al., 2011). 
This increased understanding of endogenous miRNA processing is greatly benefitting RNAi 
research, which is now able to better design synthetic siRNA and short hairpin RNAs to be 
favourably processed in cells and target mRNAs in better understood ways. There is also 
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ongoing work to manufacture synthetic mirtrons for use in clinical therapy (Curtis et al., 
2012). 
  




Figure 1.6 miRNA processing pathway 
Pictorial representation of miRNA processing in the cell. Pri-miRNA and mRNA have been 
transcribed from DNA in the nucleus. These are processed by the Microprocessor complex 
containing Drosha, or the spliceosome to pre-miRNA. This is exported to the cytoplasm by 
Exportin-5, and processed further by Dicer. The resultant miRNA duplex dissociates and the 
active mature miRNA is incorporated into RISC.   
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1.3.3 RISC and translational inhibition by miRNAs 
Critical components of RISC are ssRNA, to identify the sequence-specific target, and a 
nuclease protein from the Argonaute family; RISC typically cleaves target mRNA to prevent 
translation (Hammond et al., 2000; Hammond et al., 2001; Martinez et al., 2002). 
Mammals contain four Argonaute proteins (Ago1-4), but only Ago2 was shown to have 
catalytic activity in RISC (Liu et al., 2004). The RNA is loaded into RISC as a duplex, with 
Argonaute cleaving the non-active strand, which then allows activation of RISC (Rand et al., 
2005). This interaction is likely to occur through the PAZ domain on the proteins, which is 
able to bind to the 3' overhang on the duplex (Song et al., 2003). 
In contrast to siRNA, which shows full complementarity to target mRNA, miRNA recognises 
targets with only a short part of its sequence: a 7 nt region situated at nt 2-8 at the 5' end 
of the miRNA, known as the seed sequence. This acts as the complementary region to the 
mRNA and thus provides the miRNA specificity and function (Lewis et al., 2003). The 
miRNA targets sites typically found on the 3' UTR of mRNA (Saito and Saetrom, 2010; 
Wightman et al., 1993), but has also been shown to target open reading frames containing 
multiple binding site repeats and 5' UTRs, with this interaction occurring through the 3' 
end of the miRNA, as an addition to simultaneous interactions from the usual 5' seed with 
the 3' UTR (Lee et al., 2009; Schnall-Levin et al., 2011). In light of this, miRNAs have been 
shown to be most conserved between species at both the 3’ and 5’ ends of the miRNA 
(Okamura et al., 2008; Yang and Moss, 2003). 
A single miRNA and RISC are capable of silencing multiple mRNA target strands (Hutvagner 
and Zamore, 2002); however, how the RISC functions with miRNA is still under 
investigation, and it appears multiple pathways of regulation are possible. Research has 
discovered that some miRNA targets, where protein expression has been inhibited, are not 
diminished at the RNA level (Olsen and Ambros, 1999), whereas there is also evidence of 
other mRNA targets showing modifications, such as deadenylation, and downregulation 
(Djuranovic et al., 2012; Lim et al., 2005). However, it would appear that translational 
inhibition is underway before any destabilisation of the mRNA begins to occur (Bazzini et 
al., 2012; Djuranovic et al., 2012; Mathonnet et al., 2007), and a large area of debate with 
miRNAs is how this translational repression occurs. Research has demonstrated examples 
of inhibition of protein translation after initiation has successfully occurred, blocking 
translational elongation, but also repression acting at the stage of translational initiation, 
with a requirement for a cap on the mRNA (Bazzini et al., 2012; Mathonnet et al., 2007; 
Olsen and Ambros, 1999; Petersen et al., 2006; Pillai et al., 2005). It is likely that different 
miRNAs can act through these different mechanisms to exert their effects on mRNA 
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translation, and the Bushell group found evidence to suggest that miRNA regulation may 
occur by either of these mechanisms, which they termed type I and type II, and have been 
attempting to identify what causes this selection. Their work has shown that the promoter 
responsible for the transcription of target mRNA appeared to direct whether translation 
initiation was slowed or there was translation repression postinitiation (Kong et al., 2008). 
Theories for how a mechanism of miRNA repression is selected have not yet been 
validated, but it is suggested that during transcription from particular promoters, mRNA 
may acquire factors which direct the miRNA repression to a time at translation, or that the 
RISC may interact with initiation factors. 
1.3.4 Selection of active miRNA strand 
The traditional view was that only one strand of the duplex was the active miRNA, 
termed the major miRNA, and was incorporated into RISC, with the minor miRNA 
(formerly universally represented by miRNA*, which will be used in this thesis) degraded. 
The so-called ‘major’ form can be found as both the 3p- arm and the 5p- arm of miRNAs. 
The ’major strand’ classification was based on which miRNA was found to have the highest 
expression levels on preliminary identification, following the belief that the minor form 
was merely degraded. However, further research has shown that it is possible for miRNA* 
to have biologically repressive functions (Okamura et al., 2008; Yang et al., 2011).  Both 
papers showed that some miRNA* strands accumulated in levels greater than some 
‘major’ miRNA strands, dependent on cell type and developmental timing. An identical 
duplex can result in a different dominant miRNA strand, accumulating in higher levels than 
the alternative, when processed in different species (Griffiths-Jones et al., 2011), and can 
also switch in different cell types and upon developmental timing (Okamura et al., 2008; 
Yang et al., 2011). Griffiths-Jones et al. found that the number of target genes present in 
each of the cell types reflected the dominant miRNA arm choice, suggesting selective 
pressures, with the most biologically relevant miRNA being the chosen regulatory form 
(Griffiths-Jones et al., 2011). 
Selection of dominant miRNA strand was initially theorised to be due to 
thermodynamic properties of the duplex, with the favoured miRNA strand showing less 5’ 
thermodynamic stability (reviewed in Hutvagner, 2005). However this is now not believed 
to be the only decisive factor, as the dominant miRNA product can vary. The major miRNA 
was usually observed to be the more conserved strand of the duplex. Papers by Okamura 
and colleagues (2008) and Yang et al (2011) showed that active miRNA* was highly 
conserved between different species, producing a correlation between conservation and 
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miRNA* strand accumulation; this suggests that a high conservation of sequence between 
species reflects the biological importance. 
1.3.5 miRNAs have important roles in development 
The important role of miRNA through development can be shown by inhibition of the 
biogenesis pathway for all miRNAs, which studies have performed by interfering with Dicer 
expression. One group found that they could produce heterozygous(
+/-
) Dicer mutant mice, 
but not homozygous(
-/-
) Dicer mutants; Dicer 
-/-
 embryos, lacking mature miRNAs, showed 
abnormal early development and embryonic lethality (Bernstein et al., 2003). A separate 
study showed that Dicer could be reduced in ES cells using RNAi and cells continued to 
proliferate and express pluripotency markers. However, they did this at a slower rate than 
their Dicer-expressing counterparts, and did not contribute to chimeras, or form tumours 
or embryoid bodies (Kanellopoulou et al., 2005), showing that any differentiation requires 
expression of miRNA. To bypass this need for Dicer in early differentiation events, many 
studies have used transgenics to knock out Dicer in specific tissues in later development. A 
loss of Dicer induced in mesoderm tissue following gastrulation resulted in a failure of 
mouse axes to elongate, and a failure of hindlimb bud development (Zhang et al., 2011). 
Alternative transgenic models have shown that a loss of Dicer affected lung epithelial 
branching, reduced differentiation of skeletal muscle due to a failure in myofibre 
morphogenesis, impaired angiogenesis and reduced head size and craniofacial structures 
(Harris et al., 2006; O'Rourke et al., 2007; Yang et al., 2005; Zehir et al., 2010); all of these 
effects were found to involve an increased rate of cell death. 
The vast number of miRNAs means, however, that miRNAs are involved in the numerous 
different roles that their target RNAs have. There is also a great variety in the expression of 
miRNAs; pluripotency-specific miRNAs have been characterised, along with differentiation-
specific miRNAs, which can be widespread in their expression or restricted to very 
particular tissue types or times.  
1.3.6 The let-7 miRNA family 
Let-7 is one of these differentiation-specific miRNAs, and was discovered to be a 
heterochronic miRNA in C. elegans, with mutations causing retarded development 
(Reinhart et al., 2000; Slack and Ruvkun, 1997). The let-7 family of miRNAs is a highly 
conserved miRNA family – with one member in C.elegans, and 9 mature members in 
vertebrate species such as humans and Xenopus, as shown previously in Figure 1.5, 
although these arise from up to 12 different pre-let-7 forms (Pasquinelli et al., 2000; Peter, 
  Introduction 
40 
 
2009). In C. elegans, mutations in let-7 were able to suppress the phenotype seen in lin-28 
mutants, and binding sites for let-7 are present in the 3' UTRs of lin28a and lin28b; let-7 
blocks the translation of both lin28a and lin28b, resulting in a negative feedback loop, with 
the lin28s also exerting a negative regulation on let-7 (Reinhart et al., 2000; Slack and 
Ruvkun, 1997). As discussed in section 1.2.6, let-7 expression is commonly repressed in 
cancer, which appears to allow cells to revert to an undifferentiated state, important in 
the progression of cancer. 
1.3.7 The regulation of let-7 by lin28 
One of the earliest examples of post-transcriptional regulation of miRNA was the discovery 
that lin28 inhibits let-7 processing. Both lin28a and lin28b proteins were found to bind to 
the let-7 terminal loop and prevent processing to the mature form. This interaction was 
first identified following a perceived block of the Drosha Microprocessor, cleaving pri-let-7 
to pre-let-7, when incubated with cell extract, and lin28 was purified as bound to pre-let-7 
(Viswanathan et al., 2008). There has been speculation since this discovery over whether 
this binding is to the pri-miRNA, pre-miRNA, or both, and therefore inhibiting processing 
either by Drosha or Dicer, as both methods appear possible in vitro (Newman et al., 2008; 
Piskounova et al., 2008; Viswanathan et al., 2008). This interaction between let-7 and lin28 
and the inhibition of miRNA processing has since been repeated by a number of groups, 
using protein and RNA sequences from C. elegans, X. tropicalis and humans, and a wide 
range of binding affinities has been reported, from 0.15 nM to 2.1 µM (Desjardins et al., 
2011; Lightfoot et al., 2011; Loughlin et al., 2012; Mayr et al., 2012; Nam et al., 2011). 
These studies have all used varying techniques to determine the binding efficiency 
between lin28 constructs and let-7 sequences, including electrophoretic mobility shift 
assay (EMSA), isothermal titration calorimetry, and fluorescence titrations, and the varied 
assay conditions, and protein and RNA constructs used are likely to have contributed to 
the ranging binding affinities reported.  
Much research has since been dedicated to uncovering the mechanism by which this 
binding and the block on processing occurs. Early work in George Daley's group found that 
both the CSD and zinc fingers were required for binding let-7 (Piskounova et al., 2008), and 
subsequent work with truncated lin28 constructs, containing only one of the two RNA-
binding domains on occasion, has determined separate binding sites for the two RNA-
binding domains, and the crystallisation of the lin28a structure bound to let-7g 
demonstrated the involvement of both the CSD and zinc finger motifs in this binding 
interaction (Nam et al., 2011). 
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Piskounova and colleagues identified a cytosine residue which was conserved in the 
terminal loop of all human let-7 family members; this residue is exposed on the loop of the 
RNA, and when mutated reduced binding of the lin28 (Piskounova et al., 2008), but no 
importance has been attributed to this nucleotide by other work. It is possible that their 
mutation of the cytosine greatly altered the structure of the let-7 RNA, altering exposure 
of the true lin28 binding sites, and thus affected the binding interaction. 
The binding of the zinc finger domains is suggested to provide the specificity to the 
interaction (Mayr et al., 2012), and CSDs have been shown previously to commonly bind 
co-operatively (Ermolenko and Makhatadze, 2002). The zinc fingers, similarly to NCp7, 
recognise G-rich single-stranded RNA (Desjardins et al., 2011); the simplest sequence 
identified in let-7 for the binding of lin28 via these domains is 'NGNNG', where N 
represents any nucleotide (Loughlin et al., 2012). The most common form by which this is 
seen to occur in let-7 RNA is in the sequence of 'GGAG', which was identified as a binding 
site by Heo et al (2009). Mutations in this site have shown reduced binding affinity, with 
mutations including the loss of the 'GG' and replacements of the 2nd and 3rd guanines; 
work has suggested that the final 'G' or the first two together produced the largest effect 
on binding, all supporting this proposed binding motif (Heo et al., 2009; Mayr et al., 2012; 
Newman et al., 2008). This motif is commonly found towards the end of the terminal loop, 
before the stem-loop junction (Figure 1.7A). There is more debate, however, surrounding a 
consensus sequence for a binding site for the CSD domain. A potential binding sequence 
was identified following crystallisation of the lin28-let-7 complex as 'NNGNGAYNN', where 
Y = pyrimidine (Nam et al., 2011). Interestingly, it was previously found that mutating only 
the adenine residue within this sequence in let-7g reduced binding affinity (Newman et al., 
2008), lending strength to this motif. An alternative site has been proposed to be 
'GNUNNUNNN' (Mayr et al., 2012); this was predominantly identified using a protein 
construct of the CSD only and may be less biologically representative. These sequences are 
typically found shortly after the miRNA stem region (Figure 1.7A). The work by the Sliz lab 
proposed that the lin28 protein would be capable of folding around the let-7 RNA and 
binding one molecule by the two different RNA-binding domains; however, they used a 
protein with a truncated linker region between the RNA-binding domains which required 
the binding of two protein molecules to each let-7, and may also not fully reflect the 
endogenous interaction between protein and miRNA.  These papers have separately 
demonstrated that the prominent interaction between the RNA and lin28 proteins is 
occurring via base stacking, with hydrogen bonds providing further connections. Amino 
acids within the CSD and zinc fingers are capable of interacting with the nucleotides in the 
binding sites via pi-interactions; as these are largely non-specific this may account for the 
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degeneracy in proposed binding sequences (Loughlin et al., 2012; Mayr et al., 2012; Nam 
et al., 2011).  
The mechanism by which lin28 inhibits the processing of let-7 is also under active 
discussion. It has been shown that the binding of lin28 both remodels the RNA to block the 
RNase cleavage site and drives uridylation of the miRNA. The binding of lin28 has been 
shown to remodel let-7 by partially melting the double-stranded RNA over the Dicer 
cleavage site, subsequently protecting the miRNA from such cleavage (Lightfoot et al., 
2011; Mayr et al., 2012).  The binding of the CSD to let-7 remodels the terminal loop, by 
wrapping the miRNA around a protruding section of the CSD, into a more open structure 
which also exposes the GGAG motif, for subsequent binding by the zinc finger domains 
(Figure 1.7B), and it is believed that this binding further impacts the processing (Mayr et 
al., 2012; Nam et al., 2011). The proximity of the 'GGAG' motif in let-7 miRNAs to the 
mature sequence and the Dicer cleavage site may also mean that the cleavage site is 
physically blocked when a lin28 molecule is bound to the miRNA (Nam et al., 2011), but 
another possible regulatory mechanism is by promoting uridylation.  Work in ES cells 
demonstrated the binding of lin28 to let-7 recruits a noncanonical poly A polymerase, 
terminal uridylyltransferase 4 (TUT4, also known as ZCCHC11), which adds a uridine tail to 
the miRNA and thus targets it for degradation; TUT4 was not capable of binding to either 
lin28 or let-7 without the presence of the other (Heo et al., 2009). This firmly indicates that 
the binding of lin28 is crucial to this regulation, although it was shown that expression of 
both lin28 and TUT4 were necessary for the proper regulation of let-7 (Hagan et al., 2009). 
This work has also been confirmed in C. elegans (Lehrbach et al., 2009).   Although reports 
have indicated that derivations from 'GGAG' were still capable of being bound by lin28 
(Loughlin et al., 2012), they were not sufficient for uridylation (Heo et al., 2009), indicating 
some importance for this precise sequence. TUT4 is also a zinc finger protein (Minoda et 
al., 2006), and it has been suggested that of the 'GGAG' sequence, the second guanine 
residue is not bound by lin28, but may instead be exposed and available to be bound by 
TUT4 (Loughlin et al., 2012). TUT4 has also been implicated in the uridylation of another 
miRNA, miR-26a (Jones et al., 2009), but there has been no evidence that lin28 is involved 
in this interaction. A second factor that may additionally interact with lin28 to regulate let-
7 is Musashi1, another RNA-binding protein; this is capable of binding to lin28 in the 
presence of RNA, and a knockdown of both proteins together was more effective at 
increasing levels of mature let-7 than a lin28 knockdown alone (Kawahara et al., 2011), 
although the process by how this modifies let-7 processing remains unknown. 
The regulation of let-7 was shown to be a function of both lin28a and lin28b (Heo et al., 
2009; Mayr et al., 2012; Piskounova et al., 2008) but a separate report has indicated that 
  Introduction 
43 
 
lin28b does not act through TUT4 to inhibit let-7 biogenesis; it was shown that lin28b was 
present in the nucleus and nucleolus, and was acting independently of TUT4, blocking let-7 
processing at the pri-miRNA stage (Piskounova et al., 2011). In a different cell type lin28b 
was still shown to bind let-7 with TUT4 (Heo et al., 2009), indicating a possible difference 
of regulation upon cell type. In C. elegans there is only one form of lin-28, which was found 
to predominantly bind to the pri-let-7 form (Van Wynsberghe et al., 2011), in contrast to 
earlier reports that indicated lin-28 primarily blocked Dicer processing (Lehrbach et al., 
2009). The Pasquinelli group also found that within the nucleus, lin-28 was binding co-
transcriptionally, allowing an early association with the let-7 transcripts that may allow the 








Figure 1.7 The structure of let-7 terminal loops and alteration upon lin28 binding 
Schematic representation of let-7 terminal loop RNA. Boxes represent nucleotides, with blue 
shading indicating mature miRNA. Nucleotides given represent putative lin28 binding sites; 
those in red differ from proposed binding site. A) Loop regions of hsa-let-7f-1 and hsa-let-7g, 
to represent different possible structures. Arrow indicates Drosha cleavage site. B) Hsa-let-7f-1 
miRNA loop bound to lin28, adapted from Nam et al (2011). Blue region represents CSD and 
purple regions represent the zinc finger domains, with flexible linker between. Dashed lines 
indicate proposed stem-melting.  
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1.4 Model systems 
1.4.1 Xenopus tropicalis  
X.tropicalis and X. laevis have been used as model systems for developmental studies for 
many years. A major advantage for the Xenopus species as a model system is the ease of 
manipulation and rapid development time for developmental studies. X. tropicalis is 
favoured as a genetic model due to its diploid genome, as opposed to the tetraploid X. 
laevis(Grainger, 2012). They have been used in recent years to characterise expression 
patterns of genes and identify previously unreported genes, amongst other uses (Lea et 
al., 2009; Sivak et al., 2005). To assess gene function, embryos can be induced to 
overexpress proteins by the injection of mRNA, and proteins can also be knocked down 
using anti-sense morpholinos (MOs), which can act in two different ways to prevent new 
protein production. Splice-blocker MOs target splice sites, and by binding over these 
prevent the processing of the mRNA to a translatable form. Translation-blockers bind 
somewhere between the 5' cap to ~25 bases 3' of the AUG translational start site, and 
block binding of ribosomes. MOs are known to persist, and effects can continue to be seen 
days after use in some systems, therefore they are a potent inhibitor of protein production 
in the Xenopus embryo. It is known that zygotic transcription begins in the embryo shortly 
after midblastula transition (MBT) (Newport and Kirschner, 1982), but RNA is present in 
the oocyte, having been maternally deposited; it is from this RNA only that proteins are 
synthesised in the earliest stages of amphibian development. This occurs just prior to 
gastrulation, when the genome is transcribed and inductive signalling events begin to 
occur, and patterning of the embryo takes place, making this a key event in the 
development of these organisms. 
As much of the work on FGF function in gastrulation has already been carried out in 
Xenopus and is well characterised, as discussed earlier in this chapter, this is an ideal 
system to use to further study this stage of development with regards to new potential 
FGF targets. Additionally, attempts at generating lin28a knock outs in mice were lethal 
(Zhu et al., 2010), highlighting important embryonic processes for this gene. As Xenopus 
embryos develop externally, it is very easy to study changes occurring in the embryo at 
very early stages of development, such as gastrulation. 
1.4.2 Human stem cells 
Discoveries unearthed in vertebrate models such as Xenopus must also be investigated in 
humans to determine conservation and applicability of any findings. Carrying this out in 
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vivo in developing embryos is not possible, and in vitro cell culture models must instead be 
used. 
The stem cells with the most potential are ES cells, isolated from the inner cell mass (ICM) 
of blastocysts (Evans and Kaufman, 1981; Martin, 1981). They are pluripotent and can 
develop into any type of cell, however are difficult to successfully culture long-term in this 
state. Additionally, as the understanding of pathways which control differentiation 
remains incomplete, driving development into required cell types can be difficult to 
achieve effectively and efficiently. Unlike early Xenopus embryos, the human zygotic 
genome is activated by the 4-8-cell stage (Braude et al., 1988; Tesařík et al., 1986), and 
thus transcription is active in mammalian ES cells. A simpler model of pluripotency can 
often be provided by using embryonal carcinoma (EC) cells, which are typically cell lines 
that have been isolated from germ line tumours. These are malignant transformed cells, 
and are much easier to maintain in culture, whilst expressing a similar set of genes to ES 
cells (Josephson et al., 2007). The major drawback, however, with EC cells is that very few 
lines are truly pluripotent - some, such as the 2102Ep line are nullipotent and incapable of 
differentiation despite being an EC line which shows a very highly similar transcriptome to 
ES cells, whereas others may be pre-disposed to particular lineages (Duran et al., 2001). 
Adult stem cells offer another alternative for in vitro study. Multipotent in nature, they can 
be collected from different tissues of the body and show restrictions to germ layers and 
cell types. Mesenchymal stem cells (MSCs) are multipotent stem cells, isolated from 
primary sources such as bone marrow and adipose tissue. MSCs are already restricted to 
mesoderm, and they are capable of differentiating into diverse cell types such as bone, 
cartilage, fat, and muscle (Figure 1.8), although are not capable of haematopoiesis despite 
this also developing from mesoderm in the embryo. They can be used to model 
differentiation into these cell types, or to investigate functions within mesodermal cells, as 
they are intended for use in this thesis. As MSCs are derived from human patients, there 
can be a high degree in variability in the differentiation potential of cells. The cells 
obtained are a heterogeneous population, and due to the variability are best used to 
analyse for gross trends. It has also been shown that the site from which cells are derived 
can affect the potential for different tissue types (Strioga et al., 2012).  




Figure 1.8 Mesenchymal stem cell potential 
When dividing, MSCs are capable of self-renewal into more MSCs, or differentiation into cell 
types from mesodermal lineages such as osteocytes for bone development, chondrocytes for 
cartilage, myoblast cells to form muscle, connective stromal cells, or adipocytes for fat 
differentiation. 
1.5 Aims for this thesis 
This thesis aims to explore the potential of lin28a and its related gene lin28b as targets of 
FGF signalling. It is hoped that in exploring further the nature of this regulation, a closer 
move can be made to identifying the functions of FGF signalling in development, and 
whether this is positively regulating pluripotency through such factors. As little is known 
about the functions of lin28a and lin28b in development, the functions of these genes will 
be investigated; it is known that they are required for embryonic development but not 
what roles they are playing at this time. The inability to generate viable mammalian lin28-
null specimens highlights this importance, but the difficulty of studying processes in 
mammalian embryonic development leads us to turn to the Xenopus model, where 
development and the influence of lin28 proteins can be easily studied across embryonic 
stages. 
The interest in miRNAs is continually developing, and lin28 was one of the first discovered 
proteins to post-transcriptionally regulate miRNA. The only confirmed target so far has 
been the let-7 family, although as lin28 is a potent RNA-binding protein, it is possible that 
targeted binding sites are present in alternative miRNAs. let-7 is usually transcriptionally 
repressed at the earliest stages of development, and the investigation will aim to discover 
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if there are any other putative lin28-regulated miRNAs expressed during early 
development.  
In order to begin the investigation into the conservation of these pathways in humans, this 
thesis aims to identify if MSCs can be used to model these early effects of FGF signalling 
upon undifferentiated mesoderm cells, and if lin28 is a developmentally relevant gene in 
these cells. For any identified targets of lin28, MSCs or, if these cells are not a suitable 
model, an alternative cell line model will be explored to determine their suitability for use 
in investigating conservation of identified targets. 
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Chapter 2. Materials and Methods 
2.1 Xenopus techniques 
2.1.1 Xenopus tropicalis in vitro fertilisation and embryo culture 
Female X.tropicalis were primed by subcutaneous injection of 10 units of human 
chorionic gonadotrophin (hCG) (Chorulon; Intervet) 24-72 hours prior to laying. To 
induce ovum laying in 2.5-4 hours, the females were injected with 100 units of hCG, and 
kept at 27°C in the dark. Eggs were fertilised with a suspension of crushed testis in L15 
with 10% heat treated foetal calf serum, collected from a male that had been treated 
with 100 units of hCG 3-4 hours before fertilisation. Embryos were cultured in MRS/9 
(1/9
th
 Modified Ringer’s solution: 0.1 M NaCl, 1.8 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 
5 mM HEPES-NaOH) on 1% agarose-coated (Sigma) 60 mm dishes (VWR) at 23-27°C. 
Embryos were treated prior to the first cleavage to remove jelly coats with 3% L-cysteine 
(Sigma) in MRS/9, pH 7.8-8. Before gastrulation, embryos were transferred to MRS/20 
with 100 μg/ml gentamicin.  
2.1.2 Xenopus laevis in vitro fertilisation and embryo culture 
X. laevis females were primed by subcutaneous injection of 50 units of hCG 48 hours to 1 
month before use. To induce laying in 16 hours, females were injected with 250-350 
units of hCG and kept in the dark at 19°C. Eggs were fertilised with a suspension of 
freshly crushed testis in distilled water, collected from a male. Embryos were cultured in 
NAM/10 (1/10
th
 Normal Amphibian Medium: 110 mM NaCl, 2 mM KCl, 1 mM Ca(NO3)2, 
0.1 M EDTA, with 5 mM HEPES and 2.5 µg/ml gentamicin added to dilutions) throughout 
development at 12-24°C. Embryos were treated to remove jelly coats prior to first 
cleavage with 2.5% L-cysteine hydrochloride monohydrate (Sigma) in NAM, pH 7.8-8.  
2.1.3 Xenopus injections 
 Injections of RNA were performed on both X. laevis and X. tropicalis embryos using 
pulled glass needles (Narishige) using a pneumatic microinjector (Harvard Apparatus). 
X.tropicalis embryos were transferred to MRS/9 + 3% Ficoll (Sigma) for injection, then to 
MRS/20 before gastrulation. X. laevis embryos were transferred to NAM/3 + 5% Ficoll 
(Sigma) for injection, and transferred to NAM/10 before gastrulation.  
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 Injections were performed with in vitro transcribed mRNA (section 2.3.12), antisense 
morpholino oligonucleotides (MOs) (Gene Tools, LLC) or synthetic precursor miRNAs 
(Applied Biosystems), at required concentrations. Injections were carried out into all 
cells at either the two- or four-cell stage, with a maximum of 10 nl/embryo. X. tropicalis 
injections were targeted to the marginal zone. MOs were heated to 65°C for 3 minutes 
prior to needle-loading and injection. MOs were designed by Gene Tools, LLC, and 
sequences for those used in this project are given below (Table 2.1).  
 
Table 2.1 Sequences for antisense morpholinos 
Gene MO sequence 




All MOs used in this study were obtained from GeneTools, LLC. lin28a MOs were targeted to 
the 5' UTR region of the gene, and lin28b MO to the region around the start site of 
translation (underlined). Sequences are given 5' to 3'. 
2.1.4 Collection of embryos 
Embryos were staged according to Nieuwkoop and Faber (NF) (Nieuwkoop and Faber, 
1994). Embryos were collected for RNA and protein extraction by removing excess liquid 
and snap freezing on dry ice.  For whole-mount in situ hybridisation, membranes were 
removed from embryos pre-NF stage 25 using forceps under a microscope. Embryos 
developed to the required NF stage were fixed in MEMFA (0.1 M MOPS, pH 7.4, 2 mM 
EGTA, 1 mM MgSO4, 3.7% formaldehyde) for 1 hour at room temperature. Embryos were 
subsequently washed in methanol three times, before being stored in fresh methanol at 
-20°C. Embryos were fixed in the same manner for dpERK whole-mount immunostaining, 
but without prior membrane removal. 
2.1.5 Photographing embryos 
Embryos were photographed using a SPOT 14.2 Color Mosaic camera (Diagnostic 
Instruments Inc.) and SPOT Advanced software, on a Leica MZ FLIII microscope.  Images 
were processed using Adobe Photoshop Elements 4.0. 
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2.2 Cell techniques 
2.2.1 Isolation of MSCs from femoral heads 
Femoral heads were collected from patients undergoing hip replacement surgery at 
Harrogate District Hospital, Harrogate, and Clifton Park Treatment Centre, York, 
following informed consent. Cells collected from donors were cultured separately from 
other donor cells, and cell lines were numbered sequentially using the prefix 'FH', for 
femoral head. 
Trabecular bone was scraped from inside the femoral heads into Dulbecco’s Modified 
Eagle's Medium (DMEM) with 10% foetal bovine serum (FBS). Trabecular bone was 
minced with scissors and supernatant removed to a new tube after fragments had 
settled. This was repeated two further times then supernatants were centrifuged at 
500g for 5 minutes and the pellet resuspended in 16 ml of culture medium. To remove 
large debris, the suspension was passed through a 70 μm cell strainer, before layering 
over 12 ml of Ficoll-Paque Plus (Amersham Biosciences). The layered suspension was 
centrifuged at 350g for 30 minutes. The mononuclear cell fraction was harvested, and 
washed in 10 ml Buffer A (PBS, 0.2% bovine serum albumin (BSA), 5 mM EDTA) and 
seeded into a 75 cm
2
 flask with normal growth medium. 
2.2.2 MSC cell culture 
MSCs were cultured in DMEM with 10% FBS (batch tested) and 1 U/ml 
penicillin/streptomycin (P/S) (Invitrogen) at 37°C with 5% CO2. Medium was changed 
every 3-4 days. Cells were passaged using Trypsin-EDTA (0.05% Trypsin, 0.02% EDTA, 
Invitrogen) at ~80% confluency, and reseeded at a ratio of 1:3. 
2.2.3 EC cell culture 
Two lines of EC cells were grown, 2102Ep cell line and NTera2.D1 clonal line. Cells were 
cultured in DMEM with 10% FBS at 37°C with 5% CO2. Media was changed every 2-3 
days. Cells were passaged using Trypsin-EDTA (Invitrogen) at ~80% confluency, and 
reseeded at a ratio of 1:6. 
2.2.4 FGF treatment of cells 




 in 6-well plates 
(Corning) in DMEM with 10% FBS, 1% P/S. As FBS contains growth factors that could 
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mask effects from FGF signalling, cells were serum-starved before treatment to ensure a 
minimal presence of alternative signalling factors. 20 hours after seeding, the cells were 
serum-starved in DMEM, 0.5% FBS, 1% P/S.  Cells were treated with a range of FGF-2 
(Invitrogen) concentrations (1, 10, 25 ng/ml) in 3ml media (DMEM, 0.5% FBS, 1% P/S).  
At the relevant time points, medium was removed and cells were washed in ice cold 1x 
PBS, before being harvested in lysis buffer according to the subsequent protocol. 
Samples were collected at 6, 12, and 24 hours for RNA analysis; and 5, 15, 30 and 60 
minutes for protein analysis. 
2.2.5 ES cell samples 
ES cell samples were kindly gifted by the Coles group (University of York); H7 and H9 cell 
lines, isolated by Thomson and colleagues (1998) were cultured in feeder-free conditions 
on Matrigel, collected in cell pellets and treated with lysis buffer for RNA extraction. 
2.3 Molecular biology  
2.3.1 Agarose gel electrophoresis 
DNA and RNA samples were run on 0.8-2% agarose gels in TAE buffer (4 mM Tris acetate, 
1 mM EDTA), stained with ethidium bromide or SYBR safe (Invitrogen) at 100-150 V. 
Samples were loaded with a 1:6 ratio of loading buffer (Promega) and run alongside a 
ladder: Hyperladder IV or V (bioline), 1Kb ladder (Promega), or Q-Step 4 ladder (YorkBio). 
2.3.2 Quantification of nucleic acids 
DNA and RNA samples were analysed on a Nanodrop ND-1000 spectrophotometer which 
measured the absorbance of samples at 260 nm, to determine nucleic acid 
concentration. 260/280 and 260/230 ratios were also measured to determine purity of 
nucleic acid samples. 
2.3.3 mRNA extraction and cDNA synthesis 
Total RNA extraction from human cells 
To harvest cells, medium was removed and cells washed with 1x PBS. Cells were lysed 
directly in the culture dish with 1 ml of TRIzol (Invitrogen) and incubated for 5 minutes at 
room temperature. RNA was extracted following the manufacturer’s instructions. Lysed 
cells were scraped into a tube and 200 μl of chloroform was added; samples were 
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vortexed vigorously for 30 seconds and incubated for 5 minutes at room temperature, 
followed by centrifugation at 13,000g for 20 minutes at 4°C. The upper aqueous phase 
was removed to a new tube, and 1 volume of isopropanol was added to precipitate the 
RNA with a 30 minute incubation at 4°C. Samples were centrifuged at 13,000g for 15 
minutes at 4°C, and isopropanol removed. The pellet was washed in 70% ethanol, 
vortexed, and centrifuged for 5 minutes at 13,000g. Samples were then dried and 
resuspended in 50 μl of RNase-free water. 
 Total RNA extraction from Xenopus 
Total RNA was extracted using TRI reagent (Sigma) according to the manufacturer’s 
instructions with some modifications. 1 ml of TRI Reagent (Sigma) was added to samples 
on ice, which were homogenised by a pipette tip and incubated at room temperature for 
5 minutes. The samples were centrifuged for 10 minutes at 4°C at 13,000g, and the 
supernatant removed to a fresh tube. 200 μl of chloroform was added and the 
remainder of the protocol was as described for human cells. Following resuspension in 
WATER, an additional precipitation step was undertaken. 7.5 M LiCl and 0.05 M EDTA 
(final concentrations) were added, and RNA was incubated at -80°C overnight. Samples 
were centrifuged as before, for 20 minutes, and the resulting pellet was ethanol washed 
and resuspended in 20 μl RNase-free water. 
 cDNA synthesis 
cDNA was synthesised from total RNA using 1 μg RNA with either oligo (dT) (Invitrogen)  
or random hexamers (Invitrogen) using SuperScript II Reverse Transcriptase (Invitrogen) 
according to manufacturer’s instructions. Random hexamers were used with Xenopus 
timecourse samples where any stages were pre-MBT, with oligo(dT) used in all other 
cases. RNA, primers and dNTPs were incubated at 65°C for 5 minutes for denaturation. 
First strand buffer and dithiothreitol (DTT) were added and reactions heated before the 
addition of 1 μl Superscript II; for oligo d(T) primers the reaction was heated to 42°C for 
2 minutes, and for random hexamers the mixture was heated to 25°C for 2 minutes. Final 
reactions were incubated at 42°C for 50 minutes then 15 minutes at 70°C to inactivate 
reverse transcriptase. With random hexamers there was an initial incubation of 25°C for 
10 minutes preceding this. cDNA was diluted accordingly in nuclease-free water and 
stored at -20°C.  
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2.3.4 Reverse transcriptase PCR (RT-PCR) 
cDNA was diluted 1/5 for use in RT-PCR reactions. 25 μl reactions were set up with 
12.5 μl 2x PCR Master Mix (Promega), 1 μl 10 μM forward primer, 1 μl 10 μM reverse 
primer, 2.5 μl cDNA, and RNase-free water to 25 μl.    
Samples were run in the following cycling conditions, with annealing temperature (AT) 
and elongation time (ET) given in the table below (Table 2.2) for each primer set. 
94°C  - 5 minutes 
94°C - 20 seconds         
AT°C - 30 seconds      25 cycles for L8/GAPDH, 30 cycles for FGFR1/FGFR2 
72°C - ET 
72°C - 5 minutes; 
Primer sequences are given below (Table 2.2), which were designed across exon 
boundaries. Primers for FGFR1 and FGFR2 were designed to target multiple splice 
isoforms. PCR products were run out on an agarose gel as in 2.3.1. 
 
Table 2.2 List of RT-PCR primers 
Gene Forward primer Reverse primer AT ET 
GAPDH 
(human) 
GGTGAAGGTCGGWGTCAACGG GGTCATGAGYCCTTCCACGAT 54°C 1m 
FGFR1 
(human) 
GAAGTGCCTCCTCTTCTGGG ATCACTGCCGGCCTCTCTTC 62°C 1m30s 
FGFR2 
(human) 
TGGTCACCATGGCAACCTTG TTCATTCGGCACAGGATGAC 61°C 1m30s 








TGCTGGACACCTGTACT TTCTGCGGTTTACAGATGGA 55°C 55s 
Sequences are given 5' to 3'. AT = Annealing temperature, ET = elongation time, where m = 
minutes and s = seconds. 
2.3.5 mRNA real-time quantitative PCR (qRT-PCR) 
All cDNA for qPCR was checked prior to use by RT-PCR for housekeeping genes (Xenopus: 
L8, human cells: GAPDH).  
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Primers were designed using Primer Express II (Applied Biosystems) software. Amplified 
sequences were checked by a BLAST search, to determine specificity. Primer sequences 
are found below for genes analysed in Xenopus (Table 2.3) and humans (Table 2.4). 
 
Table 2.3 Xenopus qPCR primer sequences 
Gene Forward primer Reverse primer 
brachyury  CGGCACACACTGGGATGTT CCACAAGGAAGGGTACTGACTTG 
chordin GGATTGCTCTCGCCCAAA AATTTTCCACCAAACGTACAACCT 
lin28a  CCAAAGTCCAAACCACATGGT AGATTGGCTGTTCTTCTAAGTTAGCA 
lin28b  AAAGGTTTTGAGTCATTACGGGTAA TATCTCCCTTTGGTTTTCTTTTTTGA 
ODC  AAAGCTTGTTCTGCGCATAGCAACT AGGGTGGCACCAAATTTTAC 
sox17b ACGAAGAAAGAGGCTGGATCTG GCCCACACCATAAACGCATT 
sox3 CAGAGTAGCAGACTGCACAGTGTACA AGTGAGCGGTACAGTGCCATT 
Sequences for all qPCR primers for mRNA genes analysed in X.tropicalis. Sequences are given 
5' to 3'. 
 
Table 2.4 Human qPCR primer sequences 
Gene Forward primer Reverse primer 
DUSP6 AAGGTGGCTTCAGTAAGTTCCAA CTGCTACACGAGCCGTCTAGATT 
IL-6 CCGGGAACGAAAGAGAAGCT GCGCTTGTGGAGAAGGAGTT 
lin28a CCCCCCAGTGGATGTCTTT CCGGAACCCTTCCATGTG 
lin28b CCATGATAAACCGAGAGGGA GGCTTCTAAATCCTTCCATGA 
RPS27A TGGATGAGAATGGCAAAATTAGTC CACCCCAGCACCACATTCA 
sprouty2 CACTCGCAGGTCCATTCTTCT CCCTGAGCTGACCGTGCTT 
Sequences for all qPCR primers for mRNA genes analysed in humans. Sequences are given 5' 
to 3'. 
3 μl of cDNA was used per reaction, at 1:3 dilutions for lin28a and lin28b in Xenopus, and 
1:5 dilutions for all other genes. Reactions were carried out in triplicate per sample in 96-
well plates using SYBR green (Applied Biosystems). The reaction was set up with 12.5 μl 
2x SYBR Green PCR Master Mix, 1 μl 10 μM forward primer, 1 μl 10 μM reverse primer, 
3 μl cDNA, and made up to 25 μl with RNase-free water.  
qRT-PCR was carried out on an ABI Prism 7000 Sequence Detection System (Applied 
Biosystems). Thermal cycling was undertaken at 50°C for 2 minutes, 95°C for 10 minutes, 
and followed by 40 cycles of 95°C for 15 seconds and 50°C for 1 minute. Data was 
analysed using ABI 7000 System software (Applied Biosystems), and relative expression 
levels of each gene calculated using the 2
-ΔΔCt
 method. The Ct value for each gene was 
normalised to the Ct value of the housekeeping gene (Xenopus: ODC, human cells: 
RPS27a), and then calibrated to the control sample for each experiment. 
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Primers were initially optimised using cDNA which was diluted 10-fold in four serial 
dilutions. Samples were run at 50°C for 2 minutes, then 95°C for 10 minutes, followed by 
40 cycles of 95°C for 15 seconds and 50°C for 1 minute. To check for a single product, a 
dissociation step was run of 95°C for 15 seconds, 60°C for 20 seconds and 95°C for 15 
seconds. Resultant Ct values from the four dilutions were used to create a standard 
curve. Primers were further used if efficiency was > 97%, and had an R2 value of close to 
1. cDNA dilution was then chosen based on the dilution with a Ct value close to 25. 
2.3.6 miRNA extraction, reverse transcription and qRT-PCR 
Total RNA extraction with miRNA enrichment from human cells 
Samples to be used for miRNA analysis were isolated using the miRVana miRNA isolation 
kit (Applied Biosystems). The protocol was carried out according to manufacturer’s 
instructions. Cells were lysed in lysis buffer and collected; 1/10
th
 volume of homogenate 
additive was added and samples vortexed before being incubated on ice for 10 minutes. 
1 volume of acid phenol-chloroform was added, then samples were vortexed and 
centrifuged for 5 minutes at 13,000g at room temperature. The upper aqueous phase 
was removed to a new tube and 1 volume of ethanol added. Samples were centrifuged 
through a filter cartridge, which was then washed with miRNA wash solutions. Samples 
were eluted in 100 μl RNase-free WATER which was pre-heated to 95°C. 
Total RNA extraction with miRNA enrichment from Xenopus 
The protocol was carried out as above, with slight modifications; after lysing the 
embryos in lysis buffer and addition of homogenate additive, samples were centrifuged 
for 10 minutes at 4°C and supernatant removed to a fresh tube. The rest of the 
procedure was as for human cells, with the addition of acid phenol-chloroform. 
miRNA cDNA synthesis and qRT-PCR 
This protocol is summarised schematically in Figure 2.1. cDNA was synthesised from 
10ng RNA/RT reaction  with miRNA-specific primers for TaqMan assays (Applied 
Biosystems) using the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems) 
as manufacturer’s instructions. Sample RNA, reverse transcriptase, buffer, and RNasin 
were multiplexed and divided into separate RT reactions for each miRNA gene, with the 
specific RT-primer added (Figure 2.1), to ensure even quantities of RNA template for 
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each gene. Reactions were incubated at 16°C for 30 minutes, followed by 42°C for 30 
minutes and 85°C for 5 minutes to deactivate reverse transcriptase. 
qRT-PCR was carried out using TaqMan Universal Master Mix II (Applied Biosystems) 
with Taqman miRNA probes (Applied Biosystems) according to manufacturer’s 
instructions (Figure 2.1). All reactions were performed in quadruplicate per sample in 96-
well plates on an ABI Prism 7000 detection system (Applied Biosystems) with thermal 
cycling at 95°C for 10 minutes, followed by 40 cycles of 95°C for 15 seconds and 60°C for 
1 minute. Gene expression levels were normalised to snoRNA U6 using the  
2
-ΔΔCt
 method as described in section 2.3.5. 
Assays used were: hsa-miR-19b, hsa-miR-17-5p, hsa-miR-130b, hsa-miR-20b, hsa-miR-
363#, hsa-miR-363, hsa-miR-18b, hsa-let-7a, hsa-let-7f, custom xtr-miR-106, custom xtr-
let-7g, and U6 snRNA (all Applied Biosystems). 
  




Figure 2.1 miRNA RT and qPCR set-up 
Pictorial representation of set-up for miRNA RT and PCR, with multiplexing of reagents and 
RNA to ensure even divisions of all reaction components. Coloured lines represent different 
reaction components: blue = RNA, red = gene specific RT-primer, pink = cDNA extension, 
green = PCR primers, with non-complementary overhang to increase length of PCR product; 
these are then extended to result in the PCR products. 
  




Plasmids were transformed into DH5α competent cells. 5 μl of ligation reaction was 
added to 50 μl of competent cells and incubated on ice for 30 minutes; cells were heat 
shocked at 42°C for 90 seconds, and then chilled on ice before being incubated for 1 
hour at 37°C with shaking in 1 ml of liquid broth (LB). After incubation, transformed cells 
were plated onto LB with 1 μg/ml ampicillin and incubated overnight at 37°C.   
2.3.8 DNA minipreps 
Plasmid DNA was prepared from colonies by inoculating a 5ml culture of LB with 1 μg/ml 
ampicillin and growing overnight at 37°C with shaking. Preparations were centrifuged at 
7000g for 5 minutes to pellet the DNA, and extracted using a QIAprep Spin Miniprep kit 
(Qiagen). 
DNA was cleaned up by adding an equal volume of phenol-choloform to samples and 
vortexing for one minute. Samples were centrifuged for 5 minutes at 13,000g at 4°C, and 
the top aqueous layer removed to a fresh tube; 0.1 volumes 3 M sodium acetate (Sigma) 
and 2.5 volumes 100% ethanol were added and the solution precipitated overnight at -
20°C. Samples were centrifuged for 15 minutes as before, and the resulting pellet was 
washed in 70% ethanol, centrifuged for 5 minutes and air-dried. The DNA was 
resuspended in an appropriate volume of nuclease-free water and stored at -20°C. 
2.3.9 Cloning of pri-miR-106 cluster into pCS2+ vector 
The full sequence for the pri-miR-106 cluster was amplified from X. tropicalis genomic 
DNA using the following primers: 
F: GCGUUGUGCAAAAGUGCUUA  R: TTGTGATGCTCAGCCTTCAG 
The reaction was set up in 50 μl with 100 ng X. tropicalis genomic DNA, 5 μl 10x Pfu 
polymerase buffer, 1 μl 10 mM dNTPs, 1 μl 10 μM forward primer, 1 μl 10 μM reverse 
primer, 0.5 μl Pfu polymerase (Promega), and made up to volume with RNase-free 
water. 
 Materials and methods 
60 
 
The PCR programme was carried out as: 
94°C  - 5 minutes 
94°C - 30 seconds         
57°C - 30 seconds      30 cycles  
72°C - 1 minute 
72°C - 15 minutes; with the addition of 1 μl Taq polymerase (Invitrogen) for the final 
10 minute extension to add an 'A' overhang, making the products compatible with the 'T' 
overhang in the pGEM vector. 
PCR products were cleaned up as in 2.3.8 and ligated to the pGEM-T Easy Vector System 
(Promega). Ligation reactions were set up with 2 μl PCR product/control insert, 5 μl 2x 
buffer, 1 μl PGEM T-easy vector, 1 μl T4 Ligase (Promega) and 1 μl RNase-free WATER. 
Reactions were incubated at room temperature for 1 hour, and overnight at 4°C. 
Ligations were transformed into DH5α competent cells as in 2.3.7. Colony PCR screens 
were performed to identify colonies containing an insert of the correct size. This was 
carried out as in 2.3.4 using primers to T7 and SP6 within the plasmid, as listed below: 
SP6: AGGTGACACTATAGAATACTCA  T7: GTA ATACGACTCACTATAGGGC  
Colonies containing the correct insert were then selected for minipreps as carried out in 
2.3.8, and subsequently sequenced in the Technology facility using the primers below, to 
check for sequence mutations: 
SP6: CGATTTAGGTGACACTATAG      T7: TAATACGACTCACTATAGGG 
To subclone into pCS2+ plasmid, the pri-miR-106 cluster DNA insert was cut out of pGEM 
using EcoR1 and incubated at 37°C for 2 hours. The reaction was set up in 100 μl with 
10 μl pGEM-pri-miR-106 cluster, 10 μl 10x H buffer (Roche), 2 μl  (100 units) EcoR1 
(Promega), 78 μl RNase-free WATER. The digest was checked on a 1% agarose gel, and 
then the full reaction run on a 0.8% pure agarose gel. The band for the insert was cut 
from the gel and DNA purified using Qiagen gel extraction kit (Qiagen) according to 
manufacturer’s instructions, and eluted in 30μl of nuclease-free water.  
1 μg of pCS2+ was linearised using EcoR1 in 100 μl volume as the reaction for pGEM 
plasmid above. The linearised vector was checked on a 1% agarose gel and was then 
treated with 1 μl of calf intestinal alkaline phosphatase (CIAP) for 5 minutes at 37°C, to 
prevent the vector ligating with itself. CIAP activity was stopped by incubation at 65°C for 
15 minutes, and was cleaned up using Qiagen clean-up kit according to manufacturer’s 
instructions. 
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Excised DNA insert was incubated with linearised pCS2+, with the insert in 3 times excess 
in the following reaction; 0.5 μl pCS2+ (CIAP-treated), 1.5 μl 10x ligase buffer, 12 μl DNA 
pri-miR-106 cluster insert and 1 μl T4 ligase (Promega). Ligation reactions were 
incubated at room temperature for 1 hour and at 4°C overnight, and transformed as 
2.3.7. Colony PCRs and minipreps were carried out as in pGEM vector to check for 
correct insert size, and sequenced by the Technology Facility as above, but with the T7 
primer: TGTCTGGATCTACGTAATACG. 
2.3.10 Cloning of truncated pri-miR-17-92 clusters into pGEM vector 
To generate whole-mount in situ hybridisation probes to use on the miR-17-92 and miR-
106-363 clusters, truncated sections of the pri-RNA were cloned into a vector. Sequences 
to be cloned were produced using PCR from X.tropicalis genomic DNA and inserted into 
plasmid vector pGEM®-T Easy (Promega). PCR reaction was carried out using 100 ng 
genomic X.tropicalis DNA, and set up in 50 μl reactions as 2.3.4. Primer sequences, 
annealing temperatures and extension times are given in the table below (Table 2.5). 
PCR products were cleaned up as in 2.3.8, and ligation reactions, transformations, 
screening and sequencing as in 2.3.9.  
 
Table 2.5 Primers used for cloning  
Gene Forward primer Reverse primer AT ET 
mir-17-92 
cluster 
TGCAGTGAAGGCACTTGTAG TAAACAGGCCGGGACAAG 55°C 55s 
mir-106-
363 cluster 
TGCTGGACACCTGTACT TTCTGCGGTTTACAGATGGA 55°C 55s 
Sequences are given 5' to 3'. AT = annealing temperature, ET = elongation time, where s = 
seconds. 
2.3.11 Linearisation of plasmids  
Plasmids must be linearised to allow susbsequent RNA transcription. Plasmids were 
linearised in 100 μl reactions; 5 μg DNA was incubated with 3 μl enzyme and 10 μl 10x 
buffer, and incubated for 2 hours at 37°C. Restriction enzymes used were dependent on 
insert and plasmid (Table 2.6). Digests were run on a 2% agarose gel to check 
linearisation was completed, and templates were cleaned up by phenol-chloroform 
extraction and sodium acetate precipitation. 
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pCS2+dnFGFR4 Sal1 gift from Harumasa Okamoto 
(Hongo et al., 1999) 
pCS2+lin28a1CR Not1 Cloned by L.Faas from EST 
pCS2+lin28a2CR Not1 Cloned by L.Faas from EST 
pCS2+lin28bCR Not1 Cloned by L.Faas from EST 
2.3.12 In vitro transcription of functional mRNA  
Sense mRNA for injection was transcribed from linearised templates. Functional mRNA 
was transcribed using MEGAscript® SP6 transcription kit (Ambion) following 
manufacturer’s instructions, with methylated GTP cap analog (Ambion) to provide 
capped RNA, in a 20 μl reaction consisting of 2 μl 50 mM ATP, 2 μl 50 mM CTP, 2 μl 
50 mM UTP, 2 μl 5 mM GTP, 2.5 μl 40 mM G' cap, 2 μl 10x transcription buffer, 1 μl 
linearised template (1 μg/μl), 1 μl SP6 enzyme and 4.5 μl RNase-free water. 
RNA was checked on a 2% agarose gel, and RQ DNase (Promega) was added for 
2 minutes at 37°C to remove template DNA. RNA was then diluted with 115 μl water and 
15 μl 3 M ammonium acetate. One volume of phenol-chloroform was added, and the 
sample was vortexed and centrifuged for 5 minutes at 13,000g. The aqueous phase was 
removed to a new tube, and one volume of chloroform was added. The sample was 
vortexed, centrifuged and the aqueous layer removed as before. One volume of 
isopropanol was added and RNA was left on dry ice for 30 minutes to precipitate. 
Samples were then centrifuged for 15 minutes at 13,000g and the pellet washed in 70% 
ethanol. After being dried, the RNA was resuspended in 20 μl RNase-free water and 
stored at -80°C. 
2.3.13 In vitro transcription of pre-miRNA  
Pre-let-7g and pre-mir-363 were synthesised in vitro. DNA templates from which to 
synthesise RNA were created from PCR products, with an SP6 site inserted at the 
beginning of the sequence. PCRs were undertaken from genomic DNA for pre-let-7g and 
from a pri-miR-106-363 cluster plasmid for pre-mir-363, generated in 2.3.9. Primers are 
given in Table 2.7 and PCR conditions are given below: 
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94°C – 3 minutes 
94°C – 20 seconds 
57°C – 20 seconds                     22 cycles 
72°C – 10 seconds 
72°C – 5 minutes 
PCR products were cleaned up using a phenol-chloroform and precipitation procedure. 
RNA was synthesised using SP6 Megascript kit (Ambion) according to manufacturer’s 
instructions, without using the G' cap as used for mRNA, and cleaned up as in 2.3.12. 
 
Table 2.7 Primer sequences to synthesis templates for in vitro transcription of pre-miRNAs 







Sequences in grey corresponds to SP6 promoter recognition site. Remaining primer 
sequences cover the 3’ and 5’ ends of the pre-miRNA. Sequences are given 5' to 3'. 
2.3.14 In vitro transcription of digoxigenin labelled antisense RNA 
Antisense RNA was synthesised with digoxigenin (DIG) labelling for whole-mount in situ 
hybridisation. Plasmid templates were linearised as in 0. Synthesis was carried out using 
10x DIG labelling mix (Roche Diagnostics). Details of linearisation enzyme and RNA 
polymerase are listed in Table 2.8. 
  




Table 2.8 Clone information, restriction enzyme and polymerases used for in situ probes 
 
For in vitro transcription, reactions were set up with 10 μl 5x transcription buffer 
(Promega), 2.5 μl 10x DIG labelling mix (Roche), 5 μl 100 mM DTT, 2 μl (50 units) RNase 
inhibitor (Promega), 3 μl (150 units) SP6/T7/T3 polymerase as appropriate (Promega), 1-
2  μg linear DNA template, with RNase-free water up to 50  μl. 
The reaction was incubated initially at 37°C for 2 hours, with a further 2 hours after 
adding an additional 1 μl of the appropriate polymerase. 2 μl of the reaction was 
checked on an agarose gel, and template was then removed by incubating with 1 μl RQ1 
DNase (Promega) for 5 minutes at 37°C. After re-checking on a gel, the probe was 
cleaned up and precipitated by adding 50 μl water, 25 μl 10 M NH4OAc and 312.5 μl 
100% ethanol and left on dry ice for 1 hour. Probes were centrifuged for 15 minutes at 
13,000g, and the pellet was washed with 70% ethanol before being dried and 
resuspensed in 50 μl nuclease-free water. 
2.3.15 Whole-mount in situ hybridisation for mRNA 
Probes to be used were in vitro transcribed with DIG-labelling as in section 2.3.14. The 
method used was a modification of Harland (1991). Fixed embryos were allowed to 
warm to room temperature slowly at ambient temperature. Embryos were then washed 
for 10 minutes in 75% methanol/PBST (1x PBS, 0.01% Tween-20), followed by 10 minutes 
with 50% methanol/50% PBST, and then three times for 5 minutes in PBST. Embryos 
were treated with Proteinase K (Roche) at 10 μg/ml in PBST at room temperature for a 





Nsi1 T7 Cloned by F. Warrander 
pGEMmiR-106-363 
cluster  
Nco1 SP6 Cloned by F. Warrander 
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time dependent on stage. Embryos were then rinsed twice for 5 minutes in 0.1 M 
triethanolamine (pH7.8); to the second of these washes 12.5 μl acetic anhydride was 
added and after 5 minutes another 12.5 μl was added, for a further 5 minutes. Samples 
were washed twice in PBST and refixed in 3.7% formaldehyde for 20 minutes, which was 
followed by five further washes of 5 minutes in PBST. Embryos were pre-hybridised at 
60°C for 10 minutes in pre-hybridisation buffer (50% formamide (Ambion), 5x SSC, 
100 μg/ml heparin, 1x Denhart’s, 0.1% Tween-20, 0.1% CHAPS (Sigma), 10 mM EDTA) 
and then for a further 2 hours at 60°C in hybridisation buffer containing 1 mg/ml yeast 
RNA. The embryos were incubated overnight at 60°C with hybridisation buffer with DIG-
labelled probe. DIG-probes were heated to 80°C for 3 minutes before being added to 
hybridisation buffer. 
The next day, probe was removed and embryos were washed twice for 10 minutes in 
hybridisation buffer, then three times in 2x SSC + 0.1% Tween-20 for 20 minutes, and 
three times in 0.2x SSC + 0.1% Tween-20 for 30 minutes. The above washes were carried 
out at 60°C. Embryos were washed at room temperature twice for 15 minutes in 1x 
maleic acid buffer (MABT) (100 mM maleic acid, 150 mM NaCl, pH 7.8, 0.1% Tween-20), 
and subsequently blocked in 1x MABT with 2% Boehringer Mannheim Blocking Reagent 
(BMB, Roche) and 20% heat treated lamb serum (HTLS, Fisher) for 2 hours at room 
temperature. This was replaced with fresh solution containing anti-DIG antibody coupled 
to alkaline phosphatase (AP) (Roche) at 1/2000, and incubated overnight at 4°C.  
Embryos were then washed briefly three times in MABT, and then three times for 1 hour 
in MABT. Samples were washed for 10 minutes at room temperature in AP buffer 
(100 mM Tris, pH 9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% Tween-20), which was replaced 
with BM purple (Roche) and left at room temperature for colour to develop. Once 
developed, embryos were washed twice in PBST for 15 minutes, before being fixed 
overnight in 3.7% formaldehyde at room temperature. 
Embryos were bleached for photography in 5% hydrogen peroxide in PBST until pigment 
was lost. Embryos were subsequently washed twice for 15 minutes in PBST, and stored 
in 3.7% formaldehyde. 
2.3.16 Whole-mount in situ hybridisation for miRNA 
Probes used were 5’-DIG labelled miRNA detection probes (Exiqon), named 'hsa-miR-
363-3p', and 'xtr-miR-363*'. 
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Probes were pre-absorbed six times by repeating Day 1 with 40 embryos at stage 35 and 
hybridising with the probe overnight. Probe was used at 20 nM, in hybridisation buffer. 
Protocol was carried out according to Sweetman (2011), with adaptations made by G. 
Wheeler (UEA, personal communication). 
Fixed embryos were brought up to room temperature in methanol. They were 
rehydrated into PBST by a series of washes for 5 minutes; 75% methanol/25% PBST, 50% 
methanol/50% PBST, and twice with PBST. Embryos were treated with Proteinase K at 
10 μg/ml in PBST, for a time dependent on stage. Following two washes in PBST for 5 
minutes, embryos were re-fixed in 3.7% formaldehyde in PBST for 45 minutes. This was 
followed by two washes in PBST. Embryos were equilibrated into hybridisation buffer 
(500 ml: 250 ml formamide, 32.5 ml 20x SSC (pH 5, with citric acid), 25 ml 10% CHAPS, 
5 ml 20% Tween-20, 5 ml 0.5 M EDTA, 250 μl 200 mg/ml heparin, 1.25 ml 200 mg/ml 
yeast tRNA) with a 10 minute wash in 50% PBST/50% hybridisation buffer, and followed 
with a 10 minute wash in 100% hybridisation buffer. Hybridisation buffer was replaced 
and placed at hybridisation temperature for at least 2.5 hours (53°C for miR-363-3p, 55°C 
for miR-363-5p), which was then replaced with pre-warmed probe, pre-absorbed in 
hybridisation buffer, and incubated overnight.   
The probe was removed and kept, and embryos were then washed once for 10 minutes 
in hybridisation buffer, at hybridisation temperature. This was followed with two washes 
of 15 minutes in Wash buffer (50 ml: 25 ml formamide, 2.5 ml 20x SSC (pH 5, with citric 
acid), 250 μl 20% Tween-20), and one 10 minute wash in 50% MABT/50% Wash buffer, 
all at hybridisation temperature. Samples were then transferred to room temperature 
and two 30 minute washes in MABT were undertaken. Embryos were blocked for an 
hour in 2% BMB in MABT, and then a further hour in 2% BMB, 20% HTLS, in MABT. This 
solution was then replaced with anti-DIG AP antibody (1/2000 dilution, in 2% BMB + 20% 
HTLS in MABT) and rocked overnight at 4°C. 
Embryos were rinsed three times in MABT, and then washed six times for 1 hour in 
MABT, before replacing the solution and washing overnight at 4°C. Samples were 
washed for 10 minutes in NTMT (50 ml: 2.5 ml 1 M MgCl2, 1 ml 5 M NaCl, 5 ml 1 M Tris, 
pH 9.5, 2.5 ml 20% Tween-20), before being replaced with colour mix (NBT/BCIP in 
NTMT; 9:1000 of NBT at 75 mg/ml in 70% DMF, 7:1000 of BCIP at 50 mg/ml in 100% 
DMF) and incubated until colour began to appear. 
When colour began to develop, embryos were transferred to 5x TBST, and washed at 
room temperature or overnight at 4°C in fresh TBST. They were then put through repeat 
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cycles of colour mix and TBST washes until strong specific signal could be seen. Embryos 
were then fixed in 3.7% formaldehyde and bleached in 5% hydrogen peroxide to remove 
pigment, before being stored in fixative. 
2.3.17 Radioactivity labelling 
RNA oligonucleotides were labelled using the KinaseMax kit (Ambion) according to 
manufacturer’s instructions. 2 µM RNA oligonucleotide was incubated with 1x kinase 
buffer, 1 μl ATP [γ -
32
P]- 5 mCi/ml (Perkin Elmer), and 1 µl kinase at 37°C for one hour. 
The reaction was halted by placing on ice before continuing. For long RNA sequences 
(pre-miRNA), the reaction was placed at 95°C for 2 minutes before cooling slowly to 
allow proper annealing. 
2.3.18 Electrophoretic mobility shift assay (EMSA) with recombinant 
protein 
EMSAs were performed with recombinant protein, made in the the Anston lab (York 
Structural Biology Laboratory) in buffer (20 mM Tris pH 7.5, 150 mM NaCl, 10% sucrose, 
0.5 mM DTT). Recombinant protein sequences are shown in Table 2.9. 
 





















RNA oligonucleotides (Dharmacon), listed in Table 2.10, and precursor miRNA 
(synthesised in 2.3.13) were labelled as in 2.3.17. Probe was diluted 1:2 and 1 µl used per 
10 µl binding reaction. Reaction was carried out as in Piskounova et al. (2008). Radio-
labelled RNA was incubated with protein in binding buffer (60 mM KCl, 10 mM HEPES, 
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pH 7.6, 3 mM MgCl2, 5% glycerol, 1 mM DTT, 5 μg/μl heparin (Sigma) and 150 ng yeast 
total RNA competitor (Ambion)) for 30 minutes at room temperature. 
Loading buffer (Promega) was added 1:6 to binding reactions, which were run on a 10% 
native gel (10% acrylamide, 0.5x TB, set with APS and TEMED) and run in 0.5x TB (1 L 5x 
TB buffer: 27.5 g boric acid, 53 g Tris, in water).  Gels were run until unincorporated 
radioactivity was eluted from the gel with Orange G dye front. Gels were fixed in 10% 
methanol with 10% acetic acid in water, and dried down on Whatmann paper. Gels were 
exposed either to a Phosphor Screen (GE Healthcare) and were scanned, processed and 
analysed using a Bio-Rad Molecular FX Imager and Quantity One software (Bio-Rad); or 
exposed to Hyperfilm ECL film (Amersham) and films analysed using Image J. Analysis 
was performed on bands as a measure of volume or density, with background 
normalisation to the no-protein reaction 'bound' area. Proportion bound was calculated 
and plotted using SigmaPlot with the equation:  
Proportion bound = Bmax [lin28] 
          Kd + [lin28] 
 
Table 2.10 RNA oligonucleotide sequences 
RNA Sequence 
L-let-7g  UUUGAGGGUCUAUGAUACCACCCGGUACAGGAGAU 
L-mir-138 UUGUGAAUCAGGCCGUGACCACUCAGAAAACGGCUACUUCACAAC 
L-mir-363  UGCAAUUUUAUUUAGUUUGGUAGGAGAAAAAUUGC 
mL-mir-363  UGCAAUUUUAUUUAGUUUGGUAUGAUAAAAAUUGC 
Sequences are given 5' to 3'. 
2.3.19 EMSAs using in vivo translated protein 
EMSAs used embryo lysates from X. laevis embryos, either uninjected controls, or having 
been injected with 1 ng of mRNA to overexpress lin28a1, lin28a2 or lin28b. 
Frozen X. laevis embryos were lysed in lysis buffer (50 mM Tris-HCl pH 7.9, 25% glycerol, 
50 mM KCl, 2 mM DTT, 0.1 mM EDTA, 1/100 Protease inhibitor cocktail III (Calbiochem)) 
at 10 μl/embryo and homogenised by pipetting. Lysate was then centrifuged at 13,000g 
for 10 minutes at 4°C. The supernatant was centrifuged again for 5 minutes, and 
supernatant removed to a new tube, which was then used in binding reactions as for 
recombinant proteins. Extract was diluted as required in the lysis buffer, and 3 μl used 
per binding reaction. Supershifts were also performed when using embryo extract, to 
confirm that any shift seen was a result of the protein being overexpressed, and not due 
to changes in expression of alternative proteins. To perform these, anti-lin28 antibodies 
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(Enzo Life Sciences (UK) Ltd, custom produced, raised against peptides from the X. 
tropicalis protein sequences) were used at 1/20 dilution per binding reaction, with 1/20 
dilution pre-immune bleed used as a serum control. 20 units of RNAsin (Promega) were 
added per binding reaction with embryo lysates, due to the presence of RNases in serum 
and extract. Antibody was pre-incubated with protein and binding buffer for 20 minutes 
on ice, before labelled probe was added for a further 20 minutes at room temperature. 
Binding buffer and remainder of protocol was as in 2.3.18. 
2.3.20 Western blots 
Protein extraction from human cells 
Medium was removed from cells in culture and washed with ice cold 1x PBS. 300 μl 
PhosphoSafe (Novagen) was added per well of 6-well plates. Samples were incubated at 
room temperature for 5 minutes, and lysate was scraped into a tube. Samples were then 
centrifuged at 13,000g for 5 minutes and supernatant removed to a new tube. 
Protein concentrations were measured using a BCA protein assay kit (Pierce) as per 
instructions. BSA standards were made up and spectrophotometric change at 562 nm 
read using a plate reader from 96-well plates after the addition of working solution, and 
a standard curve was drawn. Samples were read in triplicate, and average reading was 
used and compared to the standard curve to determine protein concentration in the 
cellular extracts. 8 μg per sample was used for a western blot. 
Protein extraction from X. tropicalis 
Frozen embryos were lysed in PhosphoSafe (Novagen) at 40 μl/10 embryos and 
homogenised using a pipette tip.  Lysates were centrifuged at 13,000g for 5 minutes and 
30 μl supernatant removed to a fresh tube. Protein extracted from cells or Xenopus was 
used in equal amounts.  
SDS-PAGE and western blotting 
 SDS-PAGE was performed using the Biorad miniProtean II PAGE equipment. 5x SDS-
PAGE loading buffer (final concentrations: 250 mM Tris, pH 6.8, 10% SDS, 30% glycerol, 
250 mM DTT, bromophenol blue to colour) was added to protein samples, which were 
heated to 100°C for 2 minutes. Samples were loaded onto a 12% SDS PAGE acrylamide 
gel (10 ml resolving gel: 3.3 ml water, 4 ml 30% acrylamide mix (Sigma), 2. 5ml 1.5 M 
Tris, pH 8.8, 100 μl 10% SDS, 100 μl 10% APS, 10 μl TEMED; 5 ml stacking gel: 3.4 ml 
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water, 830 μl 30% acrylamide (Bio-Rad), 630 μl 1 M Tris, pH 6.8, 40 μl 10% SDS, 40 μl 
10% APS, 5 μl TEMED) alongside 5 µl Pageruler prestained protein ladder (Fermentas), 
and run in 1x running buffer (1 L 10x buffer: 15 g Tris-base, 72 g glycine, 50 ml 10% SDS, 
pH 8.3). Gels were run at 100 V through the stacking gel, then 200 V for 50 minutes. The 
gel was subsequently transferred for 2 hours at 100 V onto a PVDF membrane (Millipore) 
using the Trans-Blot system (Bio-Rad). PVDF membrane was saturated in 100% methanol 
and equilibrated into 1x transfer buffer (1 L 1x buffer: 5.8 g Tris base, 4.35 g glycine, 
100 ml methanol, pH 8.8) prior to transfer. 
The membrane was washed twice in PBST for 5 minutes and subsequently blocked in 
PBST + 5% Marvel milk powder for one hour. Blocking solution was replaced with PBST + 
5% milk containing primary antibody and rocked overnight at 4°C. Antibody 
concentrations are given below (Table 2.11). The membrane was washed three times for 
15 minutes in PBSAT, and then rocked for 2 hours in PBST + 5% milk with a species-
compatible horseradish peroxidase (HRP) secondary antibody (Table 2.12) at room 
temperature, with subsequent washing in PBST as before. The BM Chemiluminescent 
Substrate Kit (Roche) was used to detect protein expression according to manufacturer’s 
instructions, and membrane was exposed to Hyperfilm ECL film (Amersham) to visualise 
expression. 
When further antibody exposures were needed, the membrane was stripped in stripping 
buffer (100 ml: 0.3 g DTT, 2 ml 1 M Tris, pH 6.8, 500 µl 10% SDS, pH to 6.8 and made up 
to 100 ml with distilled water) at 55°C for 20 minutes, and washed five times in PBST. It 
was subsequently blocked and probed with antibody as previously. 
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Table 2.11 Primary antibody concentrations for western blots 






(Cat # M9692 
1/4000 1/4000 Mouse   
Total ERK (Sigma) 
(Cat # M5670) 
1/80,000 1/4000 Rabbit  
GAPDH (Sigma) 
(Cat # G8795) 
1/100,000 1/100,000 Mouse   
lin28a (Abcam) 
(Cat # ab46020) 
Not used 1/20,000 Rabbit 
lin28b (Abcam) 
(Cat #  ab71415) 
Not used 1/2000 Rabbit 
lin28a (Enzo Life 
Sciences (UK) Ltd, 
custom produced) 
1/10,000 Not used Rabbit 
lin28b (Enzo Life 
Sciences (UK) Ltd, 
custom produced) 
1/10,000 Not used Rabbit 
 





Anti-mouse HRP (GE 
Healthcare) 
(Cat # NA931) 
1:4000 1:4000 
Anti-rabbit HRP (Abcam) 
(Cat # ab6721) 
1:4000 1:4000 
2.3.21 Xenopus dpERK immunostaining 
Fixed embryos were rehydrated in 1x PBS through 15 minute stage dilutions with 
methanol (75%, 50%, 0%) and rocked for 40 minutes in potassium dichromate in 5% 
acetic acid. Embryos were washed in PBS three times for 5 minutes, and three times for 
30 minutes, until embryos were clear of orange stain; embryos were subsequently 
bleached in 5% H2O2 in PBS for 40 minutes, and washed again in PBS. The embryos were 
then blocked in BBT (1x PBS, 1% BSA, 0.1% Triton X-100) twice for one hour, and again 
for an hour in BBT + 5% horse serum (VectorLabs). Embryos were rocked overnight at 
4°C with anti-dpERK antibody (Sigma) at 1/10,000 in BBT with 5% horse serum. Four 
washes of an hour with BBT, and one hour with BBT + 5% horse serum were undertaken, 
before incubating embryos with secondary anti-mouse IgG-AP-conjugated antibody 
 Materials and methods 
72 
 
(VectorLabs) overnight at 4°C. Embryos were then washed for one hour in BBT, then for 
four hours in PBST. Protein expression was detected using BMPurple (Roche). Once a 
signal had developed, embryos were washed twice for 15 minutes in PBS and stored in 
3.7% formaldehyde in PBS. 
2.4 Microarray and bioinformatics analysis  
2.4.1 miRNA affymetrix microarray  
RNA to be used for Affymetrix miRNA microarray analysis was isolated according to 
2.3.6, with 1 μg used per sample. All further laboratory work was carried out by the 
Departmental Technology Facility, which is provided as a full service.  The quality of the 
RNA was verified using the Agilent 2011 Bioanalyzer (Agilent).  RNA was labelled using 
HSR FlashTag Biotin RNA labelling kit (Genisphere) according to manufacturer's 
instructions, which included the addition of spike-in RNA controls to act as a method 
control. Samples were then hybridised to Genechips miRNA 2.0 (Affymetrix) overnight, 
and washed on a Fluidics Station 450 (Affymetrix), all carried out according to 
manufacturer's instructions. Scanning of the chips was carried out using an Affymetrix 
Genechip Scanner. 
Data was analysed using QC tools (Affymetrix) to provide background detection and 
normalisation, and statistical comparisons were carried out using BRB-ArrayTools 
(developed by Dr. Richard Simon and BRB-ArrayTools Development Team, 
http://linus.nci.nih.gov/BRB-ArrayTools.html). 
2.4.2 mRNA human genome Agilent microarray  
Samples of human MSC RNA were isolated according to 2.3.6. All further laboratory work 
and analysis was carried out by the Departmental Technology Facility, which is provided 
as a full service.  100 ng of RNA was used per sample. This was labelled with Cy3 dye 
using the Low-Input RNA Amplification Kit (Agilent), according to manufacturer's 
instructions. The arrays used were SurePrint G3 Human GE 8x60k arrays (Agilent), and 
array scanning was carried out on the DNA Microarray Scanner (Agilent). Analysis was 
performed using GeneSpring (Agilent Technologies). 
2.4.3 Sequence alignments 
Protein homology percentages were calculated using Vector NTI (Invitrogen). Alignments 
of RNA and protein sequences were performed using Clustal X2.
 Characterising expression of lin28 genes in X. tropicalis 
73 
 
Chapter 3. Characterising expression of lin28 genes in 
X. tropicalis 
3.1 Introduction 
3.1.1 lin28a as a putative FGF target 
The gene lin28a was identified as one of a number of genes that showed altered 
expression upon inhibition of FGF signalling in previous work, which was investigating 
novel FGF targets during gastrulation in Xenopus embryos using an Affymetrix array to 
allow a large scale investigation (Branney et al., 2009). In this study, dominant negative 
forms of both FGFR1 and FGFR4 were overexpressed, which individually had previously 
been found to successfully block FGF downstream signalling and resulted in embryos with 
varying developmental defects; overexpressing these constructs effectively reduced all 
FGF signalling (Amaya et al., 1991; Hongo et al., 1999). This is likely to occur through 
promiscuous heterodimerisation with available FGFRs within the cell despite any ligand-
receptor preferences. The study by Branney et al. (2009) showed that overexpressing 
either of these receptors resulted in dysregulation of a similar set of genes. Of these, 
lin28a was identified as showing a 2.7 fold inhibition following the blocking of FGF 
signalling. 
3.1.2 lin28 expression 
Within the literature, studies have identified lin28a as being expressed in pluripotent cells 
and downregulated upon differentiation, shown both in stem cell culture populations, 
with rapid downregulation of the expression of both RNA and protein upon forming 
embryoid bodies, and also in vivo (Darr and Benvenisty, 2009; Moss and Tang, 2003; 
Polesskaya et al., 2007; Richards et al., 2004); a more extensive study into lin28a protein 
expression, showing similar results, has been carried out during murine development 
(Yang and Moss, 2003). In comparison, lin28b has not been as widely studied, but was first 
identified in hepatocarcinoma cells and additionally found to be expressed in testis, fetal 
liver and placental tissues (Guo et al., 2006). Both genes have been shown to be expressed 
in numerous cancer cells, in both primary tumours and transformed cell lines 
(Viswanathan et al., 2009). However, there has been no definitive comparison of 
expression analysis between lin28a and lin28b during development. Therefore it is 
imperative to explore the developmental expression patterns of the two lin28 genes, 
which may indicate both overlapping and distinct roles for the two proteins. 
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The possibility that FGF signalling regulates lin28a could potentially provide an exciting 
insight into the role of FGF in pluripotency, with the knowledge that lin28a is pluripotency-
specific and the current understanding of the differentiation functions of FGF signalling 
being at odds with the requirement for its presence in stem cell culture. Alternatively, as 
lin28a was identified as a possible target of FGF signalling during gastrulation, perhaps the 
lin28s play a role at this time in mediating FGF signalling and subsequently influence the 
development of mesoderm and neural differentiation. 
3.1.3 Aims 
The aims of this chapter are to: 
• To investigate the role of FGF signalling in expression of lin28a and lin28b 
• To identify when and where lin28 genes are expressed during early Xenopus 
development 
3.2 Results 
3.2.1 FGF signalling in the gastrula embryo 
To follow up the findings by Branney et al. (2009), experiments were carried out at stage 
10.5 in X. tropicalis. FGF signalling is known to occur at this stage in development, in tissue 
around the developing blastopore lip, known as the presumptive mesoderm. This is 
demonstrated by the presence of RNA coding for the FGF ligand FGF-8 (Figure 3.1A), and 
diphospho-ERK (dpERK) protein (Figure 3.1B), a rapid downstream response of FGF 
signalling, which is localised to this same area. 
 
Figure 3.1 Analysis of FGF signalling in gastrula-stage embryos 
Embryos showing expression of A) FGF-8 ligand RNA by in situ hybridisation and B) dpERK 
protein, phosphorylated downstream of FGF signalling, by whole mount 
immunohistochemistry. Embryos are viewed vegetally (veg), with dorsal side to the top. 
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3.2.2 lin28 genes as targets of FGF signalling 
Despite only lin28a being identified as a novel putative target of FGF signalling in the 
Affymetrix screen (Branney et al., 2009), both related genes, lin28a and lin28b, were 
investigated to validate and confirm them as FGF targets. FGF signalling was inhibited in 
embryos through the use of a dominant negative FGF receptor. 1 ng of dominant negative 
FGF receptor 4 (dnFGFR) mRNA was injected into X. tropicalis embryos which were then 
collected at gastrula stage 10.5, alongside uninjected controls. 
The phosphorylation of ERK is a rapid downstream response to FGF signalling, and was 
used as an indicator of inhibition of FGF signalling. Levels were investigated in gastrula 
stage embryos by western blot and whole-mount immunohistochemistry, following 
injection with dnFGFR. In accordance with a decrease in FGF signalling, levels of dpERK 
were reduced in dnFGFR-injected embryos compared to controls (Figure 3.2).  
               
Figure 3.2 Effects of FGF signalling on dpERK levels 
Embryos were injected with 1 ng dnFGFR mRNA and collected with uninjected controls at 
stage 10.5; protein was analysed by A) western blot and B) whole mount 
immunohistochemistry. Lower levels of dpERK indicate decreased FGF signalling. A) Total ERK 
(phosphorylated and unphosphorylated) and GAPDH were used as loading controls. Images 
represent three independent samples. B) Embryos are viewed vegetally (veg), with dorsal to 
the top. 
Embryos were collected at gastrula stage and analysed for expression of the lin28 genes by 
qRT-PCR and whole-mount in situ hybridisation. Inhibition of the FGF signalling pathway 
was confirmed at the transcriptional level by qRT-PCR for the known FGF target brachyury, 
which showed a significant decrease in expression in dnFGFR-injected embryos to 25% of 
control expression (Figure 3.3). Similarly, the lin28 genes also showed a significant 
decrease in expression when FGF signalling was inhibited, however not to the same extent 
as seen with brachyury. The loss of lin28a was greater than that of lin28b, with a reduction 
of 45% of expression of lin28a following inhibition of FGF signalling when compared to 
controls, and a 33% reduction in lin28b levels (Figure 3.3).    




Figure 3.3 Effects of FGF signalling on brachyury and lin28 genes, analysed by qRT-PCR  
qRT-PCR was performed on RNA from embryos injected with 1 ng dnFGFR mRNA and 
uninjected controls at stage 10.5. Fold change in expression of RNAs is shown compared to 
controls and normalised to ODC by the 2
-ΔΔCt
 method. Fold change is given as average of three 
biological replicates. Error bars represent standard error (SE). Significance calculated by t-test: 
***p<0.001. 
The location and any changes in pattern of RNA expression was observed using whole-
mount in situ hybridisation. Interestingly, in wild-type embryos, the pattern of expression 
seen for both lin28a and lin28b was surrounding the blastopore lip in the presumptive 
mesoderm, an overlap with the known region of FGF ligand expression and signalling seen 
in Figure 3.1. 
Following inhibition of FGF signalling, expression of both lin28a and lin28b was reduced 
around the blastopore lip, however some retention of expression was observed at the 
dorsal side (Figure 3.4). This dorsal expression remained at a similar level to expression in 
control embryos for lin28a, and appeared slightly enriched for lin28b.    
  




Figure 3.4 Analysis of lin28 genes by whole-mount in situ hybridisation following FGF 
signalling inhibition 
In situ hybridisation in uninjected control embryos or those injected with 1 ng dnFGFR mRNA, 
for expression of lin28a and lin28b. For lin28a, 96% from n=45 showed similar knockdown 
expression, for lin28b this was 84% from n=43. Representative images are shown; experiment 
was carried out in four biological replicates. Embryos are viewed vegetally (veg), with dorsal to 
the top. 
3.2.3 Timing of expression of lin28 genes during development  
The timing and location of gene expression can give an indication to its function and role; 
these were investigated for the lin28 genes using qRT-PCR and whole-mount in situ 
hybridisation during embryological development. As the lin28a1 and lin28a2 isoforms 
show very high sequence identity, these methods detected both forms of lin28a, due to 
design of primers and probes. 
RNA levels for lin28a and lin28b in early stages of embryos following fertilisation, from 1-
cell through to late gastrulation stages, were documented in sibling embryos using qRT-
PCR. Expression was calibrated to the stage at which highest expression was detected, 
which varied for the two genes. lin28b was found to be expressed during the earliest 
stages, which would represent maternally deposited RNAs in the oocyte. However, lin28a 
levels remained low in the embryo until MBT and the activation of zygotic transcription, 
where levels were seen to rapidly increase and were maintained at this level of expression. 
lin28b also showed an increase in expression at this time, peaking in expression at stage 
10, before levels were seen to reduce, but the gene remained expressed (Figure 3.5). 




Figure 3.5 Analysis of lin28a and lin28b gene expression during early development by qRT-
PCR 
qRT-PCR was performed on sibling embryos from 1-cell through to stage 12. Expression was 
normalised to housekeeping gene ODC using the 2
-∆∆Ct
 method, and calibrated to the highest 
expression for either gene (lin28a – stage 12 , lin28b – stage 10). Error bars show SE of 
technical replicates. Expression trends are representative of n=2. 
3.2.4 Localisation of lin28a expression during development 
This trend in lin28a expression is further seen using whole-mount in situ hybridisation.  
Only a very low level of expression was detectable before zygotic transcription (Figure 
3.6A-F). Expression began to show localisation to the animal hemisphere at stage 8 (Figure 
3.6G), and at stage 9 expression was detected within the marginal zone (Figure 3.6H). 
From gastrulation, the RNA levels were much more readily detectable, in line with the qRT-
PCR data. lin28a was found in the presumptive mesoderm at gastrula stage (Figure 3.6I), as 
shown in Figure 3.4; this is confirmed upon looking inside the embryo, this expression can 
be seen to be located in the deep sensorial cells of the embryo, below the surface 
ectoderm cells (Figure 3.6I'). During neurulation, expression of lin28a at stage 13 was 
through the dorsal midline, which may be localised to the notochord; additionally, 
expression was detected at stages 13 and 17 through the developing dorsal plate, together 
with anterior neural crest expression and posterior expression that may be in the neural 
plate or mesodermally derived tissue (Figure 3.6J, K). In the tailbud and early tadpole 
stages, expression of lin28a had become further restricted.  Expression was still 
predominantly dorsal in tailbud embryos (Figure 3.6L, M), but by stage 30 was present in 
the branchial arches and heart, the pronephros and developing nephric duct,  and dorsal 
of the cement gland, which may correspond to cranial mesoderm. Dorsal expression was 
found within the midbrain-hindbrain junction and at the very dorsal tip of the tailbud; 
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lower level expression which extended along the dorsal side of the embryo may 
correspond to neural or somite expression (Figure 3.6N). By stage 35 (Figure 3.6O), 
however, expression only persisted in the branchial arches. 
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3.2.5 Localisation of lin28b expression during development 
When studying expression of lin28b, there are both similarities and striking differences in 
the patterning of this gene compared to lin28a. The difference seen in maternal 
expression by qRT-PCR persisted here, with the detection of lin28b at stages prior to 
zygotic transcription, which was restricted to the animal hemisphere (Figure 3.7A-G). 
Expression in late blastula embryos was, as for lin28a, in the marginal zone (Figure 3.7H). 
As discussed previously, lin28b expression overlaps with lin28a in the developing gastrula, 
in the presumptive mesoderm surrounding the blastopore lip within the deep cells (Figure 
3.7I). Upon neurulation, lin28b was located around the developing neural plate, but not 
through the dorsal midline, and with strong anterior and posterior patterning as for lin28a 
(Figure 3.7J, K). By stage 20, expression in the posterior embryo appeared restricted to 
mesoderm, with prominent anterior neural patterning (Figure 3.7L). In the later tailbud, 
expression of lin28b was more widespread than lin28a, and was surrounding the eye, in 
the forebrain extending through the neural system, and in regions that would go on to 
form the branchial arches (Figure 3.7M), where it remained present in the tadpole 
embryos (Figure 3.7N, O). By stage 30, some overlap in expression was again seen 
between lin28a and lin28b, in the branchial arches and along the embryo dorsally, which 
may represent neural tissue or the dorsolateral and ventromedial somite lips. The 
expression of lin28b in the latter area was stronger than of lin28a. The nephric duct, 
branchial arches and potential cranial mesoderm also showed a similar expression pattern 
for the two genes. Differences existed, however, as lin28b was absent in the cardiac tissue 
and instead featured in the otic vesicle and persisted in the eye (Figure 3.7N). By stage 35, 
as for lin28a, expression of lin28b was only detected in the branchial arches and at low 
levels along the nephric duct (Figure 3.7O). 
 
























































































































































































































































































































3.3.1 FGF signalling regulates lin28a and lin28b during gastrulation 
It is known that the overexpression of dnFGFR4 is a potent inhibitor of FGF signalling 
(Branney et al., 2009; Hongo et al., 1999), which has been confirmed here as being 
effective through an inhibition of FGF targets, both investigating dpERK and brachyury 
levels. dpERK  is known to be downstream of multiple signalling pathways, but this early 
activity in gastrula stage embryos was discovered to be dependent upon only FGF 
expression (Christen and Slack, 1999), therefore the changes in expression  seen at the 
gastrula stage were caused by dysregulation of FGF signalling. Brachyury similarly has been 
shown to be an FGF target at this stage, with expression reduced following the inhibition 
of FGF signalling through dominant negative receptor expression (Amaya et al., 1993; 
Isaacs et al., 1994), which was also seen here.  
Experiments here found that the inhibition of FGF signalling resulted in a decreased 
expression of both of the lin28 genes, which indicates that the lin28 genes are positive 
regulatory targets of FGF, with FGF necessary to maintain their expression at a normal 
endogenous level. This result confirms that seen for lin28a in previous work, although the 
decrease in expression seen by Branney and coworkers (2009) was more dramatic, with a 
63% drop in expression levels compared to 55% seen here. The overlap in expression of 
lin28 RNAs with a domain of active FGF signalling in gastrula embryos increases the 
likelihood of an interaction. These experiments demonstrated localisation around the 
blastopore of FGF-8; previous research has shown the strong expression of this and more 
FGF ligands to the same restricted area, including FGF-3, FGF-4 and FGF-20 (Christen and 
Slack, 1997; Isaacs et al., 1995; Lea et al., 2009; Lombardo et al., 1998), and thus with this 
varied expression and the use of pathway inhibition it cannot be determined here which 
FGF ligand is responsible for the regulation of lin28 expression. 
There was a larger reduction in the level of lin28a expression compared to lin28b, which 
also showed stronger dorsal retention of expression following dnFGFR expression. These 
results may indicate that lin28b is less influenced by FGF transcriptional regulation than 
lin28a, and this is at least true of the earlier lin28b expression during the cleavage stages. 
Maternally deposited RNAs are outside of the transcriptional control of signalling 
pathways such as FGF signalling, and so it is possible that the reduced loss of lin28b mRNA 
seen when compared to lin28a or brachyury may be affected by the persistence of such 
maternal RNA. The failure to reduce expression of both lin28a and lin28b to the same 
extent as brachyury suggests that although FGF is important for correct expression of the 
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lin28 genes, it is not the only factor that is governing their expression; these additional 
regulatory pathways remain currently unidentified. 
3.3.2 Potential for further FGF regulation of lin28s in development 
Co-expression of lin28a and lin28b with FGF ligands continues to occur in later 
development. Areas of both lin28a and lin28b expression include the branchial arches, 
which have been found to express the ligands FGF-2, FGF-3, FGF-7, FGF-8, FGF-10, FGF-20 
(Lea et al., 2009). Further examples of co-expression of the lin28s with FGFs include the 
midbrain-hindbrain junction, where FGF-3, FGF-4, and FGF-8 are localised; the cranial 
mesoderm also with FGF-8 and FGF-20 expression; and the tailbud, which contains 
expression of ligands FGF-2, FGF-3, FGF-4, FGF-8, and FGF-20 (Christen and Slack, 1997; 
Lea et al., 2009). Weak expression in the pronephros was found for FGF-2 and FGF-8 which 
do not extend along the nephric duct, but instead expression of FGFR1 and FGFR2 mirrors 
the expression in these areas of the lin28s (Christen and Slack, 1997; Lea et al., 2009), 
indicating the potential of these tissues to respond to FGF signals. Expression of many FGF 
ligands overlaps with lin28b expression in the otic vesicle and the eye, but none of these 
ligands show the same dorsal expression along the length of the embryo (Lea et al., 2009). 
These multiple areas of co-expression strengthen the hypothesis that some regulation via 
the FGF pathway may occur. Work in chicken and mouse embryos has found dynamic 
expression of lin28a in the developing limb buds (Yokoyama et al., 2008), and with the 
process of limb development requiring FGF-8 and FGF-10 signalling (Mariani et al., 2008), 
the possibility that FGF signalling influences lin28 expression is further strengthened. 
Work here has not, however, determined if the lin28 genes are subject to regulation by 
FGF during these later developmental stages. Using the current method of FGF signalling 
inhibition, any effects at later stages would be masked by the misregulation caused in 
lin28a and lin28b by gastrulation stages, and an alternative method would need to be 
employed to investigate any regulation in later development whilst allowing normal 
gastrula development. With no available drugs to target all FGF signalling, as the 
commonly used SU5402 and PD173074 both target only FGFR1 (Skaper et al., 2000), the 
best available option to study this is through the use of transgenics (Kroll and Amaya, 
1996; Pownall et al., 1998). Kroll and Amaya (1996) were able to successfully overexpress a 
dominant negative FGF receptor during gastrulation or neurulation, depending upon the 
promoter used, without affecting the role of FGF in mesoderm specification, and could 
then investigate its role specifically during later stages of embryogenesis. 
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3.3.3 Expression of lin28 genes during pluripotency 
During the earliest stages of Xenopus development, it was found that lin28b was expressed 
maternally, but lin28a was not. There was, however, expression of lin28a from the onset 
of zygotic transcription. This has also been confirmed at the protein level (Faas et al., 
2012), suggesting an early developmental role for these proteins. 
In mammalian development, expression of the lin28 genes has been detected in ES cells, 
and as such these genes are linked with pluripotency. In human development, the first 
zygotic transcription occurs much earlier than in Xenopus, with transcription occurring by 
the 4-cell stage (Braude et al., 1988; Tesařík et al., 1986), and ES cells are subsequently 
collected from the ICM of blastocyst embryos (Evans and Kaufman, 1981; Martin, 1981) 
and can differentiate into all tissue types. In Xenopus, zygotic transcription does not occur 
until MBT is completed, just before gastrulation (Newport and Kirschner, 1982), and work 
here has shown expression of lin28b and lin28a in late blastula embryos is first restricted 
to the animal hemisphere; this consists of cells that are subjected to inductive signalling 
events and would be capable of differentiation into a multitude of tissue types. Expression 
of both genes is then restricted to the marginal zone and presumptive mesoderm upon the 
beginning of gastrulation. This expression is more restricted compared to the mouse 
embryo, where expression of lin28a protein at the beginning of gastrulation during E6.5 
was found across all three germ layers of the embryo (Yang and Moss, 2003). 
This work suggests that although both lin28a and lin28b in Xenopus were expressed in 
multipotent cells, capable of a diverse range of differentiation dependent on inductive 
signals, the expression of at least lin28a was more restricted than in mammalian tissues, in 
which it is expressed in a larger number of cells and for a more prolonged period of time. 
This may indicate wider functions for lin28a in mammalian tissue, but further 
investigations are needed to determine what these could be. 
3.3.4 The importance of lin28 genes during gastrulation 
An important role may be being played by these genes during gastrulation, indicated in 
part by an increase in RNA levels of both lin28a and lin28b at this time. This work supports 
and expands on findings by Moss and Tang (2003), who first detected Xenopus lin28a 
protein during gastrulation, as we also detected lin28a following MBT in gastrula stage 
embryos, but found this to occur earlier than the developmental stage that they had 
investigated (stage 11). The expression of both lin28a and lin28b in the gastrulating 
embryo is within the deep cells which are those responding to the inductive signals from 
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gastrulation. Additionally, FGF signalling is a key occurrence during germ layer 
development, and the regulation of lin28s by this pathway strengthens the hypothesis that 
a vital role is being undertaken by these genes at this stage of development, which will be 
further investigated.  
3.3.5 Conservation of lin28a expression 
The expression patterns of lin28a uncovered here show correlation to previously published 
work. 
In C. elegans and D. melanogaster, expression of lin-28 RNA and protein was found in late 
embryogenesis and early larval stages, being absent from adults (Moss et al., 1997; Moss 
and Tang, 2003). Differences were seen, however, between the RNA and protein 
expression. Levels of protein were reduced after the first larval stage in each species, 
although Drosophila later showed a resurgence of protein by pupal development, whereas 
the level of RNA remained more constant, suggesting a possibility of post-transcriptional 
control over the protein production during their development. 
Previous work on Xenopus found protein expression of lin28a was maintained from 
gastrulation though to stage 40 (Moss and Tang, 2003), and although stage 35 was the 
latest stage studied here, RNA expression was seen to persist in the X. tropicalis embryo 
until at least this stage for both lin28a and lin28b.  
A more extensive study looking at the areas to which lin28a protein was located during 
development was carried out in mice. Research found that during organogenesis at E9.5, 
expression was beginning to show restriction to particular tissues, which included the 
branchial arches and the myocardium of the heart (Yang and Moss, 2003). During later 
development, lin28 was further restricted to tissue types including the myotome of 
somites, some tubules in the developing kidney and the foregut epithelium. Embryonic 
analysis ended at E17.5, at which stage lin28a expression remained in the myocardium and 
epithelia covering skeletal muscles and the body surface. This was then compared to adult 
expression, where lin28 remained in the myocardium, the transit cells in the gut epithelia, 
and restricted structures within the kidney (Yang and Moss, 2003), retaining expression in 
cells which have the capability to rapidly turnover and regenerate. The detection of 
Xenopus lin28a RNA within the heart, branchial arches and pronephros and nephric duct 
supports previous findings of lin28 protein in equivalent developing murine structures 
(Yang and Moss, 2003). Expression of lin28a does not appear to persist in the heart at the 
latest tadpole stage studied, however there may simply be stable and persistent 
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expression of the protein, which would explain that which was detected in the mouse 
study. Were the dorsal expression in late tailbud embryos to be located in the dorsolateral 
and ventromedial somite lips, as opposed to the neural tissue, this would suggest that 
proliferative muscle-forming cells express lin28a, consistent with previous work (Yang and 
Moss, 2003; Yokoyama et al., 2008). A study using embryoid bodies found lin28a 
expression in developing primordial germ cells, and the surrounding posterior mesoderm 
(West et al., 2009). This is in agreement with the mesodermal localisation seen here in the 
Xenopus, although there does not appear to be germ cell expression. 
With differences between reported protein expression of lin28a and our observations at 
the mRNA level, characterisation of the protein locations for both lin28a and lin28b in 
Xenopus would further aid the understanding of their functions. 
3.3.6 Differences between lin28a and lin28b expression 
The large number of similar expression domains for lin28a and lin28b, and known 
overlapping roles such as in the regulation of let-7 (Viswanathan et al., 2008), suggest that 
a level of redundancy may exist between the proteins. The finding of the genes in separate 
cancer tissues may indicate the presence of some degree of redundancy in their functions, 
at least with regards to their role in cancer transformation; the same research also showed 
that lin28a and lin28b were found in different subcellular locations and acted in distinct 
ways to regulate let-7 (Piskounova et al., 2011), indicating important differences between 
the proteins. Differences in the expression patterns of the two genes were seen through 
Xenopus development, with lin28b showing a more widespread expression throughout 
much of development. As previously demonstrated in Chapter 3, lin28b is present 
maternally, suggesting it may play an additional role during the earliest stages of 
development without involvement of lin28a. There are also differences during tailbud 
development and early neurulation, with lin28b found to have stronger anterior patterning 
at stage 13, and a presence in structures such as the eye and otic vesicle along with the 
greater expression dorsally. However, the role of lin28b during development still remains 
largely unstudied and unknown, and we cannot yet determine the importance of this 
wider expression.
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Chapter 4. The function of lin28 proteins in X. tropicalis 
4.1 Introduction 
4.1.1 lin28 function in early vertebrate development 
It is known that lin28a is an important factor in pluripotent cells, although its precise role 
still remains under investigation. Early work in C. elegans was able to generate lin28 
overexpressing and null mutants. lin28 recessive mutants, with a loss of lin28 protein, 
showed precocious development (Ambros and Horvitz, 1984), whereas a gain-of-function 
mutation caused the reverse and resulted in retarded development (Moss et al., 1997). 
However, in vertebrates this work has not yet been fully replicated. In vitro research has 
yielded contrasting results; work in both human and mouse ES cells found that the use of 
lin28 siRNA reduced cell viability, with an increase in apoptosis in human but not murine 
cells (Peng et al., 2011; Xu et al., 2009), and lin28 overexpression increased cell number, 
effects they found were due to changes in the cell cycle (Xu et al., 2009). On the other 
hand, alternative research found a downregulation of lin28 did not affect cell proliferation 
or the cell cycle in human ES cells, and overexpression actually slowed self-renewal (Darr 
and Benvenisty, 2009). Within in vivo work, attempts to generate lin28a knockout mice 
resulted in mice that were underdeveloped, and died shortly after birth (Zhu et al., 2010), 
indicating a requirement of lin28a expression for successful development. However, a lack 
of phenotype or cause for premature death was not provided by Zhu and colleagues, and it 
is unknown what effects the lin28a knockout was having. 
The effects on development following increased lin28a and lin28b expression have, 
however, been more effectively studied through both transgenic mice and genetic studies 
within the human population. Transgenic lin28a overexpressing mice were found to have a 
higher body mass and bone density shortly after birth, and displayed delayed sexual 
development (Zhu et al., 2010), indicating a delay of the onset of adult development. In 
human studies, the LIN28B locus has been linked with determining the age of menarche 
(He et al., 2009; Ong et al., 2009), further linking an increase in expression with a delay in 
the onset of traits of adulthood. 
4.1.2 Potential redundancy between the lin28 proteins 
Expression of lin28a and lin28b was shown in sections 3.2.4 and 3.2.5 to overlap during 
many stages of development. The homology between lin28a and lin28b in the active RNA-
binding domains means that the proteins may potentially target the same RNAs and have 
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a high level of redundancy. Both proteins have been shown to be capable of regulating let-
7 biogenesis (Viswanathan et al., 2008), and it is possible this is also the case for further 
targets. Therefore, care must be taken when manipulating expression of the proteins to 
ensure effects can be properly attributable to them. 
4.1.3 Function of lin28s during gastrulation 
The importance of FGF signalling during gastrulation, and the increase particularly in lin28a 
expression at this time, may indicate a function for the lin28s during this stage of 
development. The localisation of both lin28 genes to the presumptive mesoderm in 
gastrula stage embryos highlights this as an area where the lin28 proteins could be 
functioning, but a role has not yet been identified. As development of, and markers for, 
lineage specification has been well documented in Xenopus embryos these are ideal 
models in which to investigate the effects that the lin28s are having upon differentiation. 
4.1.4 Aims 
The aims of this chapter are to: 
• To determine the effect of a knockdown and overexpression of lin28 proteins on 
Xenopus development. 
• To uncover the roles of the lin28 proteins with respect to FGF signalling during 
gastrulation. 
• To investigate whether the lin28s are regulating the let-7s or other miRNAs at gastrula 
stage. 
4.2 Results 
4.2.1 Effects of a knockdown of lin28 on normal development 
To analyse the effect of the lin28 proteins in Xenopus development, mRNA expression can 
be knocked down using MOs; the MOs used against all three lin28s, both lin28a isoforms 
and lin28b, are translation blockers which bind to the 5’ end of mRNA and prevent the 
binding of ribosomes. Injections were carried out of all three MOs together to reduce 
protein levels of lin28a1, lin28a2 and lin28b in a compound knockdown; this was carried 
out to avoid any protein redundancy preventing a complete loss of function that might be 
seen with a loss of just one protein. Injections of 10 ng/embryo of each MO allowed 
successful gastrulation, but there was a very high rate of death in subsequent 
development, and no embryos survived to tadpole stages for phenotypic analysis. The use 
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of a lower dose, using 5 ng/embryo of lin28a MOs and 2.5 ng/embryo of lin28b MO to a 
total of 12.5 ng/embryo, resulted in a 54% survival rate to tadpole stage, whereas survival 
rates in the CMO-injected and uninjected controls exceeded 90% and showed normal 
development (Figure 4.1A, B). Thus the reduced knockdown still impaired development of 
the embryos to this stage, but allowed some phenotypic analysis.  
Injection of the three lin28 MOs at the mild dosage resulted in abnormal development, 
with less than 5% of embryos showing a normal phenotype (Figure 4.1C-F). Mild 
phenotypes were observed in 45% of cases, with severe defects occurring in over 50% of 
surviving embryos. Dorso-anterior structures were affected, with a reduction in head size 
and eyes, often resulting in a complete loss. A shortened axis was observed, 
demonstrating a failure of the tail to elongate, which was also curved in a number of cases. 
There was a failure of the somites to develop normally, appearing reduced or disorganised 
in embryos. An enlarged proctodeum was also apparent, with a high level of failure in 
blastopore closure.  
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The injections of MO were confirmed to be effectively targeting the lin28 proteins, with a 
loss of protein seen for the MO-injected embryos only, at stage 16, using western blot 
analysis (Figure 4.2). This stage was used to study knockdown as it was sufficiently late 
enough to detect high levels of endogenous lin28 proteins, and therefore see any 
reductions. 
     
Figure 4.2 Analysis of lin28 expression upon MO treatment 
Western blot analysis of embryos injected with a total of 12.5 ng/embryo of lin28 MOs in the 
compound knockdown compared to CMO injected and uninjected control embryos at stage 16. 
GAPDH was used as a loading control. For lin28b, arrowhead indicates relevant band. 
4.2.2 Effect of lin28 proteins on germ-layer specification 
FGF signalling is known to be important in patterning the embryo, particularly in specifying 
the early mesoderm. Due to the resultant phenotype following the knockdown of lin28 
proteins together with the finding of the lin28 genes being regulated by FGF, expression of 
early germ layer markers was investigated in gastrula stage embryos. This analysis was 
carried out using the dosage of 10 ng/each MO in a compound knockdown, with CMO at 
the same total amount/embryo.  
Expression of the early mesodermal markers brachyury and chordin was examined in lin28 
knockdown embryos, as both are also FGF targets (Amaya et al., 1993; Isaacs et al., 1994; 
Mitchell and Sheets, 2001). Analysis by qRT-PCR showed that expression of both genes 
was significantly downregulated in lin28 knockdown embryos compared to wildtype 
controls; brachyury showed a 58% reduction in expression, and 50% of the control 
expression of chordin was detected following lin28 knockdown (Figure 4.3). FGF signalling 
at this stage is also involved in neural specification; sox3 is a neuro-ectodermal marker and 
additional downstream target of FGF signalling (Rogers et al., 2008), which showed a 
significant decrease in expression with lin28 knockdown, being reduced to 36% of control 
RNA levels (Figure 4.3), indicating that this effect was not merely restricted to mesodermal 
targets. No change in expression was seen for sox17b (Figure 4.3), an endodermal marker 
(Hudson et al., 1997) which is not reported to be regulated by FGF signalling.  
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Figure 4.3 Effects of lin28 on RNA expression of germ layer markers 
qRT-PCR was performed on embryos injected with 10 ng each/embryo of lin28a1, a2 and b 
MOs and control embryos, at stage 10.5. Fold change in expression of RNAs is shown 
compared to controls and normalised to ODC by the 2
-ΔΔCt
 method. Fold change is given as 
average of three biological replicates and error bars represent SE. Significance calculated by t-
test: ***p<0.001. 
 
4.2.3 Identifying miRNA targets of the lin28s  
To investigate whether the lin28 proteins were regulating the expression of any miRNAs at 
this time, an Affymetrix miRNA microarray was undertaken. Embryos subjected to the 
compound lin28 knockdown were collected and compared to control embryos at gastrula 
stage. To allow statistical analyses on the data this was carried out with three biological 
replicates, resulting in six microarray datasets. The microarray chips contained probes to 
all known miRNAs at the time, in all species, and as such a large number of probe sets 
were available for analysis, with 7626 probes in total on the chips. 
Data was processed using QC tools (Affymetrix), with a background detection and 
adjustment and normalisation applied. This output provided a 'detection call', indicating 
which miRNAs were detected as being expressed above background; the detection call 
was then used to remove miRNAs that were not detected as expressed in any sample. 
Those expressed in any of the six samples were retained for analysis, as they may have 
shown interesting changes in regulation. The number of probes detected above 
background in any samples came to 4294. This, however, included multiple control probes 
and a small number of hits in some irrelevant species, such as Zea mays, the maize plant. 
Filtering the results for X. tropicalis genes, 87 miRNAs were detected across the 
microarrays, from 167 X. tropicalis probes present on the chips (Appendix 1). Of these, 33 
were detected above background in all six microarrays, and a further three expressed in all 
control samples at least, suggesting that these miRNAs would be ones most likely to be 
expressed during this stage of development. 
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Normalised data were imported to BRB-tools to allow statistical analysis. Interestingly, 
when attempting to apply clustering analysis, the closest expression patterns were found 
between sibling embryos despite treatments, rather than those with the same 
manipulations, indicating that miRNA expression may differ vastly between unrelated 
embryos at this time. As such, limited clustering analysis could be carried out. Another 
common method of analysis with array datasets is to apply a 2-fold change threshold to 
the data, but this was not sufficient to detect many targets within this dataset as the 
changes seen between conditions were generally less than 2-fold altered. This highlights 
the fact that the majority of miRNAs detected in these embryos did not change with the 
knockdown of lin28. 
After exhausting analysis options as above, an alternative method was employed, using 
paired statistical t-tests to compare the three data sets, with a filter applied for only the 
X. tropicalis genes. This was to ensure that any miRNAs detected were biologically 
relevant, for example multiple plant species were also present on the array, which may 
have been falsely detected. When applying a t-test using a significance value of 0.01, only 
2 genes were detected as showing a significant difference, so this was expanded to a 0.05 
significance level. At this level, 10 miRNAs were found to change significantly (Table 4.1). 
These were all miRNAs that were present above background levels in each of the 
microarray datasets, and therefore deemed to be truly expressed (Appendix 1). 
Of these 10 miRNAs, 8 are members of the group of miR-17-92 clusters (Tanzer and 
Stadler, 2004) (miR-18b, miR-17-5p, miR-20b, miR-106, miR-20a, miR-18a*, miR-363-5p, 
miR-18a), which all showed downregulation upon a loss of lin28 proteins.  
Due to the highly conserved nature of miRNA, where a sequence is completely conserved 
between multiple species the same probe sequence is therefore present multiple times on 
the array, under gene names that differ by their species prefix. Re-running the analysis 
without a species filter, at 0.01 significance, now detected 31 miRNAs (Table 4.2 ). Of 
these, 23 were from the miR-17-92 clusters, which were the same members as detected 
by X. tropicalis probes with the addition of miR-92. There was no further detection in any 
species of miR-16c or miR-24a, the additional miRNAs identified in Xenopus, which are 
conserved in other species on the chips. This lent strength to the hypothesis that the 
members of the clusters were targets of lin28 at this time. 
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Table 4.1 Fold change data for putative X. tropicalis miRNA targets of lin28  
miRNA Fold change t-test p-value   
xtr-miR-18b -1.63 0.005196 
xtr-miR-17-5p -1.80 0.007282 
xtr-miR-20b -1.63 0.010716 
xtr-miR-106 -1.57 0.017647 
xtr-miR-24a +1.20 0.021995 
xtr-miR-20a -1.39 0.025513 
xtr-miR-18a-star -2.08 0.02951 
xtr-miR-363-5p -2.88 0.033074 
xtr-miR-18a -1.54 0.036532 
xtr-miR-16c -1.18 0.039499 
Fold change between control and lin28 compound knockdown embryos. Data calculated using 
BRB-tools, using paired t-test at p<0.05 significance, and probe list filtered for X. tropicalis 
genes. +/- show increase/decrease in expression following lin28 knockdown. 
 
Table 4.2 Fold change data for putative miRNA targets in all species of lin28  
Fold change between control and lin28 compound knockdown embryos. Data calculated using 
BRB-tools, using paired t-test at p<0.01 significance. +/- show increase/decrease in expression 
following lin28 knockdown. 
 
miRNA  Fold 
change 
t-test p-
value   
miRNA (cntd) Fold 
change 
t-test p-
value   
fru-miR-20 -1.54 4.90E-06 ptr-miR-106a -1.84 0.004085 
mne-miR-92 -1.72 0.000498 hsa-miR-125a-3p -1.12 0.004162 
mmu-miR-106a -1.56 0.000546 gga-miR-106 -1.67 0.004618 
bta-miR-18a -1.75 0.000918 sla-miR-17-5p -1.88 0.004663 
rno-miR-20a -1.52 0.001067 mmu-miR-17 -1.88 0.004726 
mmu-miR-327 +1.23 0.001333 xtr-miR-18b -1.63 0.005196 
sla-miR-106a -1.71 0.001347 mml-miR-92a -1.77 0.005979 
hsa-miR-1300 +2.04 0.00164 lca-miR-18 -1.78 0.006322 
mmu-miR-26a +1.12 0.001793 ppa-miR-106a -1.74 0.00641 
ssc-miR-106a -1.93 0.001806 cfa-miR-92a -1.63 0.007115 
gga-miR-20a -1.39 0.002636 lla-miR-92 -1.75 0.007158 
mmu-miR-365 -1.47 0.003219 xtr-miR-17-5p -1.8 0.007282 
ptr-miR-92 -1.77 0.003239 cfa-miR-193a +1.56 0.007537 
dre-miR-184 +3.84 0.003511 mml-miR-106a -2.02 0.008696 
lla-miR-17-5p -1.99 0.004034 ppy-miR-17-3p -1.45 0.009442 
bta-miR-148a +3.23 0.004038    
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4.2.4 Selection of miRNA housekeeping for qRT-PCR 
qRT-PCR was carried out to validate these miRNAs as lin28 targets.  A housekeeping gene 
is required for normalising expression between treatments, with mRNA targets being 
unsuitable for this process due to their length and the method of miRNA qRT-PCR. 
However, when attempting to find a suitable gene for use with X. tropicalis, many of the 
published possible housekeeping genes, such as 5.8S rRNA (Galiveti et al., 2009), were 
found not to be conserved to Xenopus, and primers for the homologues were not 
commercially available and guaranteed for specificity.  The snRNA U6 has also previously 
been validated as a housekeeping gene for miRNA analysis (Galiveti et al., 2009); U6 is a 
small RNA which is involved with controlling mRNA splicing along with U1, U2, U3, U4 and 
U5 (Thomas et al., 1990), and is conserved between humans and Xenopus, making these 
primers suitable for use. However, the suitability of U6 for a housekeeping gene in this 
experimental condition must be validated, as there was no probe to it on the microarray. 
From the microarray, miR-130b was identified as a highly expressed RNA with expression 
not altering upon embryo manipulation. It is also independent of the identified miR-17-92 
clusters and the let-7 family miRNAs, known lin28 targets. Expression of this was assayed 
using qRT-PCR in lin28 knockdown embryos compared to controls, and normalised using 
U6. Here, we saw no difference in expression between the conditions (Figure 4.4), 
implying that both U6 and miR-130b are suitable controls for these experiments. 
 
Figure 4.4 Testing the suitability of miRNA housekeeping genes 
qRT-PCR was performed on embryos injected with 10 ng each/embryo of lin28a1, a2 and b 
MOs and control embryos, at stage 10.5. Expression of miR-130b was normalised using U6 by 
the 2
-ΔΔCt
 method. Fold change is given as average of 3 biological replicates, with error bars 
representing SE. 
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4.2.5 Effects of lin28 knockdown on levels of mature let-7 during 
gastrulation 
As the let-7 family of miRNAs are known negatively regulated targets of lin28, these were 
the first miRNAs of interest to be investigated, despite not showing significant changes on 
the microarray. Levels of mature let-7 were not detected above background levels on the 
microarrays, due to low level expression. As qRT-PCR is a more sensitive technique to 
investigate expression of single miRNAs, this was used to investigate levels of let-7 family 
members let-7a, let-7f and let-7g following knockdown of lin28. 
No change in expression from control levels was detected for any of the let-7 family 
members at stage 10.5 following a loss of the lin28s (Figure 4.5). This method also found 
that expression of the mature let-7s was at a very low level, with expression only detected 
following a high number of amplification cycles. 
 
Figure 4.5 Effect of lin28s on let-7 family members by qRT-PCR analysis 
qRT-PCR was performed on embryos injected with 10 ng each/embryo of lin28a1, a2 and b 
MOs and control embryos, at stage 10.5. Fold change in expression of miRNAs is shown 
compared to controls and normalised using U6 by the 2
-ΔΔCt
 method. Fold change is given as 
average of 3 biological replicates, with error bars representing SE. 
 
4.2.6 Effect of lin28 knockdown on members of the miR-17-92 clusters 
As changes were seen in multiple members of the miR-17-92 clusters on the arrays, 
expression of miR-17-5p, miR-19b-3p, miR-106-5p, miR-18b-5p, miR-20b-5p, miR-363-3p 
and miR-363-5p was investigated using qRT-PCR. With the exception of miR-363-5p (which 
will be referred to as miR-363*), all miRNAs studied were the previously termed 'major' 
form of the pre-miRNA, and will be referred to without the 3p/5p reference from here. 
Comparing expression after lin28 compound knockdown to that in control embryos, 
expression levels of all cluster miRNAs investigated were significantly decreased with the 
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loss of the lin28s (Figure 4.6). Smaller changes were seen in miR-106, with expression 
reduced to 80% of control with the use of lin28 MOs, with the largest effects being an 
expression level of less than 50% of control for miR-20b and miR-363, and a 75% reduction 
in expression of miR-363* (Figure 4.6). 
 
Figure 4.6 Effect of lin28s on miR-17-92 and miR-106-363 cluster members by qRT-PCR 
analysis 
qRT-PCR was performed on embryos injected with 10 ng each/embryo of lin28a1, a2 and b 
MOs and control embryos, at stage 10.5. Fold change in expression of miRNAs is shown 
compared to controls and normalised using U6 by the 2
-ΔΔCt
 method. Fold change is given as 
average of 3 biological replicates, with error bars representing SE. 
4.2.7 Effect of FGF signalling on miR-17-92 cluster miRNAs 
As FGF signalling was able to influence the expression of lin28a and lin28b at this point in 
development, this led to the investigation of whether these putative miRNA targets of 
lin28 are also downstream of FGF signalling at this time. The levels of these miRNAs were 
subsequently investigated in embryos with inhibited FGF signalling, through the 
overexpression of dnFGFR. 
Following injection of 1 ng dnFGFR, the miRNAs are not uniformly reduced in expression as 
seen with lin28 MOs. The only miRNAs to show a reduction in expression were miR-18b 
and miR-363, which were reduced by 55% and 35% respectively, a smaller reduction in 
expression for miR-363 but a greater decrease for miR-18b compared to changes after 
lin28 manipulation. No changes were seen in miR-17, miR-19b, miR-18b and miR-363*, 
while a significant increase was seen in miR-106 expression (Figure 4.7). 




Figure 4.7 Effect of FGF signalling on miR-17-92 and miR-106-363 cluster members by qRT-
PCR analysis 
qRT-PCR was performed on embryos injected with 1 ng/embryo of dnFGFR and control 
embryos, at stage 10.5. Fold change in expression of miRNAs is shown compared to controls 
and normalised using U6 by the 2
-ΔΔCt
 method. Fold change is given as average of 3 biological 
replicates, with error bars representing SE. 
4.2.8 Effects of lin28 overexpression on development 
lin28 proteins were overexpressed individually in embryos. 1 ng RNA for the coding region 
of each of lin28a1, lin28a2 and lin28b was used, to prevent UTRs allowing regulation 
within the embryo and preventing overexpression. The overexpression of proteins in 
gastrula embryos was confirmed using western blot (Figure 4.8). 
    
Figure 4.8 Analysis of lin28 protein overexpression by western blot 
Western blot analysis of embryos injected with 1 ng/embryo of lin28a1, a2, or b individually 
compared to control embryos, at stage 10.5. GAPDH was used as a loading control.  
However, in contrast to the knockdown of lin28, the overexpression of these proteins did 
not result in a disrupted phenotype. Development of the embryos to tadpole stage 
appeared to be unaffected when compared to the phenotypes of controls (Figure 4.9).  
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4.2.9 Effect of lin28 overexpression on miR-17-92 clusters  
Despite the lack of a developmental phenotype, it remained possible that an 
overexpression of lin28 could alter levels of the miR-17-92 and miR-106-363 cluster 
miRNAs. Levels of mature miRNA from the miR-17-92 and miR-106-363 clusters were 
analysed by qRT-PCR for each overexpressing condition. Expression of miR-130b was also 
used as an independent control, not being related to the clusters. Mature levels of all 
miRNAs were not altered significantly upon lin28 overexpression (Figure 4.10). miR-130b, 
previously used as a negative control, was actually the miRNA which showed the highest 
degree of change in level, being increased following lin28a overexpression. 
 
Figure 4.10 Effect of lin28 overexpression on miR-17-92 and miR-106-363 cluster members by 
qRT-PCR analysis 
qRT-PCR was performed on embryos injected with 1 ng/embryo of lin28a1, a2, or b RNA and 
control embryos, at stage 10.5. Fold change in expression of miRNAs is shown compared to 
controls and normalised using U6 by the 2
-ΔΔCt
 method. Fold change is given as average of 3 
biological replicates, with error bars representing SE. 
4.3 Discussion 
4.3.1 The lin28 proteins are important in germ layer specification 
Due to the early lethality of lin28 mutations in vertebrates, and the ease of following 
Xenopus development, work here and further research from the group, presented in Faas 
et al. (2012), is a first early vertebrate in vivo study into the downstream effects of lin28 
proteins following a loss of expression. 
The knockdown in expression of lin28 proteins resulted in abnormal development, which is 
likely to result from dysregulation as early as gastrulation. Results here have shown that a 
loss of these proteins by stage 10.5 reduced expression of early germ layer markers for 
both mesoderm and neuro-ectoderm, indicating that these proteins are required for an 
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important inductive role by this early stage. Further work in our lab has demonstrated that 
significant changes in expression of mesodermal markers are also seen at stage 13, using a 
wider range of mesodermal markers(Faas et al., 2012). Whether expression of these 
markers is rescued later in development in these knockdown embryos has not yet been 
determined, however the resultant phenotypes suggest that this manipulation severely 
alters gene expression and subsequent development, and does not just result in retarded 
development, although a heterochronic effect can be seen upon other morphogens, such 
as Smad2 and some FGF ligands (Faas et al., 2012). This effect on development through 
the loss of key germ layer markers can be seen in the resultant phenotypes; a loss of 
mesodermal markers is reflected in problems seen in the development of the somites, 
which appeared reduced and disorganised. Cartilaginous structures were also affected, 
including the notochord, which would contribute to the shortened body axis, and the 
branchial arches, where lin28 expression was detected. The reduction in sox3 expression 
was reflected in a reduced development of neural and head structures, and the abnormal 
development of structures such as the eye reflects expression of lin28b here, as seen in 
Chapter 3. 
As a heterochronic gene in C. elegans, lin28 is known to control the timing of the 
progression of larval fates, and carries out this function via multiple targets and 
mechanisms (Vadla et al., 2012). In vertebrates, its role has been less clear. As lin28 is 
downregulated upon differentiation (Moss and Tang, 2003; Yang and Moss, 2003), and 
with the ability to reprogramme cells (Yu et al., 2007), it has largely been classed as a 
pluripotency factor, with any role in specifying lineage differentiation largely unknown. 
Early work demonstrated a rapid increase in let-7 at the onset of differentiation (Thomson 
et al., 2006), which suppresses self-renewal (Melton et al., 2010); it was as such thought 
that the role of lin28 in specifying cell fate was merely preventative via regulation of let-7, 
but new research is beginning to indicate a wider role with an involvement in cell fate, as 
work has seen here. 
The results from such investigations both support and contrast results shown in this 
chapter. Studies have found that lin28, known to be expressed in undifferentiated cells, 
actually increases during the first few days of embryoid body differentiation, and this is 
critical for subsequent cell fates (Kawahara et al., 2011; Wang et al., 2012). This is also 
consistent with our increased detection of lin28 expression during gastrulation, seen in 
Chapter 3. An involvement in neural development is likely, as lin28a has been found to 
persist in early neural tissues of the mouse embryo (Balzer et al., 2010; Yang and Moss, 
2003), and overexpression of lin28a or lin28b were both found to increase neuronal 
differentiation and block glial specification, by separate mechanisms (Balzer et al., 2010). 
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Mutations in lin28 proteins actually decreased the number of neural stem cells 
differentiating into neurons, indicating that a positive role in the regulation of this 
specification is likely to be played by these proteins (Balzer et al., 2010), and this idea has 
been supported by work in embryoid bodies (Kawahara et al., 2011). The known role of 
FGF signalling in neural differentiation, with sox3 an important gene for this, supports the 
possibility for a neural function of lin28. However, alternative results suggest that lin28 is 
not involved in the specification of neuronal differentiation (Wang et al., 2012), and is 
instead involved in the other germ layers of endoderm and mesoderm. Nevertheless, 
research in these alternative areas has also come to two conflicting conclusions; lin28 is 
regulated by miR-125a in embryoid bodies, and this regulation has been linked to 
subsequent endodermal, mesodermal and cardiac differentiation (Wang et al., 2012; 
Wong et al., 2012). Work by Wang et al (2012) showed an initial decrease in expression of 
miR-125  during days 3-5 of embryoid body differentiation, in tandem with the increase in 
lin28 at this time; they found that overexpressing miR-125, thus decreasing lin28, caused 
decreases in endodermal markers, such as sox17, mesodermal markers including 
brachyury and mesoderm posterior 1 (mesp1), and cardiomyocyte markers, and expression 
of all could be rescued by re-introducing lin28. This indicated the necessity for some lin28 
expression in early differentiation specification. Work here and in Faas et al. (2012) 
supports the role of lin28 in mesodermal development, however this work is in contrast to 
the published effect by Wang and colleagues (2012) upon endodermal development, even 
though investigating the same marker in sox17. On the other hand, Wong and colleagues 
(2012) were led by the discovery that miR-125 is substantially increased in expression from 
day 8 of differentiation compared to undifferentiated cells, although their results also 
showed the initial decrease in expression in the earlier days. Here they found that 
overexpressing miR-125 in undifferentiated cells, thus reducing lin28, had an opposite 
effect, prematurely increasing expression of cardiac markers, with increased expression in 
undifferentiated cells of brachyury and decreased expression of endoderm and 
pluripotency markers. Further investigation is therefore needed to clear the waters on the 
role of lin28 in promoting any particular cell fates. 
 Brachyury, chordin and sox3 are known to be FGF regulated targets (Amaya et al., 1993; 
Mitchell and Sheets, 2001; Rogers et al., 2008), and it is possible that the ability to affect 
these genes is connected to the regulation by FGF, with lin28a and lin28b having a role in 
mediating FGF signalling at this time. Animal cap experiments have supported this notion; 
animal cap explants from the embryo normally form unlayered epidermis when left to 
develop alone, but the addition of FGF or activin to the caps results in the differentiation 
of mesoderm. Following knockdown of lin28 proteins, animal caps were inhibited in 
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mesoderm development with FGF or activin treatment, indicating a reduced response to 
inductive signals (Faas et al., 2012). The current hypothesis is that lin28 works as a 
competence factor to FGF signalling, and may be modulating FGF signalling. However, the 
mechanism by which this is occurring has not yet been fully confirmed; a reduction in both 
dpERK and FGF ligand expression is seen following a loss of lin28 proteins, but how 
precisely lin28 causes this effect is unknown (Faas et al., 2012). 
Interestingly, an overexpression of the three proteins independently failed to result in an 
abnormal phenotype. It is possible that the endogenous levels of lin28 in the embryo at 
this time of gastrulation are sufficient for its function, such that an overexpression cannot 
further alter downstream effects. Any negative gene targets may already be suppressed to 
the maximum effect, and where involved with potentiating translation or any positive 
regulation, this may also be occurring already to maximum capacity. Further 
understanding of this mechanism by which lin28 functions at this time needs to be gained, 
to properly interpret this lack of phenotype. This does not match previous in vivo work, 
with mice showing a higher body mass and delayed sexual development with an 
overexpression of lin28a (Zhu et al., 2010). It is further possible that an overexpression of 
the lin28 proteins is unable to function in a usual manner within the embryos, and 
therefore we are not able to mimic accurately an actual gain-of-function. 
4.3.2 Functional redundancy between the lin28 proteins 
The overlap of expression patterns for lin28a and lin28b seen during particular stages of 
development in Chapter 3 may allow for functional redundancy, and due to this all 
experiments were carried out using a triple knockdown. Evidence of redundancy can be 
seen in knockdown embryo phenotypes, where a more severe phenotype resulted from a 
knockdown in the lin28as and lin28b together, compared to knocking down either protein 
individually (Faas et al., 2012). With the multiple areas of co-expression of lin28a and 
lin28b, there is a high chance that the proteins may be expressed in the same cells, and 
therefore redundancy of function could be anticipated. lin28a and lin28b have previously 
been classed as functioning redundantly, due to their regulation of let-7 miRNAs, however 
recent research has indicated that they may be regulating this by different mechanisms: 
lin28b was found to act primarily in the nucleus, binding and sequestering the pri-miRNA, 
whereas lin28a acted in the cytoplasm on the pre-miRNA (Piskounova et al., 2011). These 
differences indicate that there may be further important distinctions in the roles and 
functions of these proteins, not least due to their possible dissimilarity in subcellular 
locations. As the effects seen here were due to a loss of all lin28 proteins, more careful 
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analysis would need to be carried out to determine if targets identified are downstream of 
both lin28a and lin28b, or if any are effects specific to either protein. 
4.3.3 The function of lin28s in gastrula stage embryos is independent 
of let-7 regulation 
lin28a and b proteins were not found to be inhibiting levels of let-7 miRNA during 
gastrulation. However, the levels of mature let-7 miRNAs were very low at this 
developmental stage, being difficult to detect by both microarray and qRT-PCR.  
The current knowledge of let-7 expression in model systems varies. Prior analysis in 
Xenopus reported let-7f present in the blastula in precursor form, but by northern blot this 
appeared to be the precursor form, and levels of the mature RNA only began to increase 
from tailbud stages (Watanabe et al., 2005). In C. elegans, expression of let-7 was detected 
weakly from the L3 stage, and was increased in L4 and adult stages (Reinhart et al., 2000), 
much later stages than the embryonic gastrulation. Pasquinelli et al (2000) found that let-7 
expression in Drosophila began just before metamorphosis, in the late third instar phase, 
and that zebrafish expression occurred between 24 and 48 hrs post fertilisation and 
remained into adulthood. However, work in mammalian stem cells has found early 
embryonic expression; pre-let-7a was detected in ES cells, but not in the mature form 
(Newman et al., 2008; Suh et al., 2004), indicating transcription was at least occurring. 
Further to this, a knockdown of lin28 in mouse ES cells proved sufficient to increase let-7 
levels (Hagan et al., 2009). 
It remains possible the let-7 precursors and primary forms are being expressed during 
gastrulation; however the situation may be that transcription of these is at a very low level 
in Xenopus at this time and the lin28s are providing minimal regulation of the miRNAs. In 
extension to this, other regulators of let-7 processing may be present which still inhibit its 
maturation despite the loss of the lin28s. Further studies to investigate levels of pri- and 
pre-let-7s at this stage, such as by northern blots, would provide a clearer understanding 
of the levels of processing occurring at this stage of development. During later 
development, however, it appears that a knockdown of lin28 can influence the levels of 
let-7; at stage 22, increases in the mature levels of let-7g were seen following knockdown 
of lin28 proteins (Faas et al., 2012). 
Recent work has found, however, that in C. elegans lin28 carries out its earliest functions, 
the specifying of L2 fates, via a mechanism independent of let-7 (Vadla et al., 2012). This 
paper found that lin28 was supporting expression of an mRNA, hbl-1, involved in 
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regulating L2 fates, through its 3' UTR (Vadla et al., 2012). Indeed, in mammalian stem cell 
work, lin28 has been found to further act independently of let-7, by binding to mRNA and 
enhancing their translation, targets of which include IGF-2, histone H2A, stem cell genes 
such as Oct-4, and cell cycle genes including cdk4 and cyclin B (Balzer et al., 2010; 
Polesskaya et al., 2007; Qiu et al., 2010; Xu and Huang, 2009; Xu et al., 2009). The work by 
Vadla and colleagues (2012) investigated if lin28 was affecting the expression of other 
miRNAs to let-7 during this early stage of development, but did not find evidence to 
suggest that it was. In support of this, we did not find changes in many miRNAs expressed 
at this time; changes were only notable in members of the miR-17-92 clusters, which have 
not been discovered in C. elegans.   
4.3.4 The miR-17-92 cluster miRNAs as novel targets of the lin28s 
Work in this study identifies putative miRNA targets of the lin28 proteins are members of 
the miR-17-92 clusters. In the Xenopus genome there are four paralogous clusters - the 
miR-17-92 cluster, the miR-106a-363 cluster, and the two miR-93-25 clusters (Figure 4.11). 
These miRNAs are highly conserved and can be grouped into 4 families within the cluster, 
based on conserved seed sequences (reviewed in Mendell, 2008). These clusters are 
discussed further in Chapter 6. 
 
Figure 4.11 Arrangement of miR-17-92 clusters in X. tropicalis 
Scale diagram of arrangement of pri-miRNA for miR-17-92 and paralogous clusters. Coloured 
boxes show precursor sequence, with colour corresponding to family groupings based on seed 
sequence. Black box represents the 'major' mature miRNA, and white box the 'minor' form, 
where known. 
Multiple members of the miR-17-92 and miR-106-363 clusters were identified as lin28 
targets following microarray analysis, and some of these were followed up using qRT-PCR. 
Targets were selected to ensure that members from each of the miRNA families were 
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pursued. The largest difference was seen in miR-363 and miR-363*, which are both from 
the same precursor. 
Interestingly, a loss in expression of all of these miRNAs with a knockdown in lin28 protein 
suggests that the miRNAs may be positively regulated targets of lin28. The only known 
method of miRNA regulation currently undertaken by lin28 is negative, preventing 
processing of the let-7s to their mature form (Piskounova et al., 2008; Viswanathan et al., 
2008), with effects on mRNA involving potentiating translation (Polesskaya et al., 2007), 
which is unnecessary with miRNA. This would indicate that lin28 must be acting in an 
alternative mechanism to any that have previously been determined. 
4.3.5 The lin28 proteins are necessary for miR-17-92 and miR-106-363 
miRNA expression 
The loss of expression of miRNA at the mature level following a knockdown of lin28 
protein suggests that the proteins are necessary to maintain correct expression of these 
miRNAs; however, mature miRNA levels were not altered upon overexpression of lin28 
proteins, and the mechanism by which this regulation is occurring needs to be understood. 
There is a possibility that lin28 is involved in promoting or assisting the processing of these 
miRNAs, and there may be insufficient levels of pri-miRNA or pre-miRNA for an 
overexpression of protein to increase expression levels at the mature stage; further 
investigation into the levels of pri-miRNA and pre-miRNA at this stage would be important 
to understand this. Future experiments could also involve overexpressing pri-miRNA for 
the clusters, both with and without lin28 proteins, and monitoring if this is able to affect 
levels of mature miRNA. 
4.3.6 Effects of FGF signalling on miR-17-92 cluster miRNAs is unclear 
Interestingly, inhibition of FGF signalling did not result in the same effects upon miRNA 
from the miR-17-92 clusters as for the knockdown of lin28 protein. Two members of the 
clusters were reduced in expression, which were also highly reduced with a loss of lin28s, 
but there were either no changes or an increase in the other members studied.  
Inhibition of FGF signalling was seen in section 3.2.2 to decrease expression of lin28a and 
lin28b at the message level, but this could not be confirmed at the protein level with 
difficulties existing in detecting the endogenous lin28 proteins in gastrula stage embryos, 
with endogenous protein present but undetectable consistently by western blot, and as 
such no maintenance or loss of expression could be determined. It is possible, therefore, 
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that although some transcriptional regulation of the lin28 genes is occurring as a result of 
FGF signalling, following pathway inhibition the lin28 proteins may still be present in 
sufficient abundance to carry out their normal roles to some degree, and are thus able to 
still carry out their role of regulating these miRNAs. 
There is a contrast between the responses seen in miRNA genes and mRNA genes with 
upstream manipulations, with mRNA targets such as brachyury reduced similarly following 
both FGF signalling inhibition and a loss of lin28 proteins, with a potential that if lin28 is a 
mechanism by which these genes are regulated, the loss of FGF signalling was enough to 
drive this loss of regulation by the lin28s. However with miRNAs from the miR-17-92 and 
miR-106-363 clusters not showing the same reduction with FGF inhibition as for lin28 
knockdown, there is a possibility that this is not linked to any role lin28 has in mediating 
the effects of FGF signalling, or that it is an easily mantained function of the lin28s, despite 
loss of other functions. 
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Chapter 5. The response of human MSCs to FGF 
treatment 
5.1 Introduction 
5.1.1 Are FGF signalling targets conserved to humans? 
Much of the work on identifying FGF targeted gene expression has been undertaken in 
animal model systems, such as Xenopus, and it may be that genes identified as targets in 
these systems are conserved to humans and are contributing to the effects mentioned in 
previous chapters. The microarray based transcriptomic analysis by Branney et al. (2009) 
identified a large list of both putative and previously confirmed FGF targets in gastrula 
stage embryos. At this stage in development, specification of the germ layers is beginning, 
and FGF is predominantly involved with the differentiation of mesoderm. Particular genes 
of interest are lin28a and lin28b, with their known roles in pluripotency and their 
identification here as targets of FGF as described in Chapter 3. With a requirement of the 
lin28 proteins in Xenopus for correct patterning of the embryo during gastrulation, 
particularly in the control of expression of mesodermal markers as shown in Chapter 4, 
these genes may be important for competence to differentiate. The wider roles of FGF 
signalling in human cell culture are still under analysis, and the way in which FGF signalling 
is functioning in human cells remains unclear. More analysis is required to determine 
whether characterised FGF targets, with functions which are well understood, are also FGF 
targets in stem cell culture. 
5.1.2 FGF-2 in cell culture 
As discussed in section 1.1.6, the growth of human ES cells has been shown to require 
supplementation with FGF-2 to maintain pluripotency (Amit et al., 2000; Dvorak et al., 
2005); this effect may be elicited through the antagonism of BMP signalling (Xu et al., 
2005). However, the lack of requirement for FGF-2 in murine ES cell culture, and FGF 
treatment leading commonly to differentiation (Villegas et al., 2010; Ying et al., 2003), 
highlights both that FGF signalling is responsible for different outcomes dependent on the 
cell state, and that there are functions of FGF-2 which are yet to be fully understood in 
regards to proliferation and differentiation. 
The culture of MSCs has not shown a requirement for exogenous FGF-2 to maintain 
undifferentiated growth. Work has found, however, that supplementing MSC growth 
media with FGF-2 increases the rate of proliferation of the cells and enhances 
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chondrogenic and osteogenic potential (Martin et al., 1997; Pri-Chen et al., 1998; Solchaga 
et al., 2005; Tsutsumi et al., 2001). The mechanisms behind these effects have not been 
fully determined, but are likely to be occurring through activation of a number of 
pathways, including phosphorylation of ERK downstream of the MAPK pathway (Choi et 
al., 2008). 
MSCs were selected for the investigation of conserved FGF signalling, due to the flexible 
nature of their culturing both with and without FGF-2 supplementation. Also, these cells 
being already restricted to a mesenchymal fate means they may be of use in determining 
FGF targets that are important in further mesodermal development. Studies into the 
impact of FGF-2 on the culture of MSCs have previously investigated treatment over 
multiple days or weeks, and so rapid downstream targets of the pathway were likely to not 
have been detected. These rapidly activated targets could be vital for long-term roles and 
as such their identification may provide further insight into the functions of FGF-2 in cell 
culture.  
5.1.3 Aims 
The aims of this chapter are to: 
• Determine if MSCs are capable of responding to exogenous FGF-2 treatment. 
• Identify a suitable dosage and timing of FGF treatment of MSCs for activation of the 
signalling cascade and transcriptional changes to occur as a result. 
• Investigate putative FGF targets in MSCs and conservation of these to Xenopus.  
• Study expression of lin28a and lin28b in MSCs. 
5.2 Results 
5.2.1 MSCs are capable of responding to FGF 
To respond to exogenous signalling ligands, cells must express the necessary receptors 
which in this case are members of the FGFR family. RT-PCR was carried out on three donor 
samples to determine expression of FGFR1 and FGFR2. These were selected due to their 
common use as receptors for a number of FGF ligands, and are preferred by FGF2 (Zhang 
et al., 2006). Due to the existence of numerous alternative splice variants, primers were 
used that were capable of detecting multiple forms of each FGFR, resulting in different 
sized PCR products from these isoforms. Primers to FGFR1 are capable of detecting 
transcript variants: 11(1162 bp), 1 and 10 (1094 bp), 2, 12 and 14 (1088 bp), and 3, 4 and 7 
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(827 bp). FGFR2 primers can work to detect transcript variants: 2 and 3 (1170 bp), 1 
(1167 bp), 9 (903 bp), 5 (900 bp), 4 (832 bp), and 6 and 8 (822 bp). 
Due to the high degree of variability between donors, experimental replicates were carried 
out using MSCs from different patients, which are numbered sequentially using the prefix 
'FH'. Expression of varying FGFR isoforms was detected across three individual MSC donors 
(Figure 5.1). Using GAPDH as a loading control, donor variation in gene expression was 
seen; this difference was strongest in FGFR2 where higher expression was detected in MSC 
line FH403 compared to the other two. Only two discrete bands were detected for FGFR2, 
whereas FGFR1 was detected as four distinct products, with one major form being 
present.  
 
Figure 5.1 Expression of FGFRs in MSCs 
RNA was collected from MSCs during normal growth, from three independent donors (FH398, 
FH403, FH407). RT-PCR was carried out for FGFR1 and FGFR2, to detect multiple isoforms. 
GAPDH (519 bp) was used as a loading control. 
5.2.2 MSCs respond to exogenous FGF-2 treatment 
To determine how rapidly MSCs respond to exogenous FGF-2 treatment, and at what 
levels, recombinant protein was added to culture medium and downstream effectors of 
the FGF pathway were examined.  Western blot analysis for levels of dpERK protein was 
used to detect any rapid response to FGF in MSCs.  Optimisation of levels of FGF-2 was 
established using three different concentrations of recombinant FGF-2 protein: 1, 10 and 
25 ng/ml. Following the seeding of cells in normal growth medium, cells were serum-
starved for 24 hours to reduce levels of growth factors in the medium, normally present in 
FBS, to prevent activation of alternative signalling pathways. 
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These data showed that all concentrations of FGF-2 were sufficient to increase 
phosphorylation of ERK compared to basal levels (Figure 5.2), suggestive of activation of 
the downstream signalling cascade of FGF. Increases in dpERK levels were seen after as 
little as 5 minutes with FGF-2 treatment, however this was subject to FGF-2 dosage, as 
seen by a smaller increase in ERK phosphorylation with 1 ng/ml FGF-2 compared to both 
10 and 25 ng/ml treatments. By 15 minutes, levels of dpERK were greatly increased 
compared to untreated controls in all three treatment conditions. This may be the peak of 
activity, with dpERK levels at 30 minutes not at any greater abundance, and further 
decreased in level by 60 minutes compared to the earlier time points. Nevertheless, at this 
time the dpERK still remained above the basal levels prior to any FGF treatment. 
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5.2.3 Analysis of putative FGF target genes 
Effects on putative FGF target genes were investigated by qRT-PCR, again using differing 
FGF concentration levels over varying times of treatments. As this was investigating 
transcriptional changes the time frame was increased compared to that used for protein 
analysis.  Samples were collected following 6, 12 and 24 hours of treatment. Due to the 
high degree of variability between human donors, generated fold-change data were not 
averaged across biological replicates, and are presented individually to observe any 
common trends in expression. 
A number of putative FGF targets in MSCs, identified after longer-term exposure to FGF-2 
in culture (Solchaga et al., 2005), were selected for analysis. Efficient primers and 
detectable expression was found for the genes sprouty 2 (SPRY2), dual specificity 
phosphatase 6 (DUSP6) and interleukin-6 (IL-6), which were further pursued. Results 
showed that all three donors exhibited similar responses to FGF-2, with a general trend in 
upregulation of expression of these three genes following treatment.  
Expression levels of SPRY2 were increased at all times with all FGF treatments (Figure 5.3). 
There was no uniform trend across the three donors of any one treatment or time point 
that produced the largest upregulation, however donor differences were highlighted in the 
degree of changes seen. For Donor 1 (FH398), the changes seen at each time point were 
more variable, and the largest change of expression was an 8-fold upregulation at 6 hours. 
On the other hand, Donor 2 (FH403) showed the highest degree of change at 12 hours, 
with fold changes consistent with Donor 1 at this time of nearly 6-fold upregulation. Donor 
3 (FH407), however, generally showed less of an induction of expression with FGF 
treatment; nevertheless all changes were significant when compared to untreated cells at 
the same time points. Dose-dependent effects were seen for each donor at varying time 
points, but this was not the case at all times.  
An analysis of expression of DUSP6 showed, similarly to SPRY2, that all treatments caused 
a significant increase in gene expression at all time points (Figure 5.4). Using the 10 ng/ml 
and 25 ng/ml dosage of FGF-2, levels of gene expression were maintained over the 24 
hours; however the 1 ng/ml treatment resulted in a reduced induction of expression at 24 
hours compared to earlier in the experiment, although this remained significantly above 
basal levels. Again, Donor 1 and Donor 2 showed a greater induction of DUSP6 expression 
when compared to Donor 3. Dose-dependent effects were seen for Donor 1, whereas for 
Donors 2 and 3 the 10 ng/ml treatment resulted in the largest effect at all time points. 
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For IL-6, previously identified as a negatively regulated target of FGF following prolonged 
culture in FGF-2 (Solchaga et al., 2005), upregulation of RNA expression was seen across all 
three donors with all FGF-2 concentrations following 6 and 12 hours in culture (Figure 5.5). 
At 6 hours, all increases in expression were found to be significant, and occurred in a dose-
dependent manner. By 12 hours, the effects were generally the greatest, with a maximum 
upregulation seen with 10 ng/ml FGF-2 in each donor. Donor variation is clear at this time, 
with expression increased by ~3-fold at 6 hours for all donors, but at 12 hours varying from 
9-fold to 5-fold for 10 ng/ml treatment depending upon donor. Strong differences were 
seen at 24 hours; for Donor 1 FGF treatment still resulted in increased IL-6 levels, however 
the alternative two donors did not show any increase when compared to IL-6 levels in 
untreated cells, except for the 25 ng/ml dose for Donor 2. Interestingly, IL-6 expression 
was found to increase in untreated cells over the 24 hour period, this effect being seen to 
occur more strongly in Donors 2 and 3.  
 




Figure 5.3 Analysis of SPRY2 expression in MSCs following FGF treatment over 24 hours  
Analysis by qRT-PCR of SPRY2 expression following FGF-2 treatment, on separate donors. Error 
bar shows SE of three technical replicates. Fold change in expression of RNAs was calibrated to 
0 ng/ml at 6 hours and normalised to RPS27a by the 2
-ΔΔCt
 method. Statistical analysis carried 
out by t-test, comparing treatments to 0 ng/ml condition at each time point; * p< 0.05, ** p< 
0.005, *** p< 0.001.  




Figure 5.4 Analysis of DUSP6 expression in MSCs following FGF treatment over 24 hours  
Analysis by qRT-PCR of DUSP6 expression following FGF-2 treatment, on separate donors. Error 
bar shows SE of three technical replicates. Fold change in expression of RNAs was calibrated to 
0 ng/ml at 6 hours and normalised to RPS27a by the 2
-ΔΔCt
 method. Statistical analysis carried 
out by t-test, comparing treatments to 0 ng/ml condition at each time point; ** p< 0.005, *** 
p< 0.001. 




Figure 5.5 Analysis of IL-6 expression in MSCs following FGF treatment over 24 hours 
Analysis by qRT-PCR of IL-6 expression following FGF-2 treatment, on separate donors. Error 
bar shows SE of three technical replicates Fold change in expression of RNAs was calibrated to 
0 ng/ml at 6 hours and normalised to RPS27a by the 2
-ΔΔCt
 method. Statistical analysis carried 
out by t-test, comparing treatments to 0 ng/ml condition at each time point; * p< 0.05, ** p< 
0.005, *** p< 0.001. 
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5.2.4 The MSC transcriptome following FGF signalling 
To study changes across a large range of genes, a human genome Agilent microarray was 
undertaken. This dataset could then be drawn in comparison to previously identified 
targets, including those that resulted from a whole genome microarray undertaken with 
Xenopus, where FGF signalling had been inhibited (Branney et al., 2009).  Of the 83 genes 
identified, 40 of these were found to have confirmed homologues in humans.  
The microarray was carried out using RNA from one donor, treated with 10 ng/ml FGF-2 
for 6 hours. This concentration was selected as it had been shown to be more effective at 
activating MAPK signalling and inducing transcriptional effects compared to 1 ng/ml FGF-2, 
but no less effective than 25 ng/ml. Six hours was chosen as the time point as it appeared 
sufficiently early to see transcriptional changes, and using an early time point should allow 
the detection of rapid direct effects of FGF signalling. 
Analysis of the data found that 3907 genes showed a >2-fold change following FGF-
treatment. Of the transcripts identified as putative targets by the array, 1016 of these 
were lincRNAs and 428 were predicted/uncharacterised genes. From the remaining 2463 
genes, 1063 were downregulated and 1398 were upregulated following FGF treatment.  
Genes of interest were identified and fold changes are given in Table 5.1 and Table 5.2. 
Selections were made on the basis of known FGF targets, by comparison to the Xenopus 
array, and from pathways that are known to crossover with FGF signalling. 
The array data supported the prior qRT-PCR results for SPRY2, DUSP6, and IL-6, with fold 
increases of 3.95, 11.2 and 2.67 respectively (Table 5.1). This was in line with the fold 
changes seen previously for this treatment, although IL-6 showed a slightly increased 
upregulation over the previous results. 
In comparison to the Xenopus data, 11 putative gene targets were found to act in the 
same manner: 9 showed an increase in expression with FGF-2 treatment whereas they 
were reduced following FGF inhibition previously (GJB2, DUSP5, EPHA4, SPRY2, TNFRSF1B, 
DUSP1, IRX3, PNP, EGR1) (Table 5.1), and 2 were reduced upon FGF stimulation, but had 
shown increased expression upon FGF inhibition (IRG1, TSC22D3) (Table 5.2). Three genes 
showed significantly altered expression in the opposing direction (PDGFA, GIGYF2, 
CHRDL1) (Table 5.1, Table 5.2). Fold change data from the Xenopus array is shown in 
Appendix 2. 
Some members of the FGF family showed altered expression on this array, with ligands 
FGF-16 and FGF-5 being increased (Table 5.1), but a reduction was seen in the ligand FGF-
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22 and also FGFR2 (Table 5.2). There are known interactions between the FGF and wnt 
pathways, and it was seen that wnt ligands wnt5a and wnt9a showed positive regulation 
(Table 5.1), with wnt7b and wnt11 being negatively regulated (Table 5.2). The negative 
regulator DKK1 showed an increase in expression following FGF stimulation (Table 5.1). 
Another signalling pathway known to interact with FGF is the BMP pathway, and, 
interestingly, treatment with FGF-2 also resulted in an increase in BMP-2 RNA levels (Table 
5.1). XPO5 codes for exportin-5, the protein responsible for exporting pre-miRNA from the 
nucleus to the cytoplasm, and levels were increased 2.06-fold following FGF pathway 
stimulation (Table 5.1). 
 
  






DUSP6 11.2 Dual specificity phosphatase 6 , transcript variant 1, mRNA 
[NM_001946] 
GJB2 7.78 Gap junction protein, beta 2, 26kDa, mRNA [NM_004004] 
FGF-16 7.75 Fibroblast growth factor 16, mRNA [NM_003868] 
BMP2 6.43 Bone morphogenetic protein 2, mRNA [NM_001200] 
DUSP5 5.34 Dual specificity phosphatase 5, mRNA [NM_004419] 
EPHA4 4.33 EPH receptor A4, mRNA [NM_004438] 
WNT5A 4.04 Wingless-type MMTV integration site family, member 5A , mRNA 
[NM_003392] 
SPRY2 3.95 Sprouty homolog 2 (Drosophila), mRNA [NM_005842] 
SPRY4 3.81 Sprouty homolog 4 (Drosophila), transcript variant 1, mRNA 
[NM_030964] 
SPRY4 3.61 Sprouty homolog 4 (Drosophila), transcript variant 1, mRNA 
[NM_030964] 
FGF-5 3.26 Fibroblast growth factor 5, transcript variant 1, mRNA [NM_004464] 
TNFRSF1B 3.12 Tumour necrosis factor receptor superfamily, member 1B , mRNA 
[NM_001066] 
FGF-5 2.97 Fibroblast growth factor 5, transcript variant 2, mRNA [NM_033143] 
PDGFA 2.74 Platelet-derived growth factor alpha polypeptide, transcript variant 1, 
mRNA [NM_002607] 
IL6 2.67 Interleukin 6 (interferon, beta 2), mRNA [NM_000600] 
DUSP1 2.62 Dual specificity phosphatase 1, mRNA [NM_004417] 
IRX3 2.47 Iroquois homeobox 3, mRNA [NM_024336] 
PNP 2.33 Purine nucleoside phosphorylase, mRNA [NM_000270] 
DKK1 2.24 Dickkopf homolog 1 (Xenopus laevis), mRNA [NM_012242] 
EGR1 2.14 Early growth response 1, mRNA [NM_001964] 
XPO5 2.06 Exportin 5, mRNA [NM_020750] 
WNT9A 2.02 Wingless-type MMTV integration site family, member 9A, mRNA 
[NM_003395] 
Table 5.1 Candidate positively regulated targets of FGF-2 in MSCs 
Fold change data for genes identified on a human genome Agilent array in MSCs treated with 
FGF-2 compared to no treatment. Genes in green and red were identified on the Xenopus 
array: green = same direction of regulation, red = different direction of regulation. 
 
 






WNT11 -4.52 Wingless-type MMTV integration site family, member 11, mRNA 
[NM_004626] 
FGFBP3 -4.27 Fibroblast growth factor binding protein 3, mRNA [NM_152429] 
FGF-22 -3.01 Fibroblast growth factor 22, mRNA [NM_020637] 
IRG1 -2.92 Immunoresponsive 1 homolog (mouse) [Source:HGNC 
Symbol;Acc:33904] [ENST00000449753] 
FGFR2 -2.72 Fibroblast growth factor receptor 2, transcript variant 2, mRNA 
[NM_022970] 
GIGYF2 -2.36 GRB10 interacting GYF protein 2 [Source:HGNC Symbol;Acc:11960] 
[ENST00000410033] 
CHRDL1 -2.15 Chordin-like 1, transcript variant 3, mRNA [NM_145234] 
TSC22D3 -2.14 TSC22 domain family, member 3, transcript variant 2, mRNA 
[NM_004089] 
WNT7B -2.02 Wingless-type MMTV integration site family, member 7B, mRNA 
[NM_058238] 
Table 5.2 Candidate negatively regulated targets of FGF-2 in MSCs 
Fold change data for genes identified on a human genome Agilent array in MSCs treated with 
FGF-2 compared to no treatment. Genes in green and red were identified on the Xenopus 
array: green = same direction of regulation, red = different direction of regulation. 
 
5.2.5 lin28 is undetectable in MSCs 
The interest in lin28 genes as targets of FGF signalling and as developmentally important 
genes, particularly in mesoderm specification, led to investigation of their expression in 
MSCs. However, both lin28a and lin28b did not appear to be expressed in MSCs; using 
mRNA levels to infer gene expression, data from the Agilent microarray did not detect 
expression of lin28a or lin28b above background levels, and attempts at measuring lin28a 
and lin28b using qRT-PCR also failed to reliably show expression of either gene, both 
endogenously and following FGF-2 treatment (data not shown). The 2102Ep EC cell line 
expresses both of the lin28 proteins and was used as a positive control. Expression of 
lin28a and lin28b was not seen in MSCs at the protein level, analysed by western blot, in 
comparison to 2102Ep cells (Figure 5.6). 




Figure 5.6 Analysis of lin28a and lin28b by western blot in MSCs compared to EC cells 
Protein was collected and analysed from MSCs and 2102Ep cells. GAPDH was used as a loading 
control. MSC blot is representative of three separate donors. 
5.3 Discussion 
5.3.1 Investigating FGF signalling in MSCs 
Exposing MSCs to exogenous FGF protein showed promising data but did limit the 
manipulations that could be carried out on the cells. With 22 FGF ligands expressed in 
humans (Ornitz and Itoh, 2001), it would be impractical to attempt to treat with all of 
these. FGF-2 was selected here as it is the most common FGF supplement used in cell 
culture, and identifying targets of this ligand in particular may help identify stem cell 
mechanisms for both proliferation and differentiation.  
This does contrast with the methodology used in the Xenopus array with which data 
comparisons were drawn. In this, use of both dnFGFR1 and dnFGFR4 overexpression found 
that either was able to effectively inhibit all FGF signalling (Branney et al., 2009), and 
therefore would have been able to identify targets of all FGF ligands functional at the time. 
Differences between datasets may arise where genes detected in the Xenopus work are 
not downstream of the FGF-2 ligand. 
A drawback with the over-activation of a signalling pathway is that some transcriptional 
targets are likely to be missed. The control of gene expression is often under the influence 
of multiple factors, and therefore if FGF is necessary to drive expression, a decrease in 
levels may be seen with a loss of signalling, but levels would not alter upon over-
stimulation due to endogenous FGF signalling already activating expression. There is 
evidence for some autocrine FGF signalling in MSCs, which decreases as the cells increase 
in passage number (Zaragosi et al., 2006), and this may have masked the effects of adding 
FGF-2. Nevertheless, much stem cell work involves treatment with FGF-2, and by also 
following this method relevant targets are likely to be identified. 
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5.3.2 MSCs respond rapidly to FGF treatment 
Work here has found that MSCs are capable of responding to FGF-2 treatment, through 
the expression of FGFRs, which have recently been shown to be developmentally 
regulated and may affect cellular responses to FGF (Coutu et al., 2011). The response is 
rapid, with activation of the signalling cascade apparent by as little as 5 minutes, seen by a 
phosphorylation of ERK protein, and the induction of transcriptional changes by as rapidly 
as 6 hours. The effects of FGF signalling were looked at in this study in a time frame much 
shorter than those in which previous studies have been carried out, which have normally 
used 7 days as their first time of observation (Martin et al., 1997; Solchaga et al., 2005). 
However, as previous reports were looking for alterations in rates of proliferation, such 
changes would take longer to become apparent compared to transcriptional changes. The 
earliest of the time points used here, 6 hours, was pursued for further investigation to 
enhance the likelihood that any alterations in expression detected were due directly to an 
increase in FGF signalling and to attempt to limit the indirect effects, which would usually 
take longer to be initiated. 
The transcriptome analysis was carried out using the 10 ng/ml dosage of FGF-2, as results 
implicated that this generally resulted in a more increased activation of FGF signalling 
compared to using 1 ng/ml, but no reduction compared to 25 ng/ml treatment. Previous 
work found that different donors responded to different doses of FGF-2, with threshold 
effects where all treatments resulted in equivalent results, but an alternative donor 
showed increasing stimulation following increasing FGF-2 (Solchaga et al., 2005). Results 
like these highlight the effects donor difference can have on results, which were also 
demonstrated by the different fold changes seen in genes by qRT-PCR. In light of this, it is 
important that transcriptional targets identified by microarray are confirmed using cells 
from other donors. 
Reduction in dpERK by 60 minutes compared to 30 minutes with all levels of FGF-2 
suggests that perhaps there is a cyclic regulation occurring, and an initial increase in ERK 
phosphorylation cannot be sustained, and must decrease again. A similar response to this 
here was previously seen in MSCs, when using a much higher dosage of 50 ng/ml FGF-2, 
where a peak in ERK phosphorylation was seen at 5 minutes which decreased through to 
60 minutes (Choi et al., 2008). It would be interesting to see if dpERK levels are maintained 
at this lower level, perhaps with the activation of MAPK repressors which is discussed 
later, or whether there are ongoing cyclic fluxes in ERK activation.  
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5.3.3 Novel targets of FGF signalling in MSCs 
With over 1000 lincRNAs and over 2000 mRNA candidate targets showing changes in 
expression in this study, it is likely that further new targets of FGF signalling have been 
identified by the microarray carried out here. However, as mentioned above, true 
statistical analysis cannot be applied to this dataset alone, being carried out in only one 
donor, and further replicates and validation would be needed.  
lincRNAs are a class of RNA which are still being progressively understood. They have been 
found to show some evolutionary conservation between mammals, and thus are 
concluded likely to have important biological functions (Guttman et al., 2009). By 
correlating lincRNA and protein expression, the same study was able to infer potential 
roles for a number of lincRNAs, including identifying a subset that were activated by p53 
signalling, as well as other pathways (Guttman et al., 2009). Further work has connected 
particular lincRNAs with the reprogramming of stem cells, the maintenance of 
pluripotency being regulated by Nanog and other pluripotent proteins, and lincRNAs that 
were involved in germ layer specification (Guttman et al., 2011; Loewer et al., 2010). 
Unfortunately, due to differing terminology between both the papers and the Agilent 
microarray for the lincRNAs, no comparison has been drawn here between the lincRNAs 
altered upon FGF treatment in these cells and those involved in pluripotency from the 
studies; the Agilent array termed lincRNAs by chromosomal location, Loewer et al (2010) 
named the lincRNAs according to "their 3' protein-coding gene neighbour", and Guttman 
et al (2011) numbered the lincRNAs, as is the consensus for miRNAs. A more extensive 
comparison between these datasets, with a determination of corresponding names, may 
help elucidate further the effect that FGF treatment is having on these cells. 
Our interest in the lin28s in the Xenopus system led to investigating for any conservation 
of this regulation in human development, using MSCs for a mesodermal model. However, 
expression of neither lin28a nor lin28b could be detected by methods at the protein level 
and at the RNA level in MSCs. Treatment of the cells with FGF-2 did not result in 
detectable levels of lin28a or lin28b either, and thus the conservation of these as targets 
of FGF signalling in humans could not be determined. 2102Ep cells were used as a positive 
control for expression of the lin28 genes, which confirmed that the techniques were able 
to detect expression of the RNA and protein in cells.  
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5.3.4 FGF targets may respond differently to short and long-term  
FGF-2 exposure     
The initial finding that FGF-2 increased IL-6 expression contrasted with those in the 
literature that reported a negative regulation by FGF signalling (Solchaga et al., 2005). The 
positive regulation that was seen here, however, was at the earliest time points, and was 
reducing in effect by 24 hours, being non-significant in two donors by this time. This could 
indicate that perhaps a later activity of the FGF signalling is a repression of IL-6 expression, 
although this gene is initially a positive target. This is supported by work in other models, 
for example treatment of Schwann cells with FGF-2 found an increase in IL-6 at 5 and 10 
hours, which had reduced to untreated levels by 24 hours (Grothe et al., 2000). Another 
report found that after 24 hours of treatment, exogenously applied FGF-2 resulted in no 
change in IL-6 levels in HeLa cells (Delrieu et al., 1999), which may support the result found 
here, with the upregulation maybe already having been lost by this time. 
The study by Solchaga et al (2005) involved a microarray after 14 days in culture with FGF-
2 supplementation, and a further comparison between these data and the microarray  
data generated here may identify if there are further targets responding in a different 
manner to long and short term culture. This coupled with analysis of differentiation 
capabilities following different FGF treatments may give an insight into what targets of the 
FGF pathway are important for different roles. 
5.3.5 Conserved FGF signalling targets in MSCs 
A number of mRNA targets for FGF that were identified on the microarray have been 
previously identified in other species, including the Xenopus array that comparisons have 
been drawn to. This highlights these genes as good candidates for being FGF-regulated in 
MSCs, but again must be verified with alternative donors and more specific techniques 
such as qRT-PCR, to determine that they are true FGF targets in these cells. 
FGF signalling is known to cross-talk with other pathways. The FGF and wnt pathways are 
known to affect one another in the cell, as both are capable of signalling through the 
calcium pathway (reviewed in Bottcher and Niehrs, 2005; Kühl, 2002), and increased 
osteogenesis in MSCs as a result of activated FGFRs was found to occur by activation of 
both the MAPK and PKC pathways (Miraoui et al., 2009). The PKC pathway activation by 
wnt is a non-canonical pathway and wnt ligand activators of the non-canonical pathway, 
wnt7, wnt5a and wnt11 (Brade et al., 2006; Montcouquiol et al., 2006) were both 
upregulated and downregulated upon FGF treatment. wnt5a and wnt11 can activate PKC 
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via calcium pathway (Kühl, 2002). wnt9a, however, can function canonically and has been 
shown to be involved with mesenchymal differentiation (Brade et al., 2006), and 
expression of this was upregulated following FGF treatment. DKK1 is a wnt antagonist of 
the canonical pathway (Glinka et al., 1998), and was also increased with FGF signalling. 
These results show both activation and inhibition possibilities of the wnt pathway 
following FGF signalling, indicating there is no clear directional regulation of the wnt 
pathway by FGF here. Further investigation would need to look at protein levels of the wnt 
ligands, and activation of pathway factors such as PKC and β-catenin, for non-canonical 
and canonical effects. 
FGF often plays an antagonistic role to BMP signalling (Buckland et al., 1998; Streit and 
Stern, 1999), but the only change in mRNA levels of key players in the BMP pathway was 
an over 6-fold increase in expression of BMP-2. Surprisingly, no downregulation of other 
pathway components were seen. It may be the case that there is a low level of BMP 
activity in these cells, and an increase in FGF signalling does not suppress activity any 
further, or that any regulatory effects are not occurring at the transcriptional level. 
FGF stimulation in MSCs produced changes in members of the DUSP and SPRY families, 
which have been found to act in a negative feedback loop with FGF signalling. DUSP1, 
DUSP5 and DUSP6 are known to be positively regulated by FGF (Dickinson and Keyse, 
2006; Li et al., 2007), but function to inactivate ERK phosphatase (Dickinson and Keyse, 
2006), thus inhibiting FGF signalling via the MAPK pathway. Additionally, both sprouty2 
and sprouty4 prevent activation of the MAPK pathway by targeting Ras (Gross et al., 2001; 
Lee et al., 2001), whilst also being activated by the FGF pathway (Lai et al., 2011; Sasaki et 
al., 2001). Work here showed a decrease in the activation of ERK following 60 minutes of 
treatment. It is possible that transcriptional changes as a result of FGF signalling were 
rapidly induced within this timeframe, and targets such as the DUSP and sprouty families 
activated and functioning to inhibit the MAPK pathway, resulting in this reduction of 
dpERK. This puts forward the case that although 6 hours is treated here as a rapid time 
point for changes in these cells, there may be alterations in the transcriptome from much 
earlier stages still. Work on sprouty proteins in Xenopus has suggested that these proteins 
are not involved in the specification of mesoderm, but instead function to inhibit FGF 
signalling through PKCδ and Ca
2+
 release (Nutt et al., 2001; Sivak et al., 2005), whereas 
MKP1, homologous to DUSP1, does affect mesoderm specification (Gotoh et al., 1995). 
Whether these roles are conserved in MSCs, however, remains unknown. Interestingly, 
DUSP5 and DUSP6 showed larger changes in expression than the Sprouty genes, which 
might indicate that the function of these at this time is more important than the Sprouty 
genes.  
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CHRDL-1 expression in MSCs was decreased following FGF treatment; this gene shows 
homology to chordin, which is known to be a positively regulated FGF target in species 
including Xenopus and zebrafish. How closely the function of CHRDL1 matches chordin has 
not been determined, nor has it been shown to be regulated by FGF, but it is active as a 
BMP-4 antagonist (Kane et al., 2008), which would be consistent with a function 
downstream of FGF. The reason for this difference in regulation is unknown, and for 
results like this it is important for further validation to be carried out to ensure that this 
gene is working differently in the MSC system.  
A number of genes identified from the Xenopus array that were also identified as putative 
targets here have also been linked with FGF in a variety of roles: for example, EGR-1 has 
been identified as a target of FGF-1 and FGF-2, which can further work to activate PDGFA 
gene expression (Delbridge and Khachigian, 1997; Santiago et al., 1999). These genes look 
like further strong candidates as FGF-2 regulated genes in MSCs. However, there are 
additional targets identified here such as GJB2 and GIGYF  that were linked with FGF 
regulation in Xenopus (Branney et al., 2009), but have not otherwise been linked with FGF 
signalling. These genes would need further confirmation as true FGF targets in MSCs and 
investigation into their function to determine the importance of any interaction. This 
microarray was only carried out with one sample, and as such no statistical analysis can be 
carried out. The genes of interest have not here been further verified either, and this 
would need to be carried out, using qRT-PCR, to be certain that these are targets of FGF 
signalling in this system.  
The lack, or very low level, of lin28 expression in MSCs, and the absence of any increase in 
expression with treatment of FGF resulted in no further investigation of lin28 as an FGF 
target in human cells, and no further experiments were undertaken with MSCs to look at a 
conserved signalling pathway involving lin28. The decision was taken not to pursue with 
2102Ep cells as an alternative model, due to their lack of an ability to differentiate (Duran 
et al., 2001). It was identified that this nullipotency results as a loss of differentiation 
function (Duran et al., 2001) but the factors responsible for this remain currently 
unknown, therefore it is possible that the signalling pathway we are interested in is 
misregulated in these cells, and thus involved in the prevention of differentiation of 
2102Ep cells.  From this, experiments into mesodermal development and the FGF pathway 
may not be representative of true endogenous signalling. 
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Chapter 6. Physical interactions between lin28 proteins 
and miRNAs 
6.1 Introduction 
6.1.1 The miR-17-92 clusters 
The miR-17-92 clusters are a highly conserved set of miRNA clusters that have been found 
in vertebrates from zebrafish to humans (Tanzer and Stadler, 2004). The arrangement on 
the human genome is highly similar to that in Xenopus as shown in section 4.3.4, but 
contains an additional miRNA, miR-106b, and is present as three clusters (Figure 6.1A), 
which is a more typical arrangement for other species (Tanzer and Stadler, 2004). 
Chromosomal locations for the clusters have been mapped in humans: the mir-17-92 
cluster is expressed on chromosome 13 and has been found to be intronic to C13orf25, 
which does not seem to have another function in addition to producing this transcript 
(Mendell, 2008; Ota et al., 2004). miR-106a-363 is X-linked, but has not been shown to be 
linked to any other genes, and miR-106b-25 is intronic to MCM7 on chromosome 7 
(Mendell, 2008). 
The clusters are believed to have evolved through both tandem duplications and cluster 
duplications (Tanzer and Stadler, 2004), and as such many of the miRNAs present within 
the cluster are highly related. This is reflected in their seed sequences, which allow the 
'major' miRNAs from the clusters to be grouped into four subfamilies due to their 
conservation (Figure 6.1B). 
6.1.2 Possible physical interaction between lin28 and miRNA 
The lin28 proteins are known to bind to mRNA and let-7 miRNA targets to exert their 
effects, through their dual RNA-binding domains. It was hypothesised that in positively 
regulating multiple members of the miRNA cluster, the lin28s may be binding to the 
miRNAs to influence their processing. In order for a physical interaction to occur, there 
must be co-expression of the miRNAs with the lin28s. Using ES cells, with a known 
requirement for lin28a, research has uncovered expression of a number of miRNAs across 
the clusters (Foshay and Gallicano, 2009; Houbaviy et al., 2003; Suh et al., 2004; Tang et 
al., 2006; Ventura et al., 2008). Similarly to the lin28s, there are reports of upregulation of 
these cluster miRNAs in cancer, perhaps reflecting a role in pluripotency or an 
undifferentiated state. miR-17-92 is the most highly studied of the clusters; it was termed 
'oncomiR-1', due to its oncogenic capabilities (He et al., 2005), and has been linked to 
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cancers including lung, colon, prostate, breast and pancreatic cancer, leukaemia, 
medulloblastoma and retinoblastoma (reviewed in Concepcion et al., 2012; Hayashita et 
al., 2005; Volinia et al., 2006), with the miR-106a-363 cluster having a possible role in T-cell 
leukaemia (Landais et al., 2007).  
 
Figure 6.1 Organisation of miR-17-92 clusters and conservation of seed regions 
A) Arrangement of miRNAs across miR-17-92 cluster and paralogous clusters. Whole strand 
refers to pri-miRNA, coloured boxes represent pre-miRNA, the colour of which indicates 
miRNA families based upon seed sequence. Black and white boxes represent mature miRNA: 
black = 'major' miRNA, white = 'minor' miRNA. B) Human and X. tropicalis miRNA sequences 
grouped into families by seed sequence. 
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6.1.3 The binding of lin28 to let-7 
lin28 is known to interact with let-7 via binding to the terminal loop, which inhibits its 
processing (Piskounova et al., 2008; Viswanathan et al., 2008). Research has since 
attempted to uncover what the binding motifs for lin28 recognition are; one such 
identified motif is a sequence consisting of 'GGAG' (Heo et al., 2009). Further work 
confirmed this, although more recent work has expanded this to a simpler sequence of 
'NGNNG', where N = any base (Loughlin et al., 2012), and this site is believed to be 
targeted by the zinc finger domains (Loughlin et al., 2012; Nam et al., 2011). A binding site 
for the CSD has been identified as single-stranded RNA with the sequence 'NNGNGAYNN' 
in pre-let-7e, where Y = pyrimidine (Nam et al., 2011), and alternatively 'GNUNNUNNN' 
(Mayr et al., 2012). Data indicated that binding of the CSD to such sites remodelled the 
RNA, exposing the binding site for the zinc fingers, which were suggested as likely to 
provide the specificity for the interaction. 
6.1.4 Aims 
The aims of this chapter are to: 
• Identify any conserved putative lin28 binding sites in miR-17-92 and miR-106-363 
clusters. 
• Investigate if a direct interaction occurs between lin28 and putative binding sites using 
an in vitro binding assay. 
• Establish any specificity in binding preferences. 
• Discover if any differences occur with full-length lin28a proteins compared to lin28b 
protein. 
6.2 Results 
6.2.1 Presence of putative lin28 binding motif in pre-mir-363 
A published specific binding site for lin28 in let-7 is GGAG (Heo et al., 2009; Nam et al., 
2011), and any presence of this in our RNAs of interest was investigated. As the Xenopus 
miRNAs that were showing the largest changes on the microarray belonged to the miR-17-
92 and miR-106-363 clusters, the search for binding sites was only carried out in these 
two. This GGAG sequence is present in both the miR-17-92 cluster and miR-106-363 
cluster; in one instance in each cluster, the motif is present between pre-miRNA: between 
miR-19b-2 and miR-92a-1 in the miR-17-92 cluster, and between miR-19b-1 and miR-92a-2 
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in the miR-106-363 cluster (Figure 6.2). Notably, there is one other GGAG motif in the miR-
106-363 cluster, which is within the terminal loop region of pre-mir-363, the last miRNA in 
this cluster (Figure 6.2). Additionally, it has been suggested that GGUG may also provide a 
binding site for lin28 (Heo et al., 2009; Mayr et al., 2012), and there are further GGUG 
motifs present within these clusters (Figure 6.2). The identification of putative CSD binding 
sites proved more difficult to identify due to the structural importance in addition to 
sequence, so only potential zinc finger sites were followed up, as it has been hypothesised 
that these sites confer the specificity to the interaction. 
 
Figure 6.2 Location of GGAG motifs in Xenopus miRNA clusters 
Arrows indicate location of possible lin28 zinc finger binding sites in X. tropicalis miR-17-92 and 
miR-106-363 clusters. Red arrows = GGAG sequences, blue arrows = GGUG sequences. 
As the GGAG sequence within pre-mir-363 was in the terminal loop, similarly placed to the 
sequence in let-7, this was pursued. Seventeen vertebrate species have been identified so 
far as having a copy of the miR-363 miRNA (Figure 6.3). The GGAG motif is highly 
conserved between these species, with the only exceptions being the green anole lizard, 
Anolis carolinensis, which instead contains the sequence GGAC, and zebrafish. The 
zebrafish sequence shows low conservation in the loop region, and much more sequence 
identity is seen between the other species in this region (Figure 6.3). Conservation 
between all species is highest within the mature miRNAs, with the -3p 'major' form 
showing the highest conservation. The pre-miRNA sequences identified for zebrafish and 
the Tasmanian devil are also much longer sequences than in the other species, longer at 
both the -3p and -5p ends, although they continue to not show high sequence 
conservation to each other in these regions (data not shown).  
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6.2.2 Truncated lin28 protein can bind RNA 
The capability of lin28 protein to bind mir-363 was determined using electrophoretic 
mobility shift assay (EMSA). Recombinant lin28 protein was synthesised by the Anston 
group (York Structural Biology Laboratory). Due to difficulties in generating and purifying 
the protein, a truncated version of the X. tropicalis lin28a recombinant protein was 
provided (Xrt-lin28a). The protein lacked both the N- and C- 'disordered' termini, but still 
contained the RNA-binding domains (Figure 6.4).  
 
Figure 6.4 Truncation of recombinant lin28 protein 
Scale diagrams of lin28a proteins. Pink region represents CSD, and green indicates the zinc 
finger motifs. Numbers on the recombinant protein denote the first and last amino acid 
residues of the truncated form, as counted in lin28a1. 
To ensure that this truncation was not impeding the RNA-binding properties of the 
protein, binding reactions were carried out using recombinant human full-length (FL) and 
truncated termini (TT) lin28a protein, which again lacked the terminal regions. The human 
truncated protein was composed of residues 37-180, which covers the same areas of the 
protein as the Xenopus truncation of 34-177.   
As the terminal loop of pre-let-7 is a known binding target of lin28 proteins, the proteins 
were tested by EMSA with RNA corresponding to the terminal loop of human let-7g (L-let-
7g).  Both human proteins were found to cause a shift in the let-7g RNA, indicating that 
binding was occurring; concentrations between 0.2 and 0.8 µM were sufficient to cause 
the shift in RNA, showing that RNA-binding function was maintained in the TT protein. A 
similar binding efficiency was maintained between the two proteins; however this was 
slightly improved with the FL protein (Figure 6.5). 
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Figure 6.5 Binding of recombinant full-length and truncated lin28a protein to let-7 
EMSA performed with 
32
P-L-let-7g and indicated concentrations of human recombinant lin28a 
protein, either full-length (FL) or truncated (TT). Arrows indicate labelled RNA (blue) and lin28-
RNA complex (red). 
6.2.3 Binding to terminal loop regions 
To analyse binding with the Xenopus lin28a protein, a range of concentrations were tested 
with the L-let-7g RNA. The human RNA shows slight differences to the Xenopus sequence, 
but retains lin28 binding sites, and so was used for EMSA. Binding of the RNA was 
observed, with an increase in the proportion of RNA shifting with increasing amounts of 
protein (Figure 6.6A). The calculation of the dissociation constant (Kd) signifies binding 
efficiency, which at 0.314 μM indicated a high affinity interaction. A binding of all RNA was 
predicted to occur (Bmax = 1.017) (Figure 6.6B).  
As the GGAG motif was found within the pre-mir-363 terminal loop, binding was tested 
with an RNA sequence for the loop of the Xenopus precursor (L-mir-363). Using the same 
range of protein concentrations as for L-let-7g, a shift in the radio-labelled RNA was seen 
to occur with a calculated Kd of 0.448 μM and a maximum proportion of RNA bound at 
96.2% (Figure 6.7), indicating further effective binding. 




Figure 6.6 Binding of Xenopus lin28a with let-7g terminal loop  
A) EMSA performed with 
32
P-L-let-7g and indicated concentrations of Xrt-lin28a. Gel shown is 
representative of n=3. Arrows indicate labelled RNA (blue) and lin28-RNA complex (red). B) 
Band intensities were quantified from three independent experiments and the proportion 
bound was calculated. Data were used to plot a binding curve. Bmax = 1.017. 
  





Figure 6.7 Interaction of Xenopus lin28a with mir-363 terminal loop  
A) EMSA performed with 
32
P-L-mir-363 and indicated concentrations of Xrt-lin28a. Gel shown 
is representative of n=3. Arrows indicate labelled RNA (blue) and lin28-RNA complex (red). B) 
Band intensities were quantified from three independent experiments and the proportion 
bound was calculated. Data were used to plot a binding curve. Bmax = 0.962. 
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6.2.4 The specificity of lin28 targets 
To determine the specificity of this interaction, it must be shown that lin28 is not capable 
of binding to all RNA. pre-miR-138 has previously been shown to not bind with lin28 
(Piskounova et al., 2008), and RNA for the terminal loop region of this Xenopus miRNA was 
used (L-mir-138). Interestingly, some binding was detected between lin28 and the mir-138 
RNA (Figure 6.8); however, this required much greater concentrations of protein than 
either of the previous experiments. Over the concentrations used, the Bmax, calculated as 
0.22 indicated that the majority of mir-138 RNA would not be bound by the protein, and 
therefore an appropriate Kd could not be determined (plot not shown). 
Cold competition assays were also used to demonstrate any preference of lin28 for pre-
mir-363. 1 μM of Xrt-lin28 was used, as this was over the calculated Kd for the interaction 
with L-mir-363, and should bind a high proportion of the RNA, but at levels without an 
excess of protein and thus true competition for binding would occur. Indeed, when used 
without any unlabelled competitor RNA, 61% of the labelled RNA was shifted (Figure 6.9, 
Lane 2). Non-radiolabelled 'cold' RNA was used in excess amounts of 50x, 100x and 200x to 
compete with 
32
P-L-mir-363 for binding of the lin28 protein. Cold competition using the 
same sequence in excess successfully competed for binding to lin28, resulting in up to 98% 
of the labelled RNA remaining unbound with 200x cold excess (Figure 6.9, Lanes 3-5). This 
indicates that the protein was preferentially binding to the unlabelled RNA. Cold L-mir-138 
RNA was unable to compete to the same degree, and larger amounts of L-mir-363 were 
bound to the lin28: 13% remained bound to lin28 with 200x excess of L-mir-138 (Figure 
6.9, Lanes 6-8). Nevertheless, a reduction in bound L-mir-363 was seen with excess L-mir-
138, suggestive of some competition. 
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Figure 6.8 Interaction of mir-138 terminal loop with Xenopus lin28a 
EMSA performed with 
32
P-L-mir-138 and indicated concentrations of Xrt-lin28a. Arrows 
indicate RNA and lin28a-RNA complex. Gel shown is representative of n=3.  Arrows indicate 
labelled RNA (blue) and lin28-RNA complex (red). 
 
      
Figure 6.9 Cold competition of mir-363 loop binding by mir-363 compared to mir-138 
EMSA performed with 
32
P-L-mir-363 and 1 μM of Xrt-lin28a (except for RNA only lane). Arrows 
indicate RNA and lin28a-RNA complex. Reactions were competed with unlabelled RNA of L-
mir-363 or L-mir-138 in excess levels as indicated. Band intensities were quantified and 
proportion of RNA bound was calculated. Gel shown is representative of n=2. Arrows indicate 
labelled RNA (blue) and lin28-RNA complex (red). 
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6.2.5 The GGAG sequence in pre-mir-363 as a lin28 binding site 
To determine if the GGAG motif is important for the binding of lin28 with mir-363, as it is 
with let-7, an RNA sequence was used with this sequence mutated to GUAU (mL-mir-363), 
because Heo et al (2009) found that this sequence reduced the binding interaction. 
Binding of Xrt-lin28a to this mutated sequence was seen, nevertheless this was reduced 
compared to the normal sequence, with higher amounts of protein required to see a shift 
(Figure 6.10A). This result was reflected in the reduction of the maximum proportion of 
RNA bound to 58% (Figure 6.10B). 
Performing a cold competition with the mutated mir-363 against the wildtype sequence 
also demonstrated a preference for the sequence containing the GGAG motif. As before, 
competition of 
32
P-L-mir-363 with unlabelled L-mir-363 resulted in up to a complete loss of 
bound RNA (Figure 6.11, Lanes 3-5), whereas competition with unlabelled mL-mir-363 was 
slightly less effective at competing at the highest excess used, although showed greater 
competition at lower excesses (Figure 6.11, Lanes 6-8), which would have to be 
investigated further to determine if there is any significance in this. The mL-mir-363 
competed much more successfully than the mir-138 sequence previously. 




Figure 6.10 Interaction between Xenopus lin28a and a mutated mir-363 terminal loop 
A) EMSA performed with 
32
P-mL-mir-363 and indicated concentrations of Xrt-lin28a. Gel shown 
is representative of n=3. Arrows indicate labelled RNA (blue) and lin28-RNA complex (red). B) 
Band intensities were quantified from three independent experiments and the proportion 
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Figure 6.11 Cold competition of mir-363 loop binding by mutated mir-363 
EMSA performed with 
32
P-L-mir-363 and 1 μM of Xrt-lin28a (except for RNA lane). Reactions 
were competed with unlabelled RNA for L-mir-363 or mL-mir-363 in excess levels as indicated. 
Band intensities were quantified and proportion of RNA bound was calculated. Gel shown is 
representative of n=3. Arrows indicate labelled RNA (blue) and lin28-RNA complex (red). 
 
6.2.6 Expressing full-length protein endogenously 
It is possible that the C- and N- termini of the lin28a protein can play a part in the 
recognition of binding targets, with the function of these domains currently unknown. 
Additionally, it was necessary to identify if there were any obvious differences in the 
binding specificity of lin28a and lin28b. To investigate these possibilities endogenously 
translated protein was used in whole embryo extract. X. laevis embryos were utilised for 
this, due to the production of larger amounts of proteins from these embryos compared to 
X. tropicalis. Embryos were injected to overexpress lin28a1, lin28a2, or lin28b. This 
overexpression was confirmed against control uninjected embryos, which would be 
expressing normal levels of the lin28s and other proteins. Using western blot analysis, no 
endogenous protein was detected when embryos were not induced to overexpress either 
protein, with greatly increased levels following RNA injections (Figure 6.12). The lin28 
proteins were not purified from the embryo extract, and as numerous other proteins 
would be present, quantification of the lin28 protein levels was not possible. Protein was 
collected from embryos at stage 10.5, as this was the stage at which miRNA regulation had 
been identified and therefore other proteins normally expressed at this stage would 
continue to be present, which may be able to affect binding affinity. 




Figure 6.12 Analysis of lin28 protein overexpression by western blot 
Western blot analysis of embryos injected with 1 ng/embryo of lin28a1, a2, or b individually, 
compared to control embryos, at stage 10.5. GAPDH was used as a loading control.  
 
6.2.7 Assessing binding ability of full-length lin28 proteins 
The capability of the embryo extracts to bind RNA was tested using L-let-7g. Interestingly, 
it was seen that embryo extract overexpressing lin28a1 produced a shift of the RNA, 
whereas normal control extract did not (Figure 6.13A), as endogenous levels of the lin28 
proteins would be in the control extract. This was also seen for lin28a2 (Figure 6.13B) and 
lin28b (Figure 6.13C). To confirm that this shift was due to the lin28 proteins themselves 
and not another factor which had been upregulated following the lin28 overexpression, a 
supershift was performed using α-lin28a/b antibodies. For all three proteins a supershift 
was observed following the addition of the relevant antibody, with a depletion in the 
intensity of the shift which indicated the protein-RNA complex (Figure 6.13A-C, Lane 5). 
This supershift did not occur to completion, and more diluted extract was used for future 
assays due to a probable overload of protein. A pre-immune bleed serum control was also 
used to control for antibody specificity, and this did not produce a supershift (Figure 
6.13A-C, Lane 6). 
EMSA with the same embryo extract was also carried out using labelled L-mir-363. lin28a1 
and lin28a2 overexpressing extract showed binding to the RNA, which decreased with a 
dilution in the embryo extract, and these proteins were also supershifted with lin28a 
antibody (Figure 6.14A,B). Binding to the RNA was observed with lin28b, but this did not 
appear to be as strong an interaction (Figure 6.14C). Interestingly, with lin28b another 
shifted band can be seen. This does not alter in any of the conditions, and appears to be a 
lin28-independent interaction with the RNA. This band was also present in the EMSAs 
performed with lin28a proteins, but due to stronger binding to L-mir-363 with the lin28as, 
this additional band was weaker and only observed over long exposures. We cannot 
quantify the amount of lin28 proteins in the embryo extract, and so it cannot be 
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quantitated here if the lin28as are better at binding the mir-363 RNA compared to lin28b, 
or whether less lin28b protein is merely available for the interaction. These EMSAs were 
carried out using a more diluted concentration of embryo extract than with the L-let-7g, to 
allow any supershift to be seen to completion. Additionally, it was found that when using 
more concentrated embryo extract, in all embryo extract conditions, we were unable to 
detect the unbound RNA, perhaps indicating that this was possibly unstable and being 
degraded or processed by proteins in the extract, and the true proportions of bound RNA 
could not be calculated  (data not shown). 
As before, the importance of the GGAG motif in this binding interaction was tested. The 
same embryo extract and conditions were used as with the L-mir-363 for labelled mL-mir-
363. It was found that both lin28a proteins still bound the RNA, confirmed by the 
supershift (Figure 6.15A,B). Less RNA appeared shifted in this interaction than with the 
wildtype sequence, and as the same extract at the same dilutions was used here as 
previously used with the non-mutated sequence, it can be seen that the loss of the GGAG 
sequence does affect binding. For lin28b, the interaction was greatly weakened and a very 
small proportion of RNA was shifted, and also supershifted (Figure 6.15C). 
As binding was observed using the mir-138 RNA with recombinant protein, this was also 
used with embryo extract which should indicate a more biologically relevant protein 
concentration. Only in one lane with embryo extract overexpressing lin28a1 was any 
observable shift detected (Figure 6.16 ), and as such this demonstrates a clear preference 
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6.2.8 Binding of full-length pre-miRNA 
Binding reactions were then carried out with full-length pre-miRNA, using EMSA with both 
the recombinant and in vivo translated full-length protein. Use of the full-length 
endogenous sequence would also address the potential miRNA instability seen earlier with 
L-mir-363. Precursor miRNA sequences for both xtr-let-7g and xtr-mir-363 were cloned by 
RT-PCR to allow in vitro transcription of pre-miRNA. These transcripts were then labelled 
and used as for RNA sequences above. 
With let-7, previous work has suggested that the binding efficiency for the loop region is 
comparable to the whole RNA, due to the presence of the binding sites within this area 
(Desjardins et al., 2011; Piskounova et al., 2008). However, when using the recombinant 
Xt-lin28a protein against the pre-let-7g, a much increased binding affinity was seen (Figure 
6.17A), with a Kd of 0.014 µM; however a Bmax value of only 0.883 was calculated (Figure 
6.17B), although it was seen with multiple experiments that 100% of RNA was bound at a 
number of alternative concentrations (data not shown). This increase in binding efficiency 
may be partially due to using the human sequence when looking at the interaction with 
the loop, and the X. tropicalis RNA for the precursor, which do differ slightly in sequence 
and involve differences in the sequence over the supposed binding site for the lin28 CSD 
(Figure 6.18). The low apparent Bmax value may result from fitting the one-site binding 
equation over a longer range of protein concentrations, where a multiple-site binding 
equation might be more appropriate. 
Using the in vivo translated protein, pre-let-7 was bound by embryo extract overexpressing 
each of the three lin28 proteins, and not by control extract (Figure 6.19). The supershift 
again produced a reduction in the shifted band relating to the lin28-let-7 interaction, but 
proved difficult to resolve as an extra band, with more radioactivity trapped high up the 
gel than in previous cases. The serum control did not differ to the extract-only, indicating 
that the lin28s were still responsible for the majority shift. There were a larger number of 
alternatively shifted bands with all embryo extracts and this RNA compared to the loop 
alone, which appeared to be lin28-independent. This hints at a possibility of additional 
binding sites in the full precursor that are targeted by other endogenous proteins. 
Pre-mir-363 was, however, bound by Xtr-lin28a with a similar affinity as the L-mir-363. The 
RNA was seen to shift over the same range of protein concentrations as previously (Figure 
6.20A), and a Kd was calculated as 0.46 µM, which compares to the dissociation constant 
of the terminal loop, calculated earlier as 0.448 µM (Figure 6.20B).  
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Pre-mir-363 showed different results with the full-length proteins. The control extract did 
not result in a shift attributable to lin28, but binding was still evident when overexpressing 
both isoforms of lin28a (Figure 6.21A,B), and again a supershift demonstrated the role of 
the lin28 proteins themselves in this interaction. However very little binding was apparent 
with lin28b (Figure 6.21C). In all embryo extract used, binding independent of lin28 was 
seen for this RNA, and appeared to be a more dominant binding partner than the lin28s 
for this sequence. No loss of detection of the unbound RNA was seen with the precursor at 
higher concentrations of embryo extract, as with the loop earlier, indicating that such a 
result earlier would have been an artefact of the shortened sequence and not a precursor 
miRNA stability issue.  




Figure 6.17 Binding of Xenopus lin28a with pre-let-7g  
A) EMSA performed with 
32
P-pre-let-7g and indicated concentrations of Xrt-lin28a. .  Arrows 
indicate labelled RNA (blue) and lin28-RNA complex (red).  B) Band intensities were quantified 
and the proportion bound was calculated. Data were used to plot a binding curve. Bmax = 
0.8331. 
 
Figure 6.18 Alignment of pre-let-7g sequences 
Alignment of X. tropicalis (Xtr) and human (Hsa) pre-let-7g sequences. * denotes conserved 
nucleotide. Red = let-7g miRNA. Yellow = L-let-7g RNA sequence. Green boxes = suggested 
lin28 binding sites.  






























































































































































































































































































































































































































































Figure 6.20 Binding of Xenopus lin28a with pre-mir-363  
A) EMSA performed with 
32
P-pre-mir-363 and indicated concentrations of Xrt-lin28a. Gel 
shown is representative of n=2. Arrows indicate labelled RNA (blue) and lin28-RNA complex 
(red). B) Band intensities were quantified from two independent experiments and the 
proportion bound was calculated. Data were used to plot a binding curve. Bmax = 1.12. 
 
  





























































































































































































































































































































































































































































6.3.1 Xenopus lin28 proteins bind to let-7 
This work has further demonstrated binding between let-7 and lin28 proteins. The Kd for 
this interaction with the terminal loop was determined to be 0.314 µM, and for the full 
length precursor was 13.7 nM. These are both between the published Kd values for this 
interaction, which range from 0.02 nM to 2.1 µM (Desjardins et al., 2011; Heo et al., 2009; 
Lei et al., 2012; Lightfoot et al., 2011; Loughlin et al., 2012; Nam et al., 2011; Newman et 
al., 2008; Piskounova et al., 2011; Piskounova et al., 2008). The use in these experiments, 
however, of a range of protein constructs, RNA sequences and experimental conditions 
may have affected binding affinity. Additionally, the binding coefficients were calculated 
here using a one-site binding equation, as carried out by others including Piskounova et al 
(2008) and Lightfoot and colleagues (2011). However, since the discovery of multiple 
binding sites, applying the Hill equation to determine dissociation constant may be more 
appropriate, such as was performed by Desjardins et al (2011), as this allows for and 
calculates any multiple binding sites. Nevertheless, they also applied the one-site binding 
site equation and found Kd values to be in a similar range. 
Using the in vitro transcribed let-7 precursor, binding efficiency was increased greatly. This 
does differ from previous results, which found similar binding efficiencies between the 
loop and pre-let-7, which allowed the identification of the terminal loop as the lin28 
binding site (Piskounova et al., 2008). However, one explanation for this may be that the 
loop RNA sequence used here was human, and the pre-let-7 and protein were from 
Xenopus. A potentially key difference between the human and Xenopus sequences was 
present within the putative CSD binding site. The binding site published by the Sliz lab as 
'NGNGAYNNN' (Nam et al., 2011) appears, in human let-7g, to be the sequence 
'UAUGAUACC', missing the first 'G' residue, which they stated made the interaction less 
energetically stable. The Xenopus sequence is altered to 'UGUGACACC', featuring a 
different pyrimidine at position 6, and additionally has the first G residue. The increased 
binding to the Xenopus RNA may indicate that this is an improved binding site for the 
lin28. Then again, both of these sequences differ by only one important nucleotide from 
the alternatively proposed 'GUNNUNN' binding site (Mayr et al., 2012), with the human 
pre-let-7g sequence missing the first 'G' and the Xenopus sequence lacking the second 'U' 
residue which, if the more correct sequence, may not explain such different binding 
specificities between the proteins, with each showing a simple sequence mutation. Further 
analyses using truncations and mutations of both the human and Xenopus sequences may 
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help determine which of these binding motifs is more accurate, and whether any 
evolutionary differences exist between the species. 
 There may also have been folding artefacts from the RNA, allowing exposures of different 
residues for binding. The sequence for the loop was suggested to fold into the endogenous 
conformation using mFOLD, and we would expect the same favoured folding from the 
in-vitro synthesised precursor; however, in either case there may have been alternative 
folding structures that altered binding specificity and therefore efficiency. 
Both lin28a and lin28b have been shown to bind and inhibit let-7 processing (Viswanathan 
et al., 2008), and binding was seen here with all of the full-length proteins overexpressed 
in embryo extract. As we cannot quantitate the concentrations of protein in these 
extracts, we cannot conclude whether one protein shows improved binding over the 
others, but can conclude that all show capable interactions. 
At the exposures used, no binding to any RNA sequences was seen by lin28 in the control 
extract, and using longer exposures did not vastly improve this. A failure to detect much 
binding of the RNA from endogenous protein was a little surprising, particularly with the 
mir-363 RNA, following our proposal that lin28 is binding this miRNA during gastrulation, 
from which stage the embryos were collected. The levels of lin28 in extract cannot be 
quantified accurately, and so cannot be determined whether the endogenous 
concentration is similar to the Kd for the interaction; additionally, the use of assay 
conditions may not completely accurately reflect physiological conditions, which could 
affect the ability to observe endogenous interactions without gross overexpression of one 
element.  
6.3.2 Xenopus lin28 proteins bind to pre-mir-363 terminal loop 
Work here has shown that the lin28 proteins are capable of binding to elements within the 
mir-363 terminal loop. This may happen at a lower affinity than the interaction with let-7, 
evidenced by a weaker dissociation constant when using the full-length precursors, but 
nevertheless shows preferential binding compared to alternative RNA such as mir-138. 
Work here has shown that mir-138 is capable of binding to lin28, but does so at a much 
reduced affinity, nevertheless this reduced affinity was effective for the needs here. The 
high levels of protein required may also not reflect levels that are found endogenously, 
and thus may not be a likely interaction in vivo. Likewise, this may also be the case 
regarding the amounts of RNA used at high levels of excess for successful cold 
competition. As the protein concentration was selected to ensure that this was the limiting 
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factor in the interactions, an excess of any RNA would have an advantage, particularly 
when capable of binding to the protein at some level. 
All of the overexpressed full-length lin28a and lin28b proteins were able to effectively bind 
the terminal loop of the mir-363 RNA. The same embryo extract was used to investigate 
this interaction as was used with the let-7, and a slightly increased ability to shift the mir-
363 RNA was seen with the lin28a proteins over the lin28b, perhaps indicating a stronger 
interaction from these proteins. This difference was further seen when using the full 
length precursor and mutant RNA. The lin28a proteins were both able to result in a 
prominent shift of the RNA, whereas overexpression of lin28b did not. It remains unknown 
what may have caused this apparent difference in binding preference. It may be that there 
was less available or overexpressed lin28b protein compared to the lin28as, or it may 
indeed have a lower binding affinity for mir-363. The truncated RNA used to investigate 
binding in the loop was anticipated to fold in the same way as the endogenous loop on the 
precursor, causing exposure of the same residues, but this is possibly not the case. The 
stem of the precursor may be altering binding preference to this RNA, but this is not seen 
in the recombinant lin28a. It is therefore possible that the presence of the N- and C-
termini of the lin28 proteins affects their binding affinity, perhaps in combination with the 
RNA stem. One way to test this would be to use a recombinant truncated lin28b protein, 
and determine if binding to the precursor is affected to the same degree. 
6.3.3 Possible lin28 binding sites in pre-mir-363 
A similar Kd for mir-363 between the terminal loop and full length precursor binding to 
recombinant protein suggests that the binding sites are within this domain. 
The identification of 'GGAG' as a minimum binding site for uridylation activity of lin28 on 
let-7 (Heo et al., 2009) led to the conclusion that it was a minimum binding site for all 
interactions, as mutation of this sequence to 'GUAU' weakened binding, although it did 
not fully inhibit it. This sequence was consistent with the discovery that the 'GG' motif was 
important for binding (Newman et al., 2008), along with other work that demonstrated a 
loss of either of the first 'G' residues reduced binding, but not as greatly as a loss of the 
fourth 'G' or the first two in combination (Mayr et al., 2012). The high conservation of the 
GGAG sequence between species containing pre-mir-363 suggests that it may have some 
biological importance. Indeed, results here have shown that mutating this sequence does 
have a negative effect on the binding between lin28 and the pre-mir-363 terminal loop; 
however it did not abolish all interaction. This also supports the more degenerate 
sequence proposed by Loughlin and colleagues (2012) of 'NGNNG', as the sequence used 
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retained the first 'G' residue. The alteration of 'GGAG' to 'GUAU' does, however, alter the 
expected folding of the RNA. This effect on the structure may have also affected the 
binding of the protein. 
Further strength can be given to an interaction between mir-363 and lin28 with an 
identification of a binding site for the CSD. Interestingly, zebrafish pre-mir-363 contains 
the proposed motif 'NGNGAYNNN' near to the beginning of the terminal loop, but no 
other species contains this in a complete form. A conserved 'GAU' sequence is seen in 13 
other species, including humans although not Xenopus, but this is not preceded by another 
'G' residue and features at the very beginning of the loop, and as such its availability for 
binding to the lin28 protein is unknown. Alternatively, to fit the motif of 'GUNNUNN', 
there are multiple occurrences of 'GU', and 'UNNU' present within the loop region, but 
none of these match the full sequence. Nevertheless, the CSD has been described as 
showing flexibility with a broad spectrum of potential binding sequences and binds to 
pyrimidine-rich single-stranded sequences. With a large number of 'U' residues, the mir-
363 loop could be defined as this, leaving the possibility that a binding site is present 
intact. To identify any specific binding site, further mutations would need to be carried out 
on the RNA sequence to investigate how they affect binding. Determining a crystal 
structure of the RNA bound to lin28 would also identify in the nature of this interaction. 
6.3.4 The same binding interactions result in different regulatory 
mechanisms? 
The current understanding of the effects that binding via the above sites has on the let-7s 
is explained by two main mechanisms: the uridylation of the RNA and the blocking of Dicer 
cleavage. Both of these negatively regulate processing to the mature form, whereas lin28 
may be having opposite effects on the miR-17-92 and miR-106-363 clusters, and thus must 
be functioning in a different manner. 
It was discovered that both lin28a and lin28b bound to a modified form of pre-let-7 in 
cells, which was elongated with a uridylation tail, and unable to be processed by Dicer 
(Heo et al., 2008).  The authors further demonstrated that the uridylation of this RNA was 
dependent upon the binding of both lin28 and TUT4 (Heo et al., 2009). They went on to 
identify multiple miRNAs other than the let-7s that have a GGAG sequence in their 
terminal loop; they found that others, such as mir-107, could be both uridylated and 
bound by lin28, however mir-363 did not show uridylation by lin28, and a binding assay 
was not pursued (Heo et al., 2009). Work has shown here that pre-mir-363 can be bound 
by lin28, and work in Chapter 4 indicated that there is a positive regulation of the miRNA, 
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supporting the lack of uridylation seen previously. It was postulated that as TUT4 also 
contains zinc knuckles, the second G in the 'GGAG' motif may be exposed by lin28 binding 
and provide a binding site for the uridylase (Loughlin et al., 2012). The mir-363, however, 
contains this same sequence, and this does not appear to be the mechanism of action 
here. 
The binding of the RNA by lin28 has been shown to remodel the RNA, which is suggested 
to block the Dicer cleavage site (Nam et al., 2011). The remodelling of the RNA may involve 
a partial melting of the RNA stem over the Dicer cleavage site, which renders it 
unrecognisable to Dicer (Lightfoot et al., 2011), as Dicer cleaves dsRNA (Zhang et al., 2004). 
This is believed to come about following the binding of the zinc fingers to the GGAG motif 
in the let-7 RNAs, which were present four nucleotides from the 3' miRNA (Loughlin et al., 
2012; Nam et al., 2011). Again, the position of the GGAG motif in mir-363 is only three 
nucleotides from the 3' miRNA, which would perhaps be expected to show the same 
melting effect, and thus inhibition of processing, although this is not seen and the opposite 
appears to be possible. Remodelling of the miRNA loop to assist processing has previously 
been seen, with the action of hnRNPA1 on another member of the cluster, miR-18a; 
hnRNPA1 binds the RNA, whilst as pri-miRNA, aiding Drosha processing (Guil and Caceres, 
2007). Mayr and coworkers (Mayr et al., 2012) found that certain proteins with mutations 
within the CSD were unable to remodel the RNA, but were still capable of binding the RNA. 
It may be that with a different CSD binding site to the let-7s, the mir-363 is bound by the 
lin28s but is not remodelled in the same manner. This could allow exposure of different 
areas of the RNA, that may in fact support further processing or cleavage. The nature of 
any endogenous binding of lin28 to mir-363 needs to be determined to understand the 
effect and mechanism of this interaction. 
6.3.5 Putative binding sites within the miR-17-92 and miR-106-363 
clusters 
Numerous putative binding sites for the zinc finger binding domains have been identified 
here within the clusters, and one of these has been followed up here. This was the GGAG 
motif within the terminal loop of pre-mir-363.The GGUG motif within this precursor, and 
both motifs within other precursors, were present within the stem regions. With the 
remodelling of RNA upon lin28 binding (Lightfoot et al., 2011; Mayr et al., 2012), it is 
possible that these would be exposed for further binding. Additionally, the structure is not 
known of the inter-premiRNA sequences to determine whether the putative binding 
sequences here would be accessible by lin28s. The alternative binding sites for the CSD are 
highly dependent on the structure of RNA, as research has suggested that this is the 
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primary binding site, which remodels the RNA and allows the zinc fingers to bind (Mayr et 
al., 2012). Numerous occurrences of the two proposed CSD binding motifs were present 
within the clusters, but the structure of the pri-miRNA is not determined sufficiently to 
implicate them as binding sites, along with the current lack of agreement over a definitive 
CSD binding site. 
Performing binding assays with different lengths and sections of the pri-miRNA would 
enable identification of any further interactions between these clusters and lin28, and may 
help explain why changes in expression are seen in multiple members of the cluster 
following a loss of lin28 proteins. lin28 has also been shown to bind co-transcriptionally to 
let-7 in C. elegans (Van Wynsberghe et al., 2011), and it remains possible that a similar 
mechanism may be in play here, thus affecting all members of the cluster together. lin28 is 
reported to bind to mRNA by a different motif, with a stem structure displaying an adenine 
bulge, flanked by GC pairs, and this attracted alternative co-factors to the interaction on 
miRNA, for a different effect on the RNA (Lei et al., 2012). It is a further possibility that 
lin28 may bind the pri-miRNA in a similar way, and whilst it would not be promoting 
translation, it may recruit further proteins that promote processing.  
6.3.6 Current understanding of the regulation of miR-17-92 clusters  
Current understanding of the regulation of the miR-17-92 cluster is mostly at the 
transcriptional level. The cluster is directly regulated by myc, which may additionally 
regulate the miR-106a-363 cluster, with both c-myc and n-myc increasing miRNA levels 
(O'Donnell et al., 2005; Schulte et al., 2008). The miR-17-92 and miR-106b-25 clusters are 
also regulated by E2F transcription factors (Petrocca et al., 2008b; Sylvestre et al., 2007; 
Woods et al., 2007), which are also negatively regulated targets of members of one of the 
miRNA families, with miR-17, miR-20a and miR-106b proven to interact with the mRNA 
(O'Donnell et al., 2005; Petrocca et al., 2008a; Sylvestre et al., 2007). 
With the level of pri-miRNA not always reflecting the levels of mature miRNA present, and 
with different patterns of expression of the miRNAs within clusters, it would appear that 
the post-transcriptional regulation of the cluster is highly important. Known examples of 
individual processing of the cluster miRNAs include the targeting of miR-18b alone by 
hnRNPA1, which positively regulated expression (Guil and Caceres, 2007), along with 
VEGF, which increased expression of only three members of the cluster: miR-17, miR-20a 
and miR-18a (Suarez et al., 2008).  
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To determine if lin28 is directly interacting with, and regulating, the miRNA clusters, 
immunoprecipitation of the lin28 proteins could be carried out. A subsequent use of 
northern blots or RT-PCR analysis would be able to determine whether RNA from these 
miRNAs is bound in vivo. Due to the ability to resolve the different forms of miRNA on 
northern blots, of mature, precursor and primary miRNA, this technique would be able to 
demonstrate at what level any binding was occurring. This would then provide details to 
the stage in the miRNA biogenesis at which regulation is occurring. 
6.3.7 The co-expression of miR-17-92 clusters with lin28s in 
development 
Work in this chapter has shown that lin28 is capable of binding to miR-363 RNA in vitro, 
but has not demonstrated this in an endogenous setting. Any occurrence of co-expression 
between the RNA and these proteins strengthens the hypothesis that a direct interaction 
takes place, and this may occur both in development and cancer. The co-expression during 
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Chapter 7. Characterisation of miR-cluster expression 
7.1 Introduction 
7.1.1 The miR-17-92 cluster family in development  
Investigations of the expression of miR-17-92 clusters have been carried out both in the 
developing embryo and using in vitro systems of ES cells. Much of the work has focused on 
the miR-17-92 cluster, which through the use of knockout mice was concluded to be the 
most important of the miR-17-92 related clusters for development, with miR-106a-363 
and miR-106b-25 cluster manipulations not resulting in adverse developmental 
phenotypes (Ventura et al., 2008). Members of the miR-106a-363 cluster have generally 
been reported at either low levels of mature expression or have not been found to be 
expressed. On the other hand, there is a high level of conservation between species of the 
miR-106a-363 cluster, an evolutionary retention that may be indicative of an important 
function (Suh et al., 2004; Watanabe et al., 2005). A closer focus on this cluster may 
identify key roles that can be ascribed to its individual members. 
In the analysis in Chapter 4, miR-363 and miR-363* were the miRNAs that showed the 
largest changes upon a loss of lin28 expression and the potential has been demonstrated 
for a physical interaction with pre-mir-363 and the lin28s, as seen in Chapter 6. Thus these 
are the miRNAs that are of most interest at this time for investigation of their expression 
and function.  
Both miRNAs derived from pre-mir-363 are relatively unstudied, as this was the last 
member of the cluster to be identified, along with it being present on the less 
characterised cluster of the three. Much of the work determining expression of the 
clusters during development and in cancer studies was prior to pre-mir-363 being 
identified on the miR-106a-363 cluster. The few studies that have investigated miR-363 
expression as part of the cluster have also found some contrasting results. In T-cell 
leukaemia, when retroviral inserts were present upstream of or within the miR-106a-363 
cluster, research has found miR-363 both absent (Landais et al., 2007), and highly 
upregulated compared to non-cancer cells (Lum et al., 2007). Likewise, expression was not 
detected during murine development, from E. 8.5 to adulthood (Ventura et al., 2008), but 
subsequently has been reported in the chick embryo from E3.5 (Huang et al., 2010). 
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7.1.2 Interest in miR-363 vs miR-363* 
Following the processing of pre-mir-363, the 'major' mature miRNA was classed as miR-
363-3p. However, with no validated functions for miR-363, it is possible that miR-363* is 
also functional. Studies that have shown functionality in both precursor miRNA strands 
found that 'minor' strands that were highly conserved were more likely to be functional 
(Okamura et al., 2008; Yang et al., 2011), and the sequence analysis shown on the 
precursor in section 6.2.1 demonstrated a high level of conservation in both the -3p 
'major' strand, and the alternative -5p arm. In support of pre-mir-363 producing two 
functional miRNAs, expression of both miR-363 and miR-363* have been reported in the 
literature (Huang et al., 2010; Jian et al., 2011), although functions have not been 
attributed to them. 
7.1.3 Aims 
The aims of this chapter are to: 
• Identify timing and patterns of expression of miR-17-92 and miR-106-363 clusters in 
Xenopus development. 
• Characterise the expression of miR-363 and miR-363* in Xenopus development. 
• Investigate the function of miR-363 in Xenopus development. 
• Determine expression of miR-17-92 and miR-106a-363 miRNAs in human cell culture 
systems, and any co-expression with lin28. 
7.2 Results 
7.2.1 Expression of pri-miRNA during Xenopus development 
RT-PCR was carried out to investigate when in development the miR-17-92 and miR-106-
363 clusters were being transcribed. Primers were designed close to the ends of the pri-
miRNA, to ensure that the product amplified would be the full length pri-miRNA, rather 
than detecting a form of processed miRNA such as precursors. Embryos were collected 
from early development, post-fertilisation, to late gastrula stages. It was seen that there 
was no maternal RNA for these clusters. Expression of both pri-miR-17-92 and pri-miR-
106-363 began shortly after MBT, with RNA detected from stage 8 for both pri-miRNAs. 
This expression continued through gastrulation, and was still present at stage 12, the latest 
stage studied here (Figure 7.1).  
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Due to the interest in these miRNAs as potential lin28 targets during gastrulation, and 
detection of expression at this stage by RT-PCR, their expression patterns were 
investigated using whole-mount in situ hybridisation. RNA probes were used for the full 
length of the pri-miR-17-92 and pri-miR-106-363 clusters, covering the same RNA 
sequence as the RT-PCR primers. In early gastrula stage embryos, RNA for the two clusters 
was detected on the dorsal side of the embryo, with some RNA around the developing 
blastopore lip (Figure 7.2). Using this method, only a faint detection of expression was 
seen, however this was reproducible over multiple and non-sibling embryos. Both of the 
clusters showed an overlapping area of expression to one another. 
 
Figure 7.2 Analysis of cluster pri-miRNA expression in gastrula stage embryos 
Gastrula stage embryos showing expression of pri-miR-17-92 and pri-miR-106-363 clusters, by 
whole-mount in situ hybridisation. Representative of 2 separate experiments. 
7.2.2 Timing of miR-363 and miR-363* expression during Xenopus 
development 
Expression of miR-363 and miR-363* were investigated using qRT-PCR. As expression of 
the cluster was found post-MBT, sibling embryos were collected after the onset of zygotic 
transcription for a time course; embryos were sampled through early gastrulation, and 
then once an hour after stage 11.5, prior to the onset of neurulation, until tailbud stages 
were beginning at stage 22. Both mir-363 and miR-363* miRNAs increased in expression at 
gastrulation, around stage 10.5. This was a large increase in miR-363* expression, which 
steadied at the onset of neurulation, before showing a small increase through neurulation 
and peaking in tailbud embryos. In contrast, miR-363 showed a small but sustained 
increase in expression throughout neurulation, also peaking in tailbud embryos at stage 22 
(Figure 7.3). 




Figure 7.3 Analysis of mature miR-363 and miR-363* expression during Xenopus 
development by qRT-PCR 
qRT-PCR was performed on sibling embryos from stage 8 through to stage 22. Expression was 
normalised to housekeeping gene U6 using the 2
-∆∆Ct
 method, and calibrated to the highest 
expression for either gene (both stage 22). Error bars show SE of technical replicates. 
Expression trends are representative of n=2. 
Due to the high degree of primer efficiency, the comparative levels of miRNAs at these 
stages can be deduced, using the ΔCt values. At this point in analysis, data have been 
normalised to U6, the housekeeping gene, and should represent the relative level of RNA 
in the cells. Carrying this analysis further in directly comparing gene samples would allow 
accurate determination of the extent to which expression differs between genes; however, 
to do this the primer efficiencies must be equal. As we cannot guarantee a completely 
equal efficiency between the different miRNA primers, the data from different miRNAs 
should not be directly calibrated to one another. These data can still be used, though, to 
broadly infer which miRNAs are likely to be expressed at a higher abundance. 
In carrying this analysis out for the data on miR-363 and miR-363* expression during 
development, it was seen that at all stages except during gastrulation, miR-363 was 
expressed at higher levels, appearing to be the more dominant miRNA; miR-363* was 
higher at stages 10.5 and 11 only, with both miRNAs expressed at the same levels at stage 
11.5 (Figure 7.4).  




Figure 7.4 Comparative expression of miR-363 to miR-363* during development 
qRT-PCR data was collected from sibling embryos. Comparative expression levels based upon 
ΔCt values after normalisation to U6. Low number of units indicates higher expression. 
Expression trends are representative of n=2. 
 
7.2.3 Localisation of miR-363 expression 
An analysis of the location of miR-363 and miR-363* in development was carried out to 
determine any areas of overlap with the lin28s, and to further identify possible functions 
of the miRNAs. Using whole-mount in situ hybridisation to visualise this, expression was 
investigated at a range of stages over development. 
Embryos at late blastula stage, the stage at which data from Figure 7.1 indicated should be 
the earliest stage of expression, exhibited a presence of miR-363 within the animal 
hemisphere, which was further confirmed by a cross-section of the embryo, where miR-
363 was detected around the blastocoel in cells below the surface layer (Figure 7.5A, A'). 
With the increase in expression, and potential link with lin28 during gastrulation, 
expression was studied through gastrula stages. miR-363 expression was initially found 
dorsal to the blastopore lip, with some retention in the animal hemisphere. As the 
blastopore developed, the domain of miR-363 expression expanded with this, surrounding 
the blastopore lip in stages 10.5 and 11. The cells expressing miR-363 were found in the 
deep sensorial layer below the surface of the embryo, in presumptive mesoderm cells 
(Figure 7.5B-D). 
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The qRT-PCR data also suggested that there was a second major increase in miR-363 
expression late in neurulation. Expression of miR-363 at stage 19 was found to be 
predominantly on the dorsal side of the embryo, in the developing dorsal plate. It was also 
found to the anterior of the embryo, in developing neural tissue (Figure 7.5E, E'). This 
dorsal-neural expression was further seen at stage 21, although a small stripe of ventral 
expression also appeared to be present. Upon taking a cross-section of the embryo, this 
ventral expression can be more clearly seen, along with the dorsal expression which 
appeared to be localised within the notochord and surrounding somites (Figure 7.5F-F''). 
 
Figure 7.5 The expression of miR-363 during embryonic development  
Whole-mount in situ hybridisation showing expression of miR-363 in uninjected embryos 
during development. (') refers to an alternative view of the same stage embryo. blast = 
blastocoels, bl = blastopore lip, np = neural plate, not = notochord, som = somites, s = stage. 
Bottom right refers to view: an = animal, veg = vegetal, dors = dorsal, lat = lateral, A-V = 
animal-vegetal axis section, D-V = dorsal-vegetal axis section. 
7.2.4 Localisation of miR-363* expression 
The expression patterns detected for miR-363* matched those seen for miR-363. miR-
363* was detected in blastula embryos in the animal hemisphere, surrounding the 
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blastocoel and expressed below the surface cells (Figure 7.6A, A'). Expression in gastrula 
embryos began on the dorsal side, with the developing blastopore lip, and extended 
vegetally as the blastopore formed, and again was found in the deeper cells (Figure 7.6B-
D).  
Expression in the late neurula embryos was once more found on the dorsal side of the 
embryo, with some anterior neural patterning; internally, a stripe of ventral expression 
could again be seen, with dorsal expression found in and around the notochord (Figure 
7.6E-F''). 
 
Figure 7.6 The expression of miR-363* during embryonic development  
Whole-mount in situ hybridisation showing expression of miR-363* in wild-type embryos 
during development. (') refers to an alternative view of the same stage embryo. Not = 
notochord, som = somites, s = stage. Bottom right refers to view: an = animal, veg = vegetal, 
dors = dorsal, lat = lateral, A-V = animal-vegetal axis section, D-V = dorsal-vegetal axis section. 
7.2.5 Function of miR-363 
The function of mature miR-363 was investigated by overexpressing the mature miRNA, 
through the use of a synthetic precursor with a mutated miR-363* which allow the RNA to 
be favourably processed and only express miR-363. Injections of synthetic pre-mir-363 
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were carried out at 1 pmol/embryo and 0.5 pmol/embryo concentrations. At 1 pmol, there 
was an increased severity of the phenotype, but survival rates were much lower: a survival 
rate of 52% was obtained with 0.5 pmol injections, whereas only 38% of embryos survived 
to phenotype stage with injections of 1 pmol pre-mir-363. A control miRNA precursor was 
also injected; it was not predicted to target any mRNA but should be processed in the 
same manner as the mir-363 precursor, to account for any cellular processes altered by 
this. The negative control also showed a reduced survival rate, matching that of the 
0.5 pmol-injected embryos at 52%, compared to survival in uninjected controls of 87%. 
However, the negative control precursor showed no abnormal development, and 
displayed a normal phenotype upon development to late tailbud stages (Figure 7.7B). 
Overexpression of miR-363, however, resulted in an abnormal developmental phenotype, 
the severity of which increased with an increased dosage of the RNA (Figure 7.7C-G). The 
axis was commonly truncated, and was also bent in the more severe cases, which can 
indicate problems in development of the somites and notochord. A reduction in head size 
was seen, which can occur following neural defects, with a concurrent reduction in eye 
size, and two embryos subjected to 1 pmol of miRNA precursor developed no eyes. In a 
small number of embryos, cyclopia was observed, with reduced intra-ocular distance seen 
in others. An open blastopore, common following problems during gastrulation, was more 
frequently observed following injection with 1 pmol pre-miR-363, but did not occur in all 
embryos. Pigmentation was also seen to spread abdominally in some of the more affected 
embryos (Figure 7.7F). 
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7.2.6 Comparative levels of miR-17-92 clusters 
The technique exploited in section 7.2.2 to infer comparative levels of miR-363 to miR-
363* can also be used to further exploit the qRT-PCR data generated in section 4.2.6 
looking at the cluster miRNAs in gastrula embryos, and provide comparative levels of the 
different miRNAs studied during gastrulation. miR-19b, which is contained on both the 
miR-17-92 and miR-106-363 clusters, appeared to be the miRNA with the highest 
expression. This was followed by miR-20b then miR-17, which are both members of the 
same family. As seen in Figure 7.4, more miR-363* was detected at this stage than miR-
363, with miR-106 expressed at levels between these two. The least detected miRNA was 
miR-18b (Figure 7.8). All of these appeared to be expressed at higher levels than let-7g, 
which was included for an example of very low-level expression.  
 
Figure 7.8 Comparative expression pattern of miRNAs at gastrulation   
qRT-PCR data was collected from uninjected embryos at stage 10.5. Comparative expression 
levels based upon ΔCt values after normalisation to U6, averaged from 3 biological replicates. 
Low number of units indicates high level of expression. Error bars show SE of biological 
replicates. 
7.2.7 miRNA expression in human cells 
To identify if any human cellular systems are suitable models to look for conservation of 
regulation of miRNAs from the miR-17-92 clusters by lin28, any expression of these miR-
17-92 and miR-106a-363 cluster miRNAs must be determined. 
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Despite their lack of lin28a and lin28b expression, as shown in section 5.2.5, MSCs were 
analysed for expression of the miR-17-92 and miR-106a-363 cluster miRNAs. Additionally, 
ES and EC cells were also examined, due to their pluripotent state and known expression 
of lin28s, and some acknowledged expression of miRNAs from these clusters, including 
miR-106a and miR-17 amongst others (Houbaviy et al., 2003; Suh et al., 2004; Thomson et 
al., 2004). There is a known role of some of these miRNAs in cancer, which also links the 
miRNAs to important expression within undifferentiated cell types. Two ES cell lines, H7 
and H9, were characterised; these are amongst the earliest derived human ES cell lines 
generated by Thomson and colleagues (1998). The samples were a gift from M. Coles 
(University of York). Care was taken with the human ES cells to grow them in feeder-free 
conditions; this was to ensure that no material from MEFs was present due to the high 
conservation of miRNA sequences. It is possible that any miRNA expression in MEFs would 
be accidentally detected if the cells were to contaminate the ES cell sample. The EC cell 
line NTera2.D1 (NT2), a clonal cell line derived from the teratocarcinoma Tera2, was 
chosen over the 2102Ep cells used in 5.2.5, as the NT2 cells have a better differentiation 
potential (Ackerman et al., 1994; Andrews, 1988), and may therefore act as a better model 
for looking at pluripotency and differentiation mechanisms. 
Expression of the mature miRNAs from the miR-17-92 and miR-106a-363 clusters varied 
greatly between the cells studied, with ES cells showing high expression of all miRNAs, 
which were at very low levels in MSCs. To display this appropriately, data were compared 
to expression in NT2 cells in two separate figures for the different cell types (Figure 7.9, 
Figure 7.10). The data from ES and EC cells was collected from cells at different passage 
numbers on separate occasions, to ensure they were appropriate as biological replicates, 
with replicates in MSCs from three separate donors. Levels of the miRNAs within the H9 
samples were comparable, with the third replicate consistently showing slightly reduced 
expression compared to the other two samples of this ES cell line. There was a large 
degree of variability, however, in the H7 cells; one sample showed greatly increased 
expression of miR-18b, miR-20b and miR-363 over the other cell types, and expression was 
consistently higher for all other miRNAs too. In comparison to the EC cells, expression of 
all miRNAs except for miR-363* was generally increased in the ES cell lines (Figure 7.9). In 
the MSCs, expression of miR-363 was not detected, and miR-20b was expressed at greatly 
reduced levels compared to EC cells, with modest reductions in the expression of all other 
cluster miRNAs (Figure 7.10). When comparing the ES cells to MSCs, the levels of all 
miRNAs are hugely reduced in MSCs. In spite of differences in the level of expression, the 
same pattern of expression was seen within the miRNAs between ES and EC cells, with 
miR-19b expressed at the highest levels, and miR-363* at the lowest. miR-17 and miR-20b, 
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from the same miRNA family, were also relatively abundant miRNAs, commonly followed 
in expression levels by another member of the family, miR-106a. miR-363 was only the 
fifth most abundant miRNA, and only miR-363* was expressed lower than miR-18b (Figure 
7.11). A similar expression pattern was also seen in the MSCs, with miR-19b the most 
dominant miRNA, followed by miR-17. Major differences, however, were seen in the 
expression of miR-20b, which was found in these cells to be a weakly expressed miRNA 
from the cluster, along with the lack of any detectable miR-363 (Figure 7.11). 
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7.2.8 Expression of lin28 in pluripotent cells 
To determine whether there were similar trends in miRNA and lin28 expression, qRT-PCR 
was carried out to determine lin28 levels in the ES and EC cell lines. Interestingly, the levels 
of lin28a were more similar between ES and EC cell lines than the miRNA expression, with 
NT2 cells showing higher levels of lin28a compared to some samples of ES cells (Figure 
7.12). The levels of lin28b were also consistently higher in NT2 cells compared to the ES 
cells. The same trend in expression was seen across the cell samples, where those with low 
lin28a expression also showed low levels of lin28b RNA. Interestingly, H7 1, the sample 
which had shown greatly elevated levels of miRNA, did not display higher levels of the 
lin28 genes compared to other samples (Figure 7.12). 
 
Figure 7.12 Analysis of lin28a and lin28b expression in pluripotent cells 
qRT-PCR was performed on RNA from ES cell lines H9 (3 biological replicates) and H7 (2 
biological replicates), and the EC cell line NT2 (3 biological replicates). Expression was 
normalised to housekeeping gene ODC using the 2
-∆∆Ct
 method, and calibrated to one sample 
of EC cells (NT2 1). Error bars show SE of technical replicates. 
 
A summary of the data from figures 7.9 – 7.12 is included in Table 7.1, indicating which 
cells had the highest levels of expression of both the miRNAs and lin28 genes, 








Cell type Level of miR-17-92 clusters 
miRNAs 
Level of lin28s 
ES cells (H7 and H9 lines) +++ ++ 
EC cells (NTera2 line) ++ ++ 
MSCs + - 
Table 7.1 Summary of miRNA and lin28 expression in different human cell types 
Summary of expression based upon qRT-PCR data. - = no/very low expression, +-+++ = 
increasing level of expression. 
7.3 Discussion 
7.3.1 The co-expression of miR-17-92 clusters with lin28s in 
development 
The data shown here from X. tropicalis suggests that there is endogenous in vivo co-
expression of the lin28s with miR-17-92 and miR-106-363 cluster miRNAs. The switching 
on of pri-miR-17-92 and pri-miR-106-363 with MBT suggests they are early transcriptional 
targets, similarly to lin28a as was seen in section 3.2.3. All members of the clusters studied 
were shown to be expressed at varying levels in gastrula embryos, a stage at which work in 
this thesis has shown there is an important role for the lin28 proteins, with demonstrable 
increases in miR-363 and miR-363* at the onset of gastrulation. To strengthen further this 
notion of co-expression, in situ hybridisation data have shown a clear overlap in expression 
in both miR-363 and miR-363* with both lin28a and lin28b, expression of which was 
previously shown in sections 3.2.4 and 3.2.5, a key area of overlap is in the embryos 
undergoing gastrulation, with expression of the lin28s and miRNAs both found 
surrounding the blastopore, in the deep sensorial layer of cells. There are further 
similarities in the later stages studied, with overlapping dorsal and anterior expression, 
although miR-363 and miR-363* both showed additional expression in ventral areas, that 
were not found to express lin28a or lin28b. 
In determining in vivo expression during mouse development, analyses of the miR-17 
family (miR-17, miR-20a, miR-93 and miR-106a) found that expression in blastocysts varied 
for the miRNA: miR-17 and miR-20 were expressed throughout the embryo, with 
enrichment in the trophoectoderm, while miR-106a was elevated in the ICM and miR-92 in 
the primitive endoderm (Foshay and Gallicano, 2009). By E5.5, the miRNA were restricted 
to the differentiating extraembryonic cells, as opposed to the proliferative epiblast (Foshay 
and Gallicano, 2009). lin28a is also expressed in the blastocyst (Kumar et al., 2012; Xu et 
al., 2011), and although a characterisation of where lin28a is localised has not been carried 
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out in these mammalian embryos, expression can be assumed to be present in the ICM, 
due to expression in ES cells collected from this area. Work in later mouse embryos 
suggested that the miR-17-92 cluster miRNAs were at a low level of expression until E8.5, 
from when levels increased until E11.5, then steadily decreased through to the postnatal 
stages (Jevnaker et al., 2011); changes in lin28 levels have also been seen during early 
differentiation events in the embryo, with an increase in expression during the first 
differentiation events, before a steady decline in RNA levels from around E9 (Kawahara et 
al., 2011; Wang et al., 2012). This precedes the miRNA expression, but it is likely that there 
is some persistence of the protein. There is a trend of lower levels of miR-106a-363 
expression compared to the other two clusters in more adult mouse tissues (Ventura et 
al., 2008), and this was reflected by these authors' work using knockout mice: Ventura and 
colleagues were able to target deletions of the miR-17-92, miR-106-363 and miR-106b-25 
clusters and observe how this affected development. They found that deletions of either 
the miR-106a-363 or miR-106b-25 clusters alone resulted in no apparent defects, with 
normal viable mice. In contrast to this, mice lacking the miR-17-92 cluster died in the 
minutes following birth, exhibiting problems including underdeveloped lungs and ventral 
septal defects, along with decreased numbers of B-cells, and these abnormalities were 
further compounded by the additional knockout of only the miR-106b-25 cluster (Ventura 
et al., 2008). Expression of both the miR-17-92 and miR-106b-25 clusters has also been 
found in the developing cerebellum, suggesting a neural role (Uziel et al., 2009). Studies 
into the chicken embryo found multiple members of these miRNA clusters were expressed 
at high levels generally throughout embryos at multiple stages from day 5, with reduced 
levels in a few tissues, and with high levels of dorsal neural expression; these members 
included miR-17, miR-106, miR-20b, miR-18a, miR-19a, miR-92 and miR-363 (Darnell et al., 
2006), highlighting the likely importance of many of these miRNAs in development. 
The expression of lin28a in ES cells, used for modelling pluripotency, has been well 
documented (Darr and Benvenisty, 2009; Moss and Tang, 2003; Richards et al., 2004), and 
has been replicated here in two ES cell lines. Despite varying reports on the different 
miRNAs, numerous members of the mir-17-92 clusters have been identified as expressed 
in ES cells, using both cloning and sequencing, and qRT-PCR. miRNAs with detected 
expression in both murine and human ES cells include miR-106a, miR-18, miR-19b, miR-20, 
miR-92, miR-93, miR-17 and miR-106b (Foshay and Gallicano, 2009; Houbaviy et al., 2003; 
Suh et al., 2004; Tang et al., 2006; Thomson et al., 2004; Ventura et al., 2008). Differences 
in techniques may be responsible for differences in observations; for example, miR-20a 
was found to be expressed at high levels, over miRNAs such as miR-106a and miR-92, in 
work by Foshay and Gallicano (2009) who used qRT-PCR, but was not detected by other 
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investigators using sequencing analysis, although miR-106a expression was seen (Houbaviy 
et al., 2003). There have not yet been reports of miR-363 expression in ES cells, but the 
discovery of this miRNA as a member of the cluster occurred subsequent to much of this 
previous work being carried out and it is possible any expression may merely have been 
missed; results here have shown that all miRNAs studied were expressed in ES cells and 
where miR-18 has been detected previously, this was found here to be less abundant than 
miR-363. Analysis of the EC cell line NT2 also demonstrated co-expression of lin28a, lin28b 
and the miRNAs under investigation. However, there did not appear to be a correlation 
between levels of lin28 genes and expression of mature miRNAs. 
On the other hand, a correlation of omission was observed in MSCs. A low level of 
expression of miR-17-92 and miR-106a-363 miRNAs was detected in MSCs, with no 
measurable miR-363 found in the cells. We were also unable to detect expression of lin28a 
and lin28b in these cells in section 5.2.5, and this data may support the hypothesis that 
lin28 assists the expression or processing of at least pre-mir-363. 
Previous literature has concluded that the miR-17-92 cluster is the most vital in early 
development. It was supposed that due to the high similarity between the miR-17-92 and 
the miR-106a-363 clusters, potentially resulting in the same function of the miRNAs, the 
miR-106a-363 cluster is expressed at low levels so as to not interfere with the regulation 
and function of the miR-17-92 cluster (Ventura et al., 2008). On the other hand, the miR-
106a-363 cluster remains highly evolutionarily conserved, and this maintenance in the 
genome often suggests some crucial role, which perhaps has not yet been identified. Work 
here has taken a step closer to showing there is a role undertaken by this cluster in 
development. 
7.3.2 miR-363 vs miR-363* expression 
The expression of miR-363 and miR-363* during development shows they are transcribed 
in their cluster as part of an early transcription event in the developing embryo. 
The increased levels of miR-363 compared to miR-363* support the previous classification 
of miR-363-3p as the 'major' miRNA. The sequence alignment shown in section 6.2.1 
illustrates a slightly higher level of conservation in this miRNA, which was previously 
believed to indicate the dominant miRNA, although conservation in both strands 
correlates with both arms having biological functions (Okamura et al., 2008). The change in 
dominant miRNA form at gastrula stages may suggest that if miR-363* is functional, it may 
be more important during this time than the alternative form, although the increased 
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expression in later stages, despite being at levels below miR-363-3p expression, may also 
be indicative of a functional role later on. In the human cells, miR-363 was found in ES and 
EC cells to be expressed at levels greater than miR-363*, again highlighting its role as the 
major miRNA, however it was absent in MSCs. miR-363* levels did not change greatly 
between the different stem cells, but this was at much lower levels of abundance than the 
other miRNAs present in all cases. The overlapping locations of miR-363 and miR-363* 
when compared to each other is unsurprising, as both are processed from the same pre-
miRNA, although it is common that only one mature miRNA is expressed from a precursor.  
7.3.3 Possible roles of miR-363 and miR-363* 
Work here has shown that miR-363 and miR-363* are not the most highly expressed 
miRNAs from the cluster at gastrulation stage, but nevertheless may be playing a vital role. 
The detection of their changing expression in development is indicative of a function of 
these miRNAs. Expression of both miRNAs increases at gastrulation, a stage of 
development where important inductive signals are taking place, with lots of new gene 
transcription, and miRNAs such as miR-363 and miR-363* may be required to regulate 
protein expression at this time.The increase, particularly in miR-363, during neurulation 
correlates with the areas of expression being throughout the developing neural system in 
the embryo, and developmental problems in the embryo following miR-363, such as a 
shortened axis. Expression of miR-363 was found to be located in the cartilaginous 
notochord (Darnell et al., 2006), which may also affect axis development, and in anterior 
neural structures that could have caused the small head and eyes phenotype. Expression 
has also been seen in the chick embryo of miR-363 in the developing brain (Darnell et al., 
2006; Huang et al., 2010). These results are indicative of a potential role of miR-363, and 
perhaps also miR-363*, in neural development. However, the targets through which they 
may be acting have not been identified. 
Possible roles for miR-363 that have previously been published involve the specification of 
the gonads, and the developing limb bud. Huang et al (2010) found expression of both 
miR-363 and miR-363* in chicken gonads, which showed different expression dependent 
upon the sex of the chicken, and postulated a potential role in their specification. 
Interestingly, expression of lin28a was found in developing PGCs (West et al., 2009), which 
precede the development of the gonads. Expression of miR-363 has also been shown at 
the developing limb buds (Darnell et al., 2006; Huang et al., 2010), with targets having 
been confirmed as Hand2 and Tbx3, RNA coding for transcription factors that are critical 
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for limb development (Zhang et al., 2011). lin28a has also found in the developing limb 
bud (Yokoyama et al., 2008). 
7.3.4 Determining the function of miR-363 
The resultant phenotype from overexpression of miR-363 suggests that this miRNA is able 
to target mRNA during development. However, care must be taken when investigating the 
function of a miRNA by overexpression. It has been proposed that a fine balance exists in 
the cell between RISC and miRNA levels, and overexpression of a miRNA may outcompete 
other miRNAs that would normally be effective at that time. This could result in an 
alteration of cellular processes as a function of the de-repression of mRNA targets from an 
alternative miRNA, rather than further repression of the intended miRNA targets 
(Olejniczak et al., 2010). As such, alternative methods must also be carried out to 
determine proper function. 
Target identification is key to understanding function. Available software can also be used 
to provide a list of putative mRNA targets for miRNA; however, outputs from multiple 
sources should be combined to provide as accurate a candidate gene list as possible, 
because many programs use different algorithms to identify targets, taking into account 
seed sequences and conservation, locations of binding sites and structural accessibility. 
For example, TargetScan (Lewis et al., 2005) results in 893 candidate targets for miR-363. 
miRanda (John et al., 2004) reports 6,386 possible targets, and DIANA-microT (Maragkakis 
et al., 2009) suggests only 381 genes. Cross-referencing these for common suggestions 
provides a stronger list of candidates, which must then be validated experimentally to 
confirm this function. 
These alternatives could include a knockdown of the miRNA activity. This can be carried 
out using anti-sense morpholinos or commercially available anti-miRs, designed to block 
miRNA activity. A lack of miRNA activity would relieve the repression on mRNA targets, 
with any alteration of developmental phenotype then resulting as an effect of this de-
repression. Analysis of the expression of putative targets at the protein level, and less 
reliably at the mRNA level, following a knockdown of miR-363 or blockade of the miRNA 
binding site would be able to confirm genes as miRNA targets; those genes with known 
functions would then provide insight to the function of miR-363. Additionally, if any genes 
regulated by miR-363 or miR-363* were also regulated by the lin28s with expression 
investigated following lin28 knockdown, this would strengthen the possibility of miRNA 
regulation by the lin28s. 
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Data here have identified human ES and EC cells as possible systems for further analysis of 
the interactions and functions between lin28 and miRNAs, with these cell types expressing 
both the lin28 genes and miRNAs from the miR-17-92 clusters. Future work would involve 
a knockdown of the lin28 proteins, and analysis of any effect on expression of the miRNAs. 
These systems could also be used to analyse miR-363 function and gene targets; luciferase 
assays are a successful way of confirming binding sites for miRNA, and can be easily used 
in cell culture systems. Constructs can be engineered that have the 3' UTR containing 
possible binding sites, and output luciferase activity can then be measured and compared 
to alternative UTRs, or mutated sequences. The miRNA themselves can also be targeted as 




Chapter 8. General discussion 
8.1 lin28 is important in patterning the vertebrate embryo 
FGF signalling is one of the inductive pathways that is highly involved with early germ layer 
specification in the vertebrate embryo. A number of targets of this pathway that mediate 
these effects have been identified, but the knowledge of what roles these targets all play is 
currently insufficient to provide the full picture. Work in Chapter 3 has shown both lin28a 
and lin28b to be genes that are positively regulated by FGF signalling, supporting the 
earlier finding for lin28a by Branney et al (2009). The identification of this regulatory 
pathway has significant potential; this could allow the expansion of both the 
understanding of the function of lin28 proteins, by providing new pathways known to be 
downstream of FGF for investigation of any involvement of these proteins, and also the 
function of FGF signalling, with the opportunity to study how manipulating this can affect 
the currently known roles of lin28s. 
This regulatory pathway is supported by co-expression of FGF-ligands and active FGF 
signalling with lin28a and lin28b in the developing embryo, seen by comparing previous 
work documenting FGF expression (Lea et al., 2009) with lin28 expression as seen in 
sections 3.2.4 and 3.2.5. 
8.1.1 Function of lin28 in promoting differentiation 
This thesis has identified a requirement for the lin28 proteins during development for 
correct germ layer patterning, indicating a wider role for these proteins than simply the 
promotion of self-renewal and pluripotency, particularly in the specification of mesoderm 
and neuroectoderm (Figure 8.1). This widening of the roles for lin28 is supported by 
previous work, which found that suppression of lin28a in mouse ES cells reduced 
subsequent mesoderm development, with effects on markers such as brachyury and 
Mesp1, which were also reduced in Xenopus, along with reductions in adipogenesis (Faas 
et al., 2012; Wang et al., 2012),  although the mouse study also found the effect extended 
to endoderm development (Wang et al., 2012). Broader support is provided by 
observations that lin28a levels increase in developing embryoid bodies, and that lin28a 
and lin28b have roles in promoting development of skeletal muscle tissue, neurogenesis 
and lymphopoiesis (Balzer et al., 2010; Polesskaya et al., 2007; Wang et al., 2012; Yuan et 





Alternatively, lin28 may not actively promote specific lineages, but merely act as a 
competence factor for inductive FGF signalling. This appears to be the case in the Xenopus 
embryo, where the induction of mesoderm in animal cap experiments following treatment 
of inductive signals, FGF and Activin, is inhibited following knockdown of lin28 proteins 
(Faas et al., 2012). The way in which lin28 expression primes these cells for response to 
signalling factors is unconfirmed, although it was seen that there was a reduced induction 
of pERK. 
lin28 was first identified as a heterochronic gene, and it was thought that it simply acted to 
promote the timing of developmental stages (Moss et al., 1997), but recent work has 
suggested that lin28 acts as in two stages in C. elegans, controlling the timing of 
progression between multiple larval stages, and that it first functions by targeting mRNA, 
and then later through the repression of let-7 (Vadla et al., 2012). Some heterochronic 
effects were also seen in the Xenopus embryo, with a loss of the lin28s resulting in altered 
gene expression at gastrulation; earlier peaks in expression was seen in nodal-related 5, 6 
and 1, along with FGF-4 and FGF-8 (Faas et al., 2012). It is possible that the heterochronic 
effects of lin28 may explain some conflicting results discussed earlier, such as the striking 
differences seen by Wong et al. (2012) and Wang et al. (2012). When looking at marker 
expression, Wang and colleagues presented work from a longer and later sample of days, 
showing more accurately changes in expression over time (Wang et al., 2012). 
Experimental differences, such as the length of time for which cells were cultured 
following miR-125 manipulation before differentiation was induced would alter the levels 
of lin28 present during early specification events, which could result in varied outcomes 
due to the important role lin28 plays in controlling developmental timing. 
8.1.2 Potential implication for FGF culture of stem cells 
The confirmation of lin28a and lin28b as FGF targets could be an important discovery in 
aiding the ongoing understanding of human stem cell culture requirements. If this 
regulatory pathway can be clarified as being conserved in this human system, it may 
identify a mechanism by which FGF-2 supplementation aids the maintenance of ES cell 
pluripotency and self-renewal (Figure 8.1). As supplementing media with FGF-2 is the 
major difference in the culturing of mouse and human ES cells (Xu et al., 2005; Ying et al., 
2003), a target could be provided in lin28 to examine for any differences in expression 
between these species, to help identify the differences in nature of these cells. Greater 
knowledge of the pathways required for stem cell culture will assist our ability to do so, 





              
Figure 8.1 Putative pathway for functions of FGF regulation of lin28s 
The regulation of lin28 expression by FGF may control its downstream effects, involving 
embryonic patterning, particularly of mesoderm and neuroectoderm, and its role in ES cells in 
maintaining self-renewal and pluripotency. 
8.2 A novel set of miRNA targets for lin28 
This work has highlighted that multiple members of the miR-17-92 and miR-106-363 
clusters require lin28 expression for their correct endogenous mature expression. This is 
supported by the co-expression of lin28a and lin28b with pri-miR-17-92 and pri-miR-106-
363 in both timing and location during gastrulation, and also the spatial co-expression 
specifically with miR-363 and miR-363* during development.  
Although there is no strong evidence currently, it is possible that this is conserved in 
humans, with support from a correlation of expression in humans; work in Chapters 5 and 
7 has shown there is a presence of both elements of this putative regulatory pathway, the 
lin28s and the miRNAs, in pluripotent ES and EC cells, and both are notably absent or 
reduced in the multipotent MSCs. 
8.2.1 A positive miRNA regulatory mechanism of lin28? 
The big question that has not been able to be answered here is how the lin28 proteins are 
exerting these effects on the levels of mature miR-17-92 and miR-106-363 cluster miRNAs. 
A loss of lin28 protein caused a loss of mature miRNA expression, and there are multiple 




Work in Chapter 6 has shown that direct binding can occur between the lin28 proteins and 
pre-mir-363 from the clusters, indicating it is a distinct possibility that this requirement of 
lin28 expression for normal levels of the cluster miRNAs is a result of a direct interaction, 
either at the pri-miRNA or pre-miRNA stage. The prior knowledge of binding sites on let-7 
RNA was applied to these RNA, and at least one conserved binding site, 'GGAG', was 
shown in Chapter 6 to be important for the interaction of the lin28 proteins with pre-mir-
363. The proposed mechanism for let-7 regulation following binding to this particular site 
includes a melting of the dsRNA and blockage of Dicer cleavage site (Lightfoot et al., 2011; 
Mayr et al., 2012), which would not be presumed to promote any processing of the 
miRNA. Nevertheless, if regulation was occurring at the pri-miRNA level, this effect on the 
Dicer cleavage would be of little consequence. Further to this, the GGAG sequence was 
deemed sufficient for lin28 to drive uridylation of let-7, however mir-363 was found not to 
be uridylated (Heo et al., 2009), and thus another mechanism must be in force following 
binding to this site. Another possibility is that the binding of lin28 to the miRNA promotes 
stability of the miRNA until Drosha/Dicer processing, protecting it from targeting for 
degradation and maintaining levels of the RNA for processing to the mature form. Work 
has shown that, similarly to mRNA, miRNA levels can be regulated by decay, with different 
stabilities being demonstrated that can be regulated by external factors (Bail et al., 2010). 
A weaker affinity was seen for lin28a for binding of pre-mir-363 compared to let-7; if the 
interaction was to provide stability for the miRNA, this would perhaps need to be an 
interaction that could be overcome by the RNAse proteins, and thus may be of a weaker 
affinity than an interaction designed to block processing and prevent the binding of 
alternative proteins.  
A key technique to understand the timing of regulation is northern blotting, as this allows 
monitoring of the levels of all forms of the miRNA, from pri-miRNA to mature, and shifts in 
relative abundances of the different forms can be detected. This was used in early papers 
to identify let-7 as a target of lin28 (Newman et al., 2008; Viswanathan et al., 2008). 
Processing assays are also an important next step in order to understand if and how lin28 
is assisting biogenesis. In vitro assays can be performed with pri-miRNA, which can be 
transcribed and labelled in vitro, to monitor processing by Dicer and Drosha, and whether 
this is aided by lin28 incubation (Mayr et al., 2012; Viswanathan et al., 2008). The use of 
embryo extract, as used in EMSAs, can provide a more in vivo environment which may 
contain other factors that affect this miRNA biogenesis. 
Positive regulation has been documented for cluster member miR-18a by interaction with 
hnRNP A1, a nuclear protein involved in mRNA metabolism and cytoplasmic shuttling. 




pri- or pre-miRNA level, and affected processing of pri-miRNA (Guil and Caceres, 2007). 
Interestingly, their work found that no other members of the cluster were affected by 
hnRNP A1, and this interaction was dependent upon both the sequence of miR-18a and 
the positioning between miR-17 and miR-19a. Two binding sites were identified for hnRNP 
A1 within pre-mir-18: within the terminal loop and at the bottom of the stem; the binding 
to the stem melted the base pairing in this region, producing a bulge-like structure, which 
was preferentially processed by Drosha (Michlewski et al., 2008). hnRNP A1 protein has a 
further role in miRNA regulation, as it inhibits processing of let-7a, similarly to the lin28s 
(Michlewski and Caceres, 2010). This makes it possible that both lin28 and hnRNP A1 
target overlapping miRNAs, both positively and negatively. A further case of positive 
miRNA regulation is exhibited by KH-type splicing regulatory protein (KSRP). KSRP targets 
let-7a, binding to the terminal loop (Michlewski and Caceres, 2010; Trabucchi et al., 2009). 
A knockdown of KSRP also reduced mature levels of miR-20 and miR-106a, but no physical 
interaction has been demonstrated (Trabucchi et al., 2009). The exact mechanism is 
currently unknown, but KSRP was seen to associate in complexes with Drosha and Dicer, 
and be exported from the nucleus with pre-miRNA (Trabucchi et al., 2009).  
It remains a possibility that there are further indirect effects of lin28 in regulating these 
miRNAs. The interaction between mir-363 and the lin28 proteins has not yet, however, 
been proven in vivo, so it could also be possible that this regulation is indirect. This loss of 
mature expression was not seen to be a global effect on all miRNAs following lin28 
knockdown and was specific to members of the clusters, so it is unlikely that the loss of 
lin28s is affecting a fundamental part of the miRNA biogenesis pathway. However, in 
altering levels of multiple members present on different clusters, it is a possibility that the 
effect is occurring at the transcriptional level; lin28 is capable of binding miRNA co-
transcriptionally (Van Wynsberghe et al., 2011), but this could also perhaps be due to 
another target of lin28. The use of qRT-PCR and northern blots to investigate levels of the 
different forms of miRNA are therefore of great importance to developing a fuller 
understanding of the nature of this interaction. 
8.2.2 Roles of lin28 regulation of miR-17-92 clusters in development 
In order to understand the significance of the proteins regulating these miRNAs, the wider 
functions and operations of both the miRNAs and the lin28s still need to be understood. 
Any early roles of the miRNAs from the miR-17-92 cluster families are largely unknown, 
with the only major investigation into this having been carried out by the Jacks group using 




embryogenesis, as loss of the other clusters resulted in normal development (Ventura et 
al., 2008); this work identified B-cell development as a process that required normal miR-
17-92 expression, and lin28b has been shown to be involved in foetal lymphopoiesis, 
although it predominantly affected T-cells (Wang et al., 2012). It is possible that these 
miRNAs are further targets in mediating the effects of lin28 in early development, with 
other activities known to occur through direct mRNA interaction and let-7 repression 
(Figure 8.2). 
The major target of lin28 proteins from these clusters as shown here are products of pre-
mir-363, miR-363 and miR-363*. Relatively little is known about the function of these 
miRNAs, being the last to be discovered from the clusters and thus the least studied. The 
timing and location of expression could be indicative of a neural development role for miR-
363, although this needs further identification of targets to be conclusive in this area. With 
lin28a having been previously linked with neurogenesis, with no primary target identified 
to mediate such effects (Balzer et al., 2010), these miRNAs may be candidates for this. 
Identification of targets of these miRNAs, in addition to those already discovered, would 
help further the understanding of their role in development. Using a bioinformatics 
approach to suggest targets was discussed in section 7.3.4, and must be backed up with 
experimental validation. An expansion of this work would be to carry out specific 
knockdowns of the miRNAs, both individually and in full clusters, to identify redundancies 
and specific roles, with the use of anti-miRs or morpholinos in embryos. Expression of 
putative targets, with binding sites within their 3' UTR, could be assayed at the protein 
level following knockdown, and direct interactions tested through manipulations of the 
UTR; These experiments can include luciferase assays, where the 3' UTR may be compared 
to a mutated version, with the reporter only activated when a mutation prevents miRNA 
repression of the gene (Lytle et al., 2007; Tokumaru et al., 2008). 
8.2.3 Possible roles for both lin28 and the miR-17-92 clusters in cancer  
Both lin28 proteins and miRNAs from the miR-17-92 clusters have been implicated in the 
development of cancer in a range of tissues. Similarly to the results in development, 
cancer studies have so far attributed more importance as oncogenes to the miR-17-92 
miRNAs than the other clusters, classing it as 'oncomiR-1' (He et al., 2005). The miR-17-92 
cluster was first discovered to be overexpressed in B-cell lymphoma, and co-operated with 
myc to produce highly malignant tumours (He et al., 2005; Ota et al., 2004). This finding is 
consistent with a role of this cluster in the development of B-cells, with impaired numbers 




2008). Much of the effect of this cluster in B-cell lymphomas has been attributed to miR-
19a and miR-19b activity, by preventing apoptosis and promoting transformation (Mu et 
al., 2009; Olive et al., 2009). Further investigation into the origins of T-cell leukaemia has 
mapped integration points for retroviruses. These have identified both the miR-17-92 and 
miR-106-363 clusters as common areas for integrations, resulting in increased pri-miRNA 
levels (Landais et al., 2007; Lum et al., 2007; Wang et al., 2006).  
There are numerous other types of cancer which have also reported increased expression 
of miRNAs from these clusters, and it is the case that the miRNAs believed to be 
responsible for the oncogenic effects of cluster overexpression differs between cancers. 
There have also been different findings reported for the same cancer types for some 
miRNAs; for instance, one study found that over 70% of T-cell tumours with an insertion at 
the miR-106a-363 cluster had an overexpression of both miR-106a and miR-363 (Lum et 
al., 2007), whereas another detected increased levels of miR-106a, but no miR-363 
expression (Landais et al., 2007). A summary of cancers reported to overexpress both the 
whole pri-miRNA for clusters and individual miRNAs is shown in Table 8.1. 
The importance of the clusters in pluripotency or differentiation specification is perhaps 
reflected in their implication in the development of multiple blastomas. The miR-17-92 
and miR-106b-25 clusters were found to promote development of retinoblastomas 
(Conkrite et al., 2011), and the miR-17-92 cluster has been linked with medulloblastomas; 
the overexpression of the cluster in granule neural progenitors was sufficient to promote 
tumour formation (Uziel et al., 2009), indicating, as with the retinoblastomas, that a 
regulated level of miRNA expression is required for normal development. Members of the 
clusters are again increased in neuroblastoma and correlated with a poor prognosis in 
patients (Mestdagh et al., 2010; Schulte et al., 2008); the expression of miR-17-92 cluster 
miRNAs increased proliferation and tumourigenicity, with a knockdown abolishing 










Table 8.1 Overexpression of miRNAs in cancers 
miRNA Cancer 
 miR-17-92 cluster B-cell lymphoma, T-cell leukaemia, retinoblastoma, 
medulloblastoma, neuroblastoma 
miR-106a-363 cluster T-cell leukaemia, T-lymphoma 
miR-106b-25 Retinoblastoma 
miR-17 Pancreas, colon, prostate, breast, lung, neuroblastoma  
miR-19 B-cell lymphoma, T-cell leukaemia 
miR-106a, miR-20 Colon, pancreas, prostate, lung, T-cell leukaemia 
miR-92 Pancreas, prostate, stomach, T-cell leukaemia 
Table listing cancers which feature currently identified overexpression of miRNAs. Data was 
collated from multiple studies (Anzick et al., 1997; Bautista et al., 1998; Conkrite et al., 2011; 
Fontana et al., 2008; He et al., 2009; Landais et al., 2007; Lum et al., 2007; Mestdagh et al., 
2010; Mu et al., 2009; Olive et al., 2009; Ota et al., 2004; Schulte et al., 2008; Uziel et al., 2009; 
Volinia et al., 2006; Wang et al., 2006). 
A number of putative targets that mediate these oncogenic effects have been suggested. 
PTEN is a tumour suppressor that is involved in cell cycle regulation and inhibits the 
PI3K/Akt pathway; miR-19 was found to repress PTEN protein, and a gain of PTEN 
increased cell apoptosis (Mu et al., 2009; Olive et al., 2009). Bim is a member of the BCL-2 
protein family, and is a pro-apoptotic regulator that works at the mitochondrial 
membrane; targeting of Bim translation by multiple members of the miR-17-92 clusters 
has been demonstrated, including miR-19, the miR-17 family, and miR-92 and miR-25 from 
the miR-363 family (Fontana et al., 2008; Petrocca et al., 2008a; Petrocca et al., 2008b; 
Ventura et al., 2008). Members of the miR-17 family have been shown to further regulate 
p21 and retinoblastoma (RB1) protein (Conkrite et al., 2011; Fontana et al., 2008; Petrocca 
et al., 2008a; Petrocca et al., 2008b; Volinia et al., 2006); p21 is a cyclin-dependent kinase 
inhibitor which prevents cell cycle progression and is a target of the tumour suppressor 
p53, and RB1 is another well known tumour suppressor that also inhibits cell cycle 
progression, and the function of this protein is commonly lost in cancer, showing in some 
cases heterogeneous protein expression despite ubiquitous RNA expression, indicative of 
post-transcriptional regulation (Ali et al., 1993; Murphree and Benedict, 1984). Further 
potential targets of the miRNAs, which are implicit in cancer development, were identified 
in the work by Volinia and colleagues (2006), although few of these have yet been 
confirmed. Their work did, however, validate TGF-β-2 receptor (TGFBR2), commonly 
mutated in gastric and colon cancer (Myeroff et al., 1995), as a target of miR-20, and 
possibly also other members of this miRNA family (Volinia et al., 2006).  
Overexpression of lin28s in cancer was discussed in section 1.2.6, and although largely 




have not been investigation with reference to the cluster miRNAs above, lin28 
overexpression has similarly been reported in principal solid tumours for breast, non-small 
cell lung, prostate and colon cancer (Inamura et al., 2007; King et al., 2011; Nadiminty et 
al., 2012; Pan et al., 2011; Sakurai et al., 2012; Takamizawa et al., 2004). There is 
overwhelming evidence for the involvement of multiple of these cluster miRNAs in 
leukaemia development, including miR-19 and miR-106a, and there are new fields of work 
linking the lin28s to lymphoid development. With lin28b expressed in foetal HSCs and 
promoting lymphopoiesis (Yuan et al., 2012), and miR-125, a negative regulator of lin28, 
driving the opposing lineage of myeloid cells, and also being expressed in myeloid 
leukaemia (Chaudhuri et al., 2012), it appears possible that a misregulation in lin28b could 
therefore be linked to malignancies. Recent work in the mouse has demonstrated that an 
overexpression of lin28b in HSCs resulted in T-cell malignancies, including peripheral T-cell 
lymphoma (Beachy et al., 2012). The role of lin28 in blastomas has also not been heavily 
explored, but there is research linking the lin28s to neuroblastomas. lin28b has been 
shown to be expressed in some neuroblastoma samples, as a target of myc (Cotterman 
and Knoepfler, 2009), and interestingly, cultured neuroblastoma cells show cell cycle 
arrest when treated with retinoic acid, with increases in miR-125 suggesting that this 
miRNA is misregulated in neuroblastoma, which would allow increased lin28 (Laneve et al., 
2007). 
With both the lin28 proteins and the miR-17-92 clusters being implicated in a number of 
cancers, it is possible that co-expression of these proteins and miRNAs can contribute to 
oncogenic properties of cancers (Figure 8.2). Determining the extent and mechanism of 
any regulation between these may be key to aiding the ongoing understanding of cancer 
development and maintenance. Additionally, important cancer targets of the miRNAs have 
already been identified, as discussed above, and would be good markers to investigate 
following lin28 knockdown in embryos or cells, to see if these are indirect downstream 





Figure 8.2 Potential downstream targets and effects of lin28 
lin28 functions to repress let-7, and is required for expression of miR-17-92 and miR-106-363 
cluster miRNAs. These regulations may then lead to effects in both normal development and 
cancer. Known cancer targets of the miRNAs include PTEN, Bim, p21 and RB1, which may in 
this pathway be downstream of lin28. 
8.3 Future directions 
8.3.1 Functions of lin28a versus lin28b 
In order to avoid protein redundancy, knockdown of protein expression was carried out in 
combination of all three Xenopus lin28 proteins; however, it is possible that functions of 
these proteins clarified here may not be attributable to both lin28a and lin28b, or indeed 
the two lin28a isoforms. The difference in maternal expression between the genes is 
suggestive of different early developmental roles for the proteins. Knockdowns carried out 
with MOs to target either lin28a or lin28b should be analysed to see to what extent the 
functions identified here are lost; this may assist in determining lin28a and lin28b-specific 
roles. As lin28b is expressed maternally, the technique of maternal depletion should be 
investigated to fully understand the earliest functions of this protein. In this technique, the 
mRNA is targeted with antisense oligonucleotides pre-fertilisation and, when depleted, 
ensures that the protein is absent until transcription begins just prior to gastrulation 
(Wylie and Heasman, 1997). Any abnormalities arising as a result of maternal depletion of 
lin28b would provide an indication as to what role the protein is playing during the earliest 
stages of development. 
Interestingly, although work in Chapter 3 showed earlier expression of lin28b compared to 
lin28a, it is lin28a that has been documented to be strongly expressed in ES cells. This may 




activated in the mammalian embryo (Braude et al., 1988; Tesařík et al., 1986), and work 
here has demonstrated lin28a expression following activation of the zygotic 
transcriptome. Additionally, work in this thesis showed a wider spread of tissue types were 
expressing lin28b, and lin28a showed restrictions to cells consistent with previous work, 
such as to proliferative muscle tissue and pluripotent areas (Yang and Moss, 2003).There 
was a degree of overlap in expression, which may suggest some redundancy in function, 
but also different areas of expression, which highlights differences between the proteins. 
Intracellularly, there are further differences, with lin28a being predominantly cytoplasmic 
and lin28b showing nuclear and nucleolar localisation (Piskounova et al., 2011). The 
majority of studies investigating direct targets have also focused more heavily on lin28a, 
and have not clarified these targets as also being downstream of lin28b. A known function 
of both lin28a and lin28b is the repression of let-7 biogenesis, although they operate to 
control this in different ways (Viswanathan et al., 2008). 
A potential difference in binding affinity was shown in this work between lin28a and lin28b 
for pre-mir-363, which did not appear to exist for let-7, already known to be a target of 
both lin28a and lin28b. This might therefore be an indicator of a lin28a-specific, or lin28a-
preferred role. Further binding and processing assays, with the additional resource of a 
recombinant lin28b, would contribute to the understanding of this novel miRNA 
interaction. 
8.3.2 Conservation of regulatory pathway in humans 
The implications discussed for these findings will hold greater merit if this regulation of 
miRNAs by lin28 is shown to be conserved to humans.  
As this regulatory pathway was identified following a loss of lin28 protein, with less 
apparent results as a result of lin28 overexpression, it would therefore be most suitable to 
study this in human cell culture by the same methodology: investigating miRNA expression 
levels following a loss of the lin28s. This is supported by work in ES cells, where an 
overexpression of lin28a did not result in expression changes in miRNAs from the miR-17-
92 clusters, both in ES cells and multipotent cells (Balzer et al., 2010; Yuan et al., 2012), as 
we saw following overexpression in Xenopus in Chapter 4.  
There has been, though, one study which carried out a knockdown of lin28a in mouse ES 
cells and a subsequent global miRNA analysis. This work only identified major changes in 
let-7 miRNAs, with no recognition of miRNAs decreased in expression as hypothesised for 




regulation is conserved in these cells, however it is possible that the levels of the cluster 
miRNAs were low in this study, or that changes did occur but not to a large degree of fold 
change, which is what the authors were examining. 
Work here has clarified that both ES cells and EC cells express not only the lin28a and 
lin28b genes, but also multiple members of the miR-17-92 and miR-106a-363 clusters. This 
makes them suitable models for investigating conservation of this pathway. One point to 
be noted is that lin28a may be required for ES cell survival and undifferentiated state, and 
thus a reduction in expression of this may render the cells incapacitated and not allow 
accurate analysis of downstream lin28 effects. The advantage of EC cells, however, is that 
they are not as sensitive to such requirements, and are more likely to survive the loss of 
any essential ES cell markers, and could provide the ideal model for investigating this 
potential regulatory pathway. These cell systems can be treated with siRNA or shRNA to 
reduce expression of the lin28s, allowing for subsequent analysis of miRNAs. These 
knockdowns can be carried out using transient transfections, or through the use of stable 
manipulations such as lentivirus.  
8.4 Conclusions 
In summary, work in this thesis has highlighted new regulatory relationships during 
development, both the regulation of lin28a and lin28b by FGF signalling, and the 
identification of miRNAs that may be positively regulated by the lin28s. This study is a first 
instance of a successful knockdown of both lin28a and lin28b in the vertebrate embryo, 
which has provided the opportunity for identification of downstream targets and 
functions, characterising the genes as important not only for pluripotency but also in 
driving differentiation. The potential for lin28 proteins to be involved in a previously 
undiscovered alternative mechanism for regulatory control over miRNAs expands the 
capabilities of these proteins, and their roles can begin to be investigated more broadly. 
The potential regulation of miR-17-92 and miR-106-363 cluster miRNAs by lin28 could have 




Chapter 9. Appendices 
Appendix 1 Putative miRNA expressed in stage 10.5 X. tropicalis embryos 
miRNA # arrays 
detected 
miRNA (cntd) # arrays 
detected 
miRNA (cntd) # arrays 
detected 
Xrt-miR-103 6/6 Xrt-miR-140 5* Xrt-miR-365 2 
Xrt-miR-106 6 Xrt-miR-181a 5* Xrt-miR-27b 2 
Xrt-miR-107 6 Xrt-miR-19a 5^ Xrt-miR-146b 2 
Xrt-miR-130a 6 Xrt-miR-148a 5^ Xtr-miR-128 2 
Xrt-miR-130b 6 Xrt-miR-130c 5^ Xtr-miR-148b 2 
Xrt-miR-15b 6 Xrt-miR-16a 4^ Xtr-miR-200b 2 
Xrt-miR-15c 6 Xrt-miR-222 4^ Xtr-miR-182* 1 
Xrt-miR-16b 6 Xrt-miR-30e 4^ Xtr-miR-489 1 
Xrt-miR-16c 6 Xrt-miR-367 4* Xtr-miR-10b 1 
Xrt-miR-17-5p 6 Xrt-miR-155 4 Xtr-miR-10c 1 
Xrt-miR-181b 6 Xrt-miR-429 4 Xtr-miR-135 1 
Xrt-miR-18a 6 Xrt-miR-17-3p 4 Xtr-miR-153 1 
Xrt-miR-18a* 6 Xrt-miR-126 4 Xtr-miR-184 1 
Xrt-miR-18b 6 Xrt-miR-218 3 Xtr-miR-189 1 
Xrt-miR-19b 6 Xrt-miR-124 3 Xtr-miR-22* 1 
Xrt-miR-202 6 Xrt-miR-23a 3 Xtr-miR-31b 1 
Xrt-miR-20a 6 Xrt-miR-15a 3 Xtr-miR-96 1 
Xrt-miR-20b 6 Xrt-miR-9b* 3 Xtr-miR-183 1 
Xrt-miR-214 6 Xrt-miR-142-5p 3 Xtr-miR-208 1 
Xrt-miR-22 6 Xrt-miR-30a-5p 3 Xtr-miR-20a* 1 
Xrt-miR-223 6 Xrt-miR-204 3 Xtr-miR-9a* 1 
Xrt-miR-23b 6 Xrt-miR-205a 3   
Xrt-miR-24a 6 Xrt-miR-129 3   
Xrt-miR-26 6 Xrt-miR-92b 3   
Xrt-miR-30b 6 Xrt-miR-31 2   
Xrt-miR-30c 6 Xrt-miR-181a-2* 2   
Xrt-miR-30d 6 Xrt-miR-133d 2   
Xrt-miR-363-3p 6 Xrt-miR-191 2   
Xrt-miR-363-5p 6 Xrt-miR-150 2   
Xrt-miR-427 6 Xrt-miR-206 2   
Xrt-miR-92a 6 Xrt-miR-451 2   
Xrt-miR-93a 6 Xrt-miR-202* 2   
Xrt-miR-93b 6 Xrt-miR-210 2   
List of miRNA detected above background  in arrays. Where less than 6, * indicates 




Appendix 2 Changes in expression for FGF targets in X. laevis 
Gene Fold Change 
Egr1 -12.4 
Purine phosphorylase (PNP) -7.9 
Ephrin receptor A4 (EPHA4) -4.8 
Xiro3 (Irx3) -4.4 
P75-like fullback receptor (TNFRSF1B) -4.2 
Sprouty2 -3.1 
DUSP5 -3.0 
Chordin (CHRDL1) -2.8 
MKP1 (DUSP1) -2.7 
Gr10 interacting protein2 (GIGYF2) -2.1 
Connexin29 (GJB2) -2.1 
XIRG protein (IRG1) +13.5 
PDGF A Chain (PDGFA) +5.6 
Glucocorticoid inducible leucine zipper 
(TSC22D3) 
+4.1 
 Data from Branney et al (2009), following inhibition of FGF signalling. Human homologue gene 
name is given in brackets where different to Xenopus. +/- indicates up/downregulation of gene 




List of abbreviations 
  
(dp-)ERK (diphospho-)Extracellular regulated kinase 
AIB1 Nuclear receptor coactivator 3 
AP Alkaline phosphatase 
APS Ammonium persulfate 
BCIP 5-bromo-4-chloro-3'-indolyphosphate p-toluidine salt 
BLAST Basic local alignment search tool 
BMB Boehringer Mannheim blocking reagent 
BMP Bone morphogenetic protein 
bp Base pairs 
BSA Bovine serum albumin 
cDNA Complementary DNA 
CHAPS 3-[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate 
CIAP Calf intenstinal alkaline phosphatase 
DAG Diacylglycerol 
DGCR8 DiGeorge syndrome critical region 8 
DIG digoxigenin 
DMEM Dulbecco’s Modified Eagle's Medium 
DMF Dimethylformamide 
dnFGFR Dominant negative fibroblast growth factor receptor 
dNTPs 2’-deoxynucleoside 5’’-triphosphates 
dsRNA Double stranded RNA 
DTT Dithiothreitol 
EBs Embryoid bodies 
EC Embryonal carcinoma (cell) 
EDC 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide 
EDTA Ethylenediaminetetraacetic acid 
EMSA Electrophoretic mobility shift assay 
ES Embryonic stem (cell) 
Exp5 Exportin 5 protein 
FBS Foetal bovine serum 
FGF(R) Fibroblast growth factor (receptor) 
FRS2 FGFR substrate 2 
hCG Human chorionic gonadotrophin 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
HRP Horseradish peroxidase 
HSC Haematopoietic stem cell 
HSPGs heparan sulphate proteoglycans 
HTLS Heat treated lamb serum 




IGF Insulin-like growth factor 
IP3 Inositol-1,4,5-triphosphate 
iPS Induced pluripotent stem (cell) 
kDa kiloDalton 
KSRP KH-type splicing regulatory protein KSRP 
LB Liquid broth 
LIF Leukaemia inhibitory factor 
lincRNA Long intergenic non-coding RNA 
MAB(T) Maleic acid buffer (with 0.01% Tween-20) 
MAPK Mitogen-activated protein kinase 
MBT Midblastula transition 
MEFs Mouse embryonic fibroblasts 
Mesp1 Mesoderm posterior 1 
miRNA microRNA 
MO(s) Anti-sense morpholino(s) 
MOPS 3-(N-morpholino)propanesulfonic acid 
mRNA Messenger RNA 
MRS Modified Ringer's saline 
MSC Mesenchymal stem cell 
NAM Normal amphibian medium 
NBT Nitro-blue tetrazolium chloride 




PBS (T) Phosphate buffered saline (with 0.01% Tween-20) 
PCR Polymerase chain reaction 
PFA Paraformaldehyde 
piRNA Piwi interacting RNA 
PI3K Phosphoinositide-3 kinase 
PKC Protein kinase C 
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INTRODUCTION
The RNA-binding protein LIN-28 was originally identified in
Caenorhabditis elegans as a regulator of timing during development
(Ambros and Horvitz, 1984; Moss et al., 1997). Lin28 family
proteins contain a unique combination of both zinc knuckle and cold
shock RNA-binding domains that has been conserved during
evolution, and Lin28 proteins are present in a wide range of animal
groups (Moss and Tang, 2003).
There is considerable interest in the function of Lin28 proteins as
regulators of pluripotency in stem cells. LIN28A is expressed at
high levels in proliferative, pluripotent embryonic stem (ES) cells,
but is downregulated during human and murine ES cell
differentiation (Darr and Benvenisty, 2008; Viswanathan et al.,
2008). Furthermore, LIN28A, in combination with NANOG, OCT4
and SOX2, can reprogram somatic cells to a pluripotent ES cell
phenotype (Yu et al., 2007). Lin28 proteins are involved in post-
transcriptional regulation via direct association with target mRNAs
(Polesskaya et al., 2007; Xu and Huang, 2009; Qiu et al., 2010; Jin
et al., 2011; Peng et al., 2011; Lei et al., 2012) and recent studies
show their role in negatively regulating the biogenesis of mature
let-7 family miRNAs (Heo et al., 2008; Piskounova et al., 2008;
Viswanathan et al., 2008; Hagan et al., 2009; Nam et al., 2011). let-
7 miRNA expression levels generally correlate with the
differentiated state of cells, and low let-7 expression has been linked
with poor prognosis in several cancer types (Boyerinas et al., 2010).
A prevailing model suggests that the balance between the levels of
Lin28 proteins and let-7 miRNAs is important for the self-renewal
and differentiation of ES cells (Viswanathan and Daley, 2010).
However, a recent study indicates that LIN28A is not required for
the self-renewal of ES cells (Darr and Benvenisty, 2008). At present,
the exact role of Lin28 proteins in stem cell regulation is unclear.
Genome-wide association studies have also implicated Lin28
genes as regulators of growth and timing of developmental events
in humans (Lettre et al., 2008; Hartge, 2009; Viswanathan and
Daley, 2010). Analysis of LIN28A-overexpressing mice indicates
that these roles are conserved in other vertebrate species (Zhu et al.,
2010). However, most of the evidence available at present is focused
on processes in later development, and the role of Lin28 proteins in
early development, at the time when the main body is established,
remains elusive.
Here, we investigate the function of lin28a and lin28b in the early
development of the amphibian Xenopus, a well-established model
for understanding the role of growth factors in regulating lineage
restriction during vertebrate development. We show that lin28a and
lin28b have overlapping, but distinct, expression profiles. Notably,
lin28b protein is present maternally in the early embryo, whereas
lin28a protein is only present after the activation of the zygotic
genome at the mid-blastula transition (MBT). lin28a and lin28b are
expressed in the pluripotent cells of the animal hemisphere and are
enriched in the cells of the early mesoderm. Our data suggest a role
for fibroblast growth factors (FGFs) in regulating the expression of
lin28 genes within the mesoderm.
In addition, individual and compound knockdowns of the three
Xenopus lin28 proteins lead to dramatic inhibition of dorsal
development that is characterised by greatly reduced development
of axial and paraxial mesoderm. We show that knockdown of lin28
function in pluripotent cells of the early embryo compromises their
ability to respond appropriately to mesoderm-inducing growth
factors. Furthermore, lin28 knockdown leads to shifts in the
temporal expression profiles of a number of key genes involved in
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SUMMARY
Lin28 family proteins share a unique structure, with both zinc knuckle and cold shock RNA-binding domains, and were originally
identified as regulators of developmental timing in Caenorhabditis elegans. They have since been implicated as regulators of
pluripotency in mammalian stem cells in culture. Using Xenopus tropicalis, we have undertaken the first analysis of the effects on the
early development of a vertebrate embryo resulting from global inhibition of the Lin28 family. The Xenopus genome contains two
Lin28-related genes, lin28a and lin28b. lin28a is expressed zygotically, whereas lin28b is expressed both zygotically and maternally.
Both lin28a and lin28b are expressed in pluripotent cells of the Xenopus embryo and are enriched in cells that respond to mesoderm-
inducing signals. The development of axial and paraxial mesoderm is severely abnormal in lin28 knockdown (morphant) embryos. In
culture, the ability of pluripotent cells from the embryo to respond to the FGF and activin/nodal-like mesoderm-inducing pathways
is compromised following inhibition of lin28 function. Furthermore, there are complex effects on the temporal regulation of, and
the responses to, mesoderm-inducing signals in lin28 morphant embryos. We provide evidence that Xenopus lin28 proteins play a key
role in choreographing the responses of pluripotent cells in the early embryo to the signals that regulate germ layer specification,
and that this early function is probably independent of the recognised role of Lin28 proteins in negatively regulating let-7 miRNA
biogenesis.
KEY WORDS: lin28a, lin28b, Xenopus, Mesoderm, miRNA, let-7, Pluripotency, Germ layer, FGF, Activin, Nodal
Lin28 proteins are required for germ layer specification 
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mesoderm specification. This represents the first evidence that
Lin28 family genes play a key role in regulating the timing of, and
responses to, growth factor signalling in the early development of
a vertebrate embryo.
A key finding of this study is that, although amphibian lin28
proteins exhibit let-7 miRNA-binding activity, no significant effects
on the abundance of let-7a, let-7f and let-7g miRNAs are detected
in lin28 knockdown embryos, at the stage when germ layer
specification occurs. Our data indicate that the requirement for lin28
function in the initial specification of the mesoderm is likely to be
independent of its role in let-7 family biogenesis. By contrast, lin28
function seems to be required to regulate let-7 levels at later stages,
after germ layer specification, indicating differential roles for lin28




X. tropicalis embryos were produced as previously described (Khokha et
al., 2005; Winterbottom et al., 2010). Embryos were injected at the 2- or 4-
cell stage and cultured at 22°C. Animal cap explants were dissected at
Nieuwkoop and Faber (NF) stage 8 (Nieuwkoop and Faber, 1994) and
treated with 10 U/ml recombinant FGF4 protein (Isaacs et al., 1992) or 5
U/ml recombinant murine activin (Sigma).
mRNAs
mRNA was synthesised as described previously (Branney et al., 2009). The
dominant-negative X. laevis FGFR4a (dnFGFR4) plasmid was a gift from
Harumasa Okamoto (Hongo et al., 1999). Constructs coding for C-terminal
HA epitope-tagged lin28 proteins were generated by PCR using reverse
primers including a sequence coding for the YPYDVPDYA peptide.
Subclones of the coding region of each lin28 isoform lacking both 5 and
3 UTRs were generated by PCR.
Morpholino antisense oligonucleotides (MOs)
MOs were synthesized by Gene Tools. Standard control MO, 5-
CCTCCTACCTCAGTTACAATTTATA-3; lin28a1 MO, 5-GGTCTGCC -
TTGAAGTTGTCCCAGCT-3; lin28a2 MO, 5-GAGTCTCTTCTA-
TCTGAGGTCAGGC-3; lin28b MO, 5-TCCTTCGGCCATGATGCC -
TCCTGCT-3.
miRNA duplexes
The let-7 duplex and mutant let-7 duplex sequences injected have been
reported previously (Kloosterman et al., 2004).
In situ hybridisation
DIG-labelled probes were synthesized using DIG Labeling Mix (Roche
Diagnostics). In situ hybridisation was performed as previously described
(Harland, 1991; Reece-Hoyes et al., 2002).
Western blots
Western blots were carried out as described previously (Winterbottom et
al., 2010). Affinity-purified X. tropicalis anti-lin28 antisera were produced
by Enzo Life Sciences (Exeter, UK) in rabbits by inoculation of peptides
corresponding to the C-terminal sequences of X. tropicalis lin28a1/a2
(EEQPISEEQELIPETME) or lin28b (SRKGPSVQKRKKT) proteins.
Antibody dilutions were as follows: anti-lin28a and anti-lin28b, 1:1000;
anti-HA (Sigma), 1:5000; anti-ERK1/2 (Sigma), 1:100,000; anti-dpERK
(Sigma), 1:4000; anti-p-Smad2 (Millipore), 1:1000; anti-GAPDH (Santa
Cruz), 1:2000; anti-mouse POD (Amersham Biosciences), 1:5000; anti-
rabbit POD (Amersham Biosciences), 1:10,000. POD detection was carried
out using the BM Chemiluminescence Blotting Substrate (Roche) and ECL
Hyperfilm (Amersham).
Immunofluorescence
Cryosectioned embryos were processed for immunohistochemistry as
described (Roth et al., 2010), with the following modifications: prior to
sectioning, embryos fixed in MEMFA for 1 hour at room temperature were
transferred to 15% fish gelatine/15% sucrose for 16 hours followed by a
second 16-hour incubation in 25% fish gelatine/15% sucrose. Embryos
were then sectioned at 15 µm. Lin28a and lin28b rabbit polyclonal
antibodies were used at 1:200. Goat anti-rabbit Alexa Fluor 488
(Invitrogen, A11034) was used at 1:250. Once processed, slides were
mounted in Vectashield mounting medium with DAPI (Vector Labs, H-
1200). Peptide competition assays were carried out using the relevant
epitope peptides at 1 µg/ml for 45 minutes at room temperature.
Fluorescence was imaged on a Zeiss LSM 710 confocal microscope
mounted on an Axio Observer.Z1 inverted stage.
Quantitative PCR (Q-PCR) for mRNA expression
Total RNA was isolated using TRI Reagent (Sigma). cDNA was synthesised
using SuperScript II reverse transcriptase and oligo(dT) primers
(Invitrogen). Q-PCR reactions were carried out in triplicate on an ABI Prism
7300 detection system (Applied Biosystems) using SYBR Green I PCR
Master Mix (Applied Biosystems). Relative expression levels of each gene
were calculated using the 2–ΔΔCt method (Livak and Schmittgen, 2001) and
normalised to ornithine decarboxylase (ODC).
Q-PCR for miRNA expression
Total RNA was isolated using miRVana miRNA Isolation Kit (Applied
Biosystems). cDNA was synthesized with miRNA-specific primers for
TaqMan assays (Applied Biosystems) using the TaqMan MicroRNA
Reverse Transcription Kit (Applied Biosystems). Q-PCR reactions were
carried out in quadruplicate using TaqMan Universal Master Mix II
(Applied Biosystems) with TaqMan miRNA probes (Applied Biosystems).
miRNA expression levels were normalised to U6.
RNA electrophoretic mobility shift assay (EMSA)
RNA oligonucleotides (2 µM) were labelled using the KinaseMax Kit
(Applied Biosystems). Binding reactions were performed at room
temperature in 10 μl total volume (Piskounova et al., 2008), with 0.5 μl
labelled probe and diluted embryo extract in lysis buffer comprising 50 mM
Tris pH8, 25% glycerol, 50 mM KCl, 2 mM DTT, 0.1 mM EDTA and
Proteinase Inhibitor Cocktail III (Calbiochem). Binding buffer comprised 60
mM KCl, 10 mM HEPES pH 7.6, 3 mM MgCl2, 5% glycerol, 1 mM DTT,
5 μg/μl heparin and 150 ng yeast tRNA/reaction. Twenty units of RNasin
(Promega) were added per binding reaction with embryo lysates. Binding
reactions were resolved on 8-10% polyacrylamide native gels. Supershifts
were carried out using a 1:20 dilution of custom lin28a or lin28b antiserum
(Enzo Life Sciences), or the corresponding pre-immune bleed (serum
control) per binding reaction. Antiserum was pre-incubated with the protein
sample and binding buffer for 20 minutes on ice, before labelled probe was
added for 20 minutes at room temperature. The sequence of the let-7g
terminal loop is: 5-UUUGAGGGUCUAUGAUACCACCCGGUAC -
AGGAGAU-3.
RESULTS
Identification of X. tropicalis lin28a and lin28b
A previous study showed that a lin28a orthologue is present in
Xenopus laevis (Moss and Tang, 2003). Analysis of Lin28 family
cDNAs in the closely related diploid species X. tropicalis identified
one lin28b orthologue and two sequences closely related to lin28a.
Alignments of the X. tropicalis lin28a and lin28b protein sequences
are shown in supplementary material Fig. S1A. Analysis of the
lin28a genomic locus indicates that the two lin28a-related
sequences, which we have designated lin28a1 and lin28a2, result
from alternative splicing of two small exons coding for different N-
termini (supplementary material Fig. S1B).
Expression of X. tropicalis lin28a and lin28b
Previous studies showed that Lin28a mRNA and protein are
expressed widely in all three germ layers during early development
of mouse and chicken (Yang and Moss, 2003; Yokoyama et al., 2008).











Transcription of lin28a begins shortly after the MBT (Fig. 1A); before
the MBT there is only a low level of maternally deposited lin28a
mRNA present. The level of lin28b mRNA also begins to rise after the
MBT, but in contrast to lin28a there is a relatively high level of
maternal lin28b mRNA. In keeping with these data, western blot
analyses show that low levels of lin28a protein are detected just after
the MBT at blastula stage 9+. By the start of gastrulation at stage 10,
the level of lin28a protein has risen significantly, and continues to rise
through the gastrula stages (Fig. 1B). Maternally deposited lin28b is
detected in pre-MBT stage embryos and protein levels remain
constant through late blastula and gastrula stages.
Analysis of lin28 mRNA localisation reveals that maternal lin28b
mRNA is enriched in the animal hemisphere relative to the vegetal
hemisphere (Fig. 1I,J). Animal localisation of lin28b persists in the
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deep sensorial layer of the presumptive ectoderm into blastula stages
(Fig. 1K,L). The initial zygotic expression of lin28a and lin28b is
enriched in the presumptive mesoderm of the circumblastoporal
region of the embryo (Fig. 1C,E,M). Both genes show a marked
dorsal to ventral expression gradient within the mesoderm
(Fig. 1C,D,M,N). Expression of both genes persists in the deep
sensorial cell layer of the animal hemisphere during gastrula stages
(Fig. 1F,G,O).
By the end of gastrulation lin28a is expressed around the closed
blastopore, with dorsal expression in the ectoderm extending further
toward the anterior of the embryo than on the ventral side (Fig. 1H).
lin28b expression is localised to the dorsal side of the embryo and
is enriched at both the anterior and posterior ends of the neural plate
(Fig. 1P).
Fig. 1. Expression of lin28a and lin28b in the X. tropicalis embryo. (A,B) Temporal expression profiles of lin28a and lin28b mRNA (A) and protein (B) in
early cleavage to late gastrula stage embryos as assessed by Q-PCR and western blot, respectively. (C-P) Spatial expression of lin28a (C-H) and lin28b (I-P)
as assessed by in situ hybridisation. (C,E,M) Vegetal view; (D,F,H,K,N) transverse sections, lateral view; (G,L,O) higher magnification of F, K and N,
respectively; (J) vegetal view of I. Stages are indicated: stage 8, mid-blastula; stage 10 to 10.5, early gastrula; stage 12.5 to 13, late gastrula. dbl, dorsal
blastopore lip; vbl, ventral blastopore lip; es, ectodermal superficial layer; bs, basal sensorial layer. (Q-V) Fluorescence microscopy of cryosections from
the circumblastoporal region of early gastrula stage 10.5 embryos. (Q) Immunolocalisation of lin28a expression. Red arrows indicate nuclear enrichment.
(R) Nuclear DAPI staining in same section as Q. (S) Merge of Q and R. (T) Immunolocalisation of lin28b expression. (U) Nuclear DAPI staining in same
section as T. (V) Merge of T and U. (W) Expression levels of lin28a, lin28b and the ubiquitously expressed housekeeping gene ornithine decarboxylase
(ODC) in dnFGR4-injected embryos as compared with control embryos by Q-PCR. Solid line represents mRNA levels in corresponding control embryos











Differential subcellular localisation of lin28a and
lin28b proteins
It has recently been shown that mammalian Lin28a and Lin28b
localise to different subcellular compartments and that this
differential localisation in part accounts for the dissimilar modes of
action of the two proteins; Lin28a protein is found mainly in the
cytoplasm whereas Lin28b is highly enriched in the nucleus of cells
in culture (Piskounova et al., 2011). We investigated whether
amphibian lin28 proteins are also differentially localised within the
cells of the early embryo. Immunofluorescence shows that lin28a
and lin28b are localised in cells of the circumblastoporal region of
the Xenopus embryo at the start of gastrulation (Fig. 1Q-V).
Moreover, control experiments indicate that the observed
immunofluorescence is specific for each of the proteins; the
immunoreactivity can be effectively competed out by the relevant
peptide immunogens (supplementary material Fig. S2).
Lin28a immunoreactivity is present throughout the cytoplasm of
most cells and is also commonly seen in bright cytoplasmic puncta
(Fig. 1Q-S). However, lin28a protein does not appear to be excluded
from the nucleus, and in some cells (red arrows, Fig. 1Q)
immunoreactivity is enriched in the nucleus. By contrast,
immunoreactivity for lin28b is enriched in the nuclei of most
expressing cells, but is also found at lower levels in the cytoplasm
(Fig. 1T-V). We note that the bright, punctate, cytoplasmic
fluorescence observed with lin28a is less common with lin28b.
FGF signalling and the regulation of lin28
expression
Our previous study showed that X. laevis lin28a is downregulated
in response to global inhibition of FGF signalling (Branney et al.,
2009), highlighting lin28a as a component of a putative FGF-
regulated pathway operating during the process of germ layer
specification. Here we show that the levels of both lin28a and lin28b
mRNAs are significantly downregulated in X. tropicalis gastrula
stage embryos in response to FGF inhibition with a dominant-
negative FGF receptor (Fig. 1W), indicating that FGF signalling is
required for normal lin28 expression during Xenopus development.
Furthermore, our observation that lin28 expression is enriched in
the early mesoderm is in keeping with a role for FGF in regulating
normal lin28 expression because the early mesoderm represents a
key domain of FGF activity in the early embryo (Christen and Slack,
1999; Branney et al., 2009).
Effects of lin28a and lin28b inhibition
To gain insight into lin28 function during development, we
investigated the effects of overexpressing or knocking down lin28
proteins in the early embryo. Injection of up to 1 ng of synthetic
lin28a or lin28b mRNAs has no gross phenotypic effects on the
development of X. tropicalis embryos (data not shown). By contrast,
single or compound knockdowns of lin28a1, lin28a2 and lin28b
proteins using translation-blocking MOs produce a spectrum of
phenotypic effects ranging from mild inhibition of dorso-anterior
development, including loss of eyes and head structures, to a severe
shortening of the dorsal axis (Fig. 2A,B; supplementary material
Fig. S3A,C-F). The highest proportion of severe phenotypes is
observed in the lin28a1, lin28a2 + lin28b (all lin28 MOs) compound
knockdown embryos (Fig. 2B). Lin28 MOs used in this study
effectively inhibit the translation of epitope-tagged lin28 proteins
encoded by synthetic mRNAs containing the respective MO target
sequences (supplementary material Fig. S3B), as well as the
endogenous lin28a and lin28b proteins (Fig. 2C,D). Moreover, the
observed effects are specific, as the phenotypic effects of lin28
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knockdown are rescued by co-injection of non-targetable lin28
mRNAs (supplementary material Fig. S3A,C-I).
Histological analysis of lin28 compound knockdown (morphant)
embryos shows that the organisation of tissues in the dorsal axis is
disturbed compared with controls (Fig. 2E,G), and that these effects
are not restricted to a single germ layer. Thus, the patterning of the
ectodermally derived brain and neural tube is highly abnormal in
morphants (Fig. 2E,F), and, in keeping with the observed inhibited
axial elongation, notochord and skeletal muscle tissue is reduced,
indicating that the development of the dorsal axial and
paraxial/somitic mesoderm is also abnormal (Fig. 2E-H).
Lin28 and the expression of genes in the early
mesoderm
Given the observed effects of lin28 knockdown on the
differentiation and patterning of mesodermal structures at larval
stages, we were interested to see whether these late effects might
result from prior effects on lin28 function in the early mesoderm,
which, as discussed, is a site of zygotic lin28a and lin28b
expression. Effects on the levels of a number of key genes expressed
in, and required for, the specification of the mesoderm were
analysed in lin28 morphant embryos at early gastrula stages.
Xenopus brachyury (Xbra) is a T-box transcription factor that is
widely expressed in the early mesoderm (Smith et al., 1991). Chordin
is a secreted BMP inhibitor expressed in the presumptive dorsal axial
mesoderm (Sasai et al., 1994; Holley et al., 1995). MyoD is a bHLH
transcription factor expressed in the myogenic lineage within the
paraxial mesoderm from early gastrula stages (Hopwood et al., 1992).
In situ hybridisation analysis shows that the levels of expression and
size of the expression domains of the Xbra, chordin and myoD genes
are greatly reduced in lin28 morphants (Fig. 3A). By contrast, no
effects on the expression domain of the early endoderm marker
Sox17b are observed in morphants (Fig. 3A).
Further quantitative analysis of gene expression levels in
morphant embryos reveals significant inhibition of several genes
expressed in the very early mesoderm, ranging from a 35%
reduction for mesogenin to 80% reduction for Tbox6 (Fig. 3B).
Lin28 knockdown alters the response of
pluripotent cells to mesoderm-inducing signals
The FGF pathway is required for the normal development of the
vertebrate mesoderm (Dorey and Amaya, 2010; Pownall and Isaacs,
2010). Our observation that lin28 expression is reduced in response
to FGF inhibition and that lin28 genes are expressed in tissues that
respond to FGF prompted us to investigate the effects of lin28
knockdown on FGF-mediated mesoderm induction.
The cells of the amphibian animal hemisphere constitute a
pluripotent stem cell population that, upon exposure to appropriate
growth factor signals, can be induced to form all three germ layers
(De Robertis, 2006; Heasman, 2006). Blastula stage explants of
animal hemisphere cells, known as animal caps, cultured in isolation
differentiate as masses of atypical epidermis. However, when
cultured in the presence of FGF these same cells respond by
differentiating as a range of mesodermal tissue types (Slack et al.,
1987; Isaacs, 1997). Fig. 4A shows control animal caps after 3 days
in culture with or without FGF4 protein. The untreated control
animal caps typically form rounded masses of tissue, which
histology reveals as consisting of unlayered, atypical epidermis
(Fig. 4B). By contrast, culture in the presence of FGF induces the
formation of fluid-filled vesicles that are surrounded by epidermis
but contain a range of mesodermal tissues, including mesenchyme











experiment is undertaken with animal caps from lin28 morphant
embryos, the appearance of explant cultures in isolation is broadly
unchanged. However, lin28 knockdown greatly inhibits the
formation of fluid-filled vesicles and the differentiation of
mesoderm following culture in the presence of FGF (Fig. 4A,B),
indicating that lin28 function is required for animal caps to respond
appropriately to FGF signalling.
Current models suggest that FGFs are not the primary signals for
mesoderm specification in amphibians, but are secondary signals
produced in the nascent mesoderm in response to the primary
signals, such as nodal and activin (Isaacs et al., 1994; Schulte-
Merker and Smith, 1995; Isaacs, 1997). We therefore investigated
whether lin28 knockdown also interferes with the ability of activin
to induce mesoderm and gastrulation-like elongation in animal cap
explants. Similarly, we found that lin28 knockdown blocks the
elongation of animal hemisphere explants and the differentiation of
mesoderm induced by activin (Fig. 4C,D).
Thus far, we have shown that lin28 knockdown inhibits the ability
of pluripotent cells from the embryo to differentiate into mesoderm in
response to growth factor signals and that the expression levels of
genes activated by these signals are reduced in lin28 morphant
embryos in vivo, when germ layer specification is occurring. We next
investigated whether lin28 knockdown interferes with ERK/MAP
kinase phosphorylation, which is a characteristic, direct response to
FGF signalling (Umbhauer et al., 1995; Christen and Slack, 1999;
Branney et al., 2009). Fig. 4E is a western blot showing that activin
or FGF treatment of animal cap explants upregulates the levels of
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ERK phosphorylation at early gastrula stages. However, ERK
phosphorylation in response to FGF is reduced following lin28
knockdown, indicating that lin28 function is involved in the very
earliest responses of pluripotent cells to FGF signalling.
Activin treatment of animal cap explants also induces ERK
phosphorylation. Strikingly, lin28 knockdown greatly reduces ERK
phosphorylation in response to activin. In contrast to ERK activation
by FGF signalling, ERK phosphorylation in response to activin is a
secondary, indirect response, requiring the downstream activation of
transcription from FGF ligand-encoding genes (Schulte-Merker and
Smith, 1995). As mentioned above, a pathway that involves primary
mesoderm inducers, such as nodal/activin, activating the
transcription of FGFs, including FGF4 and FGF8 as secondary
mesoderm inducers/maintenance factors, is believed to operate
during mesoderm formation in vivo. We investigated whether lin28
function is necessary for the normal activation of transcription of
the endogenous FGF4 and FGF8 genes in vivo. The expression
levels of FGF4 and FGF8 are significantly reduced in lin28
morphant embryos at early gastrula stages (Fig. 4F).
Heterochronic effects of lin28 inhibition during
early amphibian development
lin-28 was originally identified as a heterochronic gene in C.
elegans. lin-28 mutations lead to the aberrant, precocious activation
of later developmental events (Ambros and Horvitz, 1984; Moss et
al., 1997). We examined whether the inhibition of lin28 function in
Xenopus also leads to the misregulation of developmental events in
Fig. 2. Phenotype of lin28 morphants. (A-D) Range of
axis defects in X. tropicalis lin28 morphants, from
unaffected (‘normal’) to open blastopore. (B) Percentage of
phenotypes in lin28a1, lin28a2, lin28b and all lin28 (i.e.
in28a1 + lin28a2 + lin28b) morphant embryos. (C,D)
Depletion of lin28a (C) and lin28b (D) proteins in lin28
(lin28a1 + lin28a2 + lin28b) morphant embryos as
assessed by western blot at stage 20. GAPDH, loading
control. (E-H) Histology on sagittal (E,F) and transverse
(G,H) sections of lin28 morphants (F,H) and controls (E,G).
fb, forebrain; ge, gut endoderm; nt, neural tube; ntc,











the early amphibian embryo. To this end, we investigated the timing
of activation of gene transcription and growth factor signalling in
the early embryo during the process of germ layer specification.
Fig. 5 represents a developmental timecourse of gene expression
in synchronously developing, sibling control and lin28 morphant
embryos cultured at 27°C, with time points set at 30-minute
intervals. This timecourse encompasses the pre-MBT to early
gastrula stage of development, with the latter time points
corresponding to the stages at which our analyses detect aberrant
mesodermal gene expression in lin28 morphants. Transcription from
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nodal-related 5 (nr5) and nr6 is upregulated rapidly in control
embryos following the MBT at mid-blastula stage 8. The
upregulation of nr1 expression in normal development is a slightly
delayed response, relative to nr5 and nr6. At the time resolution
provided by our experiments, we see no evidence of precocious nr5
or nr6 transcription in response to lin28 knockdown; however, the
expression of these genes at stage 8 is significantly higher in
morphants (Fig. 5B,C). Subsequently, the shapes of the expression
profiles from control and morphant embryos for nr5 and nr6 are
very similar; however, the profiles in morphants are shifted to the
Fig. 3. Effect of lin28 knockdown on mesodermal gene
expression. (A) Expression of brachyury, chordin, myoD and
sox17b in control and lin28 morphant X. tropicalis embryos
assessed by in situ hybridisation at gastrula stage 10.5. 
(B) Expression of the indicated mesodermal markers in lin28
morphants relative to expression in control embryos as
assessed by Q-PCR at stage 10.5. *P<0.05, **P<0.005 (Student’s
t-test), for morphant expression compared with control
expression. ODC is a ubiquitously expressed housekeeping
gene. Error bars indicate s.d.
Fig. 4. Effect of lin28 knockdown on FGF and activin/nodal
signalling. (A,C) Animal cap explants from control and lin28
morphant X. tropicalis embryos, with or without FGF (A) or
activin (C) treatment. (B,D) Histology on sections of animal caps
from A and C, respectively. ae, atypical epidermis; bl, blood; mes,
mesenchyme; ms, muscle. (E) Western blots showing dpERK
expression levels in animal cap explants from control and lin28
morphant embryos, with or without activin or FGF treatment.
GAPDH, loading control. (F) Expression levels of FGF4 and FGF8
in lin28 morphants at stage 10.5 relative to controls as assessed
by Q-PCR. Solid line represents mRNA levels in corresponding
control embryos (set at 1). **P<0.005 (Student’s t-test), for













left. Thus, peak levels of nr5 and nr6 are reached earlier and the dip
in expression levels, which is detected at the start of gastrulation in
controls, occurs somewhat earlier in lin28 morphants. A similar
shifted expression profile is also seen with nr1, with initial
expression levels higher in morphants and the peak expression level
being achieved earlier (Fig. 5A).
Smad2 is a key intracellular effector that is rapidly
phosphorylated and activated in response to activin/nodal signalling
(Baker and Harland, 1996; Bourillot et al., 2002; ten Dijke and Hill,
2004). The developmental timecourse of phospho-Smad2 (p-
Smad2) levels was analysed and, in keeping with the expression
profiles of the nodal-related genes, the initial level of p-Smad2 is
higher and the reduction of p-Smad2 levels at early to mid-gastrula
stages occurs somewhat earlier in morphants than in controls.
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A similar timecourse analysis was also undertaken with the FGF
ligand genes FGF4 and FGF8, and with Xbra, which is activated as
an immediate early response to both FGF and activin signalling.
Again, the initial expression of all three genes is significantly
elevated in morphants relative to control siblings (Fig. 6A-C), as
are levels of activated ERK (Fig. 6D). However, in keeping with
our previous results we find that gene expression levels are
significantly reduced by early to mid-gastrula stages in lin28
morphant embryos.
let-7 miRNAs in Xenopus development
Recent evidence suggests that Lin28 proteins regulate the
pluripotent state in stem cells in vitro through the negative
regulation of let-7 miRNA biogenesis (Viswanathan et al., 2008;
Fig. 5. Effects on the temporal regulation of nodal-related pathway
components in lin28 morphants. (A-C) Temporal expression profiles of
nr1 (A), nr5 (B) and nr6 (C) from NF blastula stage 7+ to gastrula stage 11
as assessed by Q-PCR in control and lin28 morphant X. tropicalis embryos.
Relative expression levels were calculated as the proportion of the
maximum expression level in controls (set at 1) and fold change values
are expressed relative to controls (set at 1). *P<0.05 (Student’s t-test), for
morphant compared with control expression. (D) Western blot showing
the expression levels of p-Smad2 at the NF stages analysed above.
GAPDH, loading control. Error bars indicate s.d.
Fig. 6. Effects on the temporal regulation of FGF pathway
components in lin28 morphants. (A-C) Temporal expression profiles of
FGF4 (A), FGF8 (B) and Xbra (C) from NF blastula stage 7+ to gastrula stage
11 as assessed by Q-PCR in control and lin28 morphant X. tropicalis
embryos. Relative expression levels and fold change values were
calculated as in Fig. 5. *P<0.05 (Student’s t-test), for morphant compared
with control expression. (D) Western blot showing the expression levels












Hagan et al., 2009; West et al., 2009). We examined whether the
observed developmental effects in lin28 morphants correlate with
altered let-7 expression levels. Fig. 7A shows the expression profiles
in early Xenopus development of the mature forms of let-7a, let-7f
and let-7g, which are regulated by Lin28 in mammalian cell culture
(Viswanathan et al., 2008; Heo et al., 2009). We note that cycle
threshold values (Cts) for all three let-7 miRNAs are relatively high,
indicating that these miRNAs are present at low levels during early
Xenopus development (data not shown).
Lin28 binding to the terminal loop region of immature let-7
miRNAs is crucial for regulating biogenesis of the mature miRNAs
(Piskounova et al., 2008; Heo et al., 2009; Lightfoot et al., 2011).
Cell lysates from Xenopus embryos overexpressing lin28a1, lin28a2
or lin28b mRNAs contain activities that are able to bind to the
terminal loop of let-7g (Fig. 7B-D). Moreover, we confirm that the
binding activities correspond to the overexpressed lin28 proteins by
showing that the addition of a relevant anti-lin28 antibody is able to
supershift each riboprotein complex.
These data indicate that let-7 miRNAs are potential regulatory
targets of lin28 proteins during amphibian development and it is
possible that elevated levels of mature let-7 miRNAs contribute to
the phenotype arising from lin28 knockdown. Indeed,
overexpression of mature let-7a leads to a phenotype characterised
by ventral bending of the main body axis, whereas overexpression
of a mutant let-7 has less of an effect on axial development
(supplementary material Fig. S4A,B). However, the phenotypic
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effects of let-7 overexpression are different from those produced by
lin28 knockdown (compare with Fig. 2A).
We next analysed the levels of mature let-7a, let-7f and let-7g
miRNAs in lin28 compound knockdown embryos (Fig. 7E).
Surprisingly, we found no significant changes in the overall levels
of let-7 miRNAs in lin28 morphant embryos at early gastrula stage
10.5. This is the stage when our analyses indicate that changes in
mesodermal gene expression are already apparent in lin28
morphants. Therefore, the observed effects from lin28 knockdown
on early mesoderm specification are unlikely to be mediated
through a lin28/let-7 regulatory pathway. By contrast, by early
tailbud stage 22, the overall level of let-7g is significantly higher in
lin28 morphants compared with control embryos, indicating a role
for lin28 proteins in regulating the biogenesis of at least some let-7
miRNAs during later development.
DISCUSSION
A model for lin28 function during germ layer
specification
lin28 genes are expressed in pluripotent cells of the amphibian
embryo. We propose that lin28 function is required in order for the
pluripotent cells of the amphibian embryo to respond appropriately
to mesoderm-inducing growth factors.
During amphibian development, both lin28a and lin28b are
regulated by the FGF signalling pathway. In addition, knockdown
of lin28 function inhibits the ability of pluripotent embryonic cells
Fig. 7. let-7 in Xenopus development.
(A) Q-PCR analysis of let-7a, let-7f and let-
7g expression from stage 9 to stage 22.
Expression is calibrated to stage 22 for
each gene. (B-D) RNA EMSA supershifts
showing let-7g terminal loop RNA-
binding activity of dilutions of protein
extracted from Xenopus embryos
overexpressing lin28a1 (B), lin28a2 (C) or
lin28b (D) proteins. Lane 1, labelled let-7g
terminal loop alone; lanes 2 and 3, let-7g
plus 1:4 and 1:8 dilutions of control
embryo lysate, respectively; lanes 4 and 5,
let-7g plus 1:4 and 1:8 dilutions,
respectively, of lysate from lin28-
overexpressing embryos; lane 6, let-7g
plus 1:4 dilution of control embryo plus
relevant lin28 antibody; lane 7, let-7g plus
1:4 dilution of control embryo lysate plus
relevant pre-immune serum; lane 8, let-7g
plus 1:4 dilution of lin28-overexpressing
embryo lysate plus relevant lin28
antibody; lanes 9, let-7g plus 1:4 dilution
of lin28-overexpressing embryo lysate
plus relevant pre-immune serum. (E) Q-
PCR analysis of relative expression of let-7
miRNAs in lin28 morphants compared
with control embryos at stage 10.5 and
22. Solid line represents miRNA levels in
corresponding control embryos (set at 1).
*P<0.05 (Student’s t-test), for morphant













to differentiate into mesoderm in response to FGF signals.
Knockdown of lin28 function also compromises the ability of
embryonic cells to respond to the mesoderm-inducing activity of
activin, a TGFβ superfamily member that mimics the activity of
endogenous mesoderm-inducing factors, such as nodal-related
proteins. Furthermore, lin28 function is required for the appropriate
early expression of FGF and nodal-related genes. Taken together,
our data support a model in which lin28 genes are components of
the regulatory pathway involved in the specification and patterning
of the amphibian mesoderm, modulating responses both upstream
and downstream of FGF signalling.
Transcriptional regulation of lin28 genes
Current understanding of the transcriptional regulation of
vertebrate Lin28 genes is limited. Our data suggest a role for FGF
signalling in regulating the expression of Xenopus lin28 genes.
However, unlike some other known transcriptional targets of FGF
signalling in amphibian development, such as brachyury,
inhibiting FGF signalling does not completely block the
expression of Xenopus lin28a or lin28b (Amaya et al., 1993). This
suggests that additional pathways are likely to contribute to the
transcriptional regulation of lin28 genes in the amphibian embryo.
We note that during the preparation of this manuscript it was
reported that expression of Lin28b is regulated by FGF in the
developing chick embryo (Bobbs et al., 2012), suggesting that an
FGF-Lin28 regulatory axis might be a conserved feature of
vertebrate embryo development.
Lin28 regulation of timing in early amphibian
development
Lin28 knockdown leads to precocious elevation and subsequent
precocious reduction in signalling by both the FGF and nodal
pathways, indicating that lin28 function is involved in regulating
the timing of signalling events in the early amphibian embryo.
Recent evidence suggests that amphibian ventx transcription factors,
which have Nanog-like activity, are also involved in regulating the
timing of cell commitment to specific lineages in Xenopus (Scerbo
et al., 2012). Both Lin28 and Nanog-related factors are implicated
in the maintenance of the pluripotent state in mammalian stem cells.
We propose that, similarly to ventx, lin28 participates in regulating
the timing of responses to signalling pathways involved in cell
lineage restriction in early amphibian embryogenesis.
lin-28 was originally identified as a heterochronic gene that
encodes a factor promoting early developmental fates in C. elegans
(Ambros and Horvitz, 1984; Moss et al., 1997). Subsequent
evidence indicating that Lin28 proteins are involved in regulating
the pluripotent state of mammalian stem cells in culture has further
supported their role as factors promoting early stem cell phenotypes
versus later differentiated cell fates (reviewed by Viswanathan and
Daley, 2010). Our data provide the first evidence that Lin28 genes
are involved in regulating the timing of events in the early
development of a vertebrate embryo, as opposed to stem cells in
culture.
However, the role of lin28 in mesoderm development appears to
be complex; although lin28 knockdown leads to precocious
elevation of pathways involved in mesoderm specification,
subsequent patterning and differentiation of the mesoderm are
impaired. Thus, amphibian lin28 genes appear to function as
developmental ‘gatekeepers’ involved in regulating the transition
from the pluripotent to mesodermal cell fate. Evidence indicates
that this might represent a conserved function of Lin28 genes, as it
has recently been shown that Lin28a knockdown inhibits
RESEARCH ARTICLE Development 140 (5)
mesodermal gene expression during murine ES cell differentiation
(Wang et al., 2012).
The proposed gatekeeper role of Lin28 proteins provides an
intriguing link with the recently demonstrated function of FGFs as
regulators of the transition from the pluripotent state to lineage
restriction in ES cells. FGF signalling is required to allow ES cells
to respond appropriately to signals involved in specifying particular
lineages, including the mesoderm (Kunath et al., 2007). It will be
interesting to determine whether an FGF-Lin28 axis, similar to that
proposed in this study, operates in mammalian ES cells in culture.
let-7-independent function of lin28
Much recent work has focussed on Lin28 proteins as negative
regulators of let-7 miRNA biogenesis. Although this is undoubtedly
a key feature of Lin28 function, in some situations there is
increasing evidence that Lin28 proteins have other, let-7-
independent functions. A recent study indicates that LIN28A can
function independently of regulating let-7 abundance during the
differentiation of P19 embryonal carcinoma cells (Balzer et al.,
2010). Furthermore, during C. elegans development LIN-28 has
been shown to act through a two-step mechanism involving an
initial let-7-independent phase and subsequent let-7-dependent
phase (Vadla et al., 2012).
Our data also suggest early let-7-independent and later let-7-
dependent roles for lin28 during amphibian development. It has
been proposed that the initial let-7-independent function in C.
elegans involves LIN-28 directly interacting with, and promoting
translation from, target mRNAs (Vadla et al., 2012). There is
increasing evidence that such direct, miRNA-independent
regulation of mRNA translation by Lin28 proteins is a key element
of their function, and a wide range of mRNA targets have been
identified (Polesskaya et al., 2007; Xu and Huang, 2009; Qiu et al.,
2010; Jin et al., 2011; Peng et al., 2011; Lei et al., 2012). We
speculate that lin28 function during early amphibian development
might similarly involve direct regulation of mRNA translation. This
would seem particularly relevant to lin28b, which is present before
the onset of zygotic transcription and is therefore a potential
regulator during a phase of development that is critically dependent
upon the translational regulation of maternally deposited mRNAs.
In this regard, we note that Y-box proteins, which like lin28 contain
a cold shock domain, are involved in translational control during
the maternal phase of Xenopus development (Bouvet and Wolffe,
1994; Matsumoto and Wolffe, 1998). At present, the target mRNAs
with which lin28 proteins might interact during early amphibian
development remain to be identified.
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